2018-05-28 12:28:33,059:INFO: Disease Protein Prediction in the PPI Network
2018-05-28 12:28:33,059:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-28 12:28:33,059:INFO: ======================================
2018-05-28 12:28:33,059:INFO: Loading PPI Network...
2018-05-28 12:30:30,758:INFO: Disease Protein Prediction in the PPI Network
2018-05-28 12:30:30,758:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-28 12:30:30,758:INFO: ======================================
2018-05-28 12:30:30,759:INFO: Loading PPI Network...
2018-05-28 12:30:43,454:INFO: Loading Disease Associations...
2018-05-28 12:30:43,462:INFO: Loading PPI Matrix...
2018-05-28 12:30:51,879:INFO: Running Experiment...
2018-05-28 12:30:51,879:INFO: Experiment Progress: 0.0% -- 0/1
2018-05-28 12:31:59,865:INFO: Disease Protein Prediction in the PPI Network
2018-05-28 12:31:59,866:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-28 12:31:59,866:INFO: ======================================
2018-05-28 12:31:59,866:INFO: Loading PPI Network...
2018-05-28 12:32:12,351:INFO: Loading Disease Associations...
2018-05-28 12:32:12,358:INFO: Loading PPI Matrix...
2018-05-28 12:32:19,440:INFO: Running Experiment...
2018-05-28 12:32:19,441:INFO: Experiment Progress: 0.0% -- 0/1
2018-05-28 12:32:20,178:INFO: Neuroendocrine Tumors Recall-at-100: 30.00%
2018-05-28 12:34:01,534:INFO: Disease Protein Prediction in the PPI Network
2018-05-28 12:34:01,534:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-28 12:34:01,534:INFO: ======================================
2018-05-28 12:34:01,535:INFO: Loading PPI Network...
2018-05-28 12:34:18,327:INFO: Loading Disease Associations...
2018-05-28 12:34:18,333:INFO: Loading PPI Matrix...
2018-05-28 12:34:23,033:INFO: Running Experiment...
2018-05-28 12:34:23,034:INFO: Experiment Progress: 0.0% -- 0/1
2018-05-28 12:34:23,866:INFO: Neuroendocrine Tumors Recall-at-100: 30.00%
2018-05-28 12:41:51,266:INFO: Disease Protein Prediction in the PPI Network
2018-05-28 12:41:51,266:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-28 12:41:51,266:INFO: ======================================
2018-05-28 12:41:51,266:INFO: Loading PPI Network...
2018-05-28 12:42:12,348:INFO: Loading Disease Associations...
2018-05-28 12:42:12,404:INFO: Loading PPI Matrix...
2018-05-28 12:42:21,622:INFO: Running Experiment...
2018-05-28 12:42:21,624:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-28 12:42:23,301:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 40.00%
2018-05-28 12:42:23,302:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-28 12:42:24,861:INFO: Psychoses, Substance-Induced Recall-at-100: 5.00%
2018-05-28 12:42:24,861:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-28 12:42:25,622:INFO: Zellweger Syndrome Recall-at-100: 100.00%
2018-05-28 12:42:25,622:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-28 12:42:28,646:INFO: Psoriasis Recall-at-100: 12.38%
2018-05-28 12:42:28,647:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-28 12:42:29,226:INFO: Nephrotic Syndrome Recall-at-100: 18.33%
2018-05-28 12:42:29,227:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-28 12:42:29,807:INFO: Nephrosis Recall-at-100: 20.00%
2018-05-28 12:42:29,807:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-28 12:42:30,369:INFO: Mouth Diseases Recall-at-100: 20.00%
2018-05-28 12:42:30,369:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-28 12:42:31,359:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 86.67%
2018-05-28 12:42:31,359:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-28 12:42:33,344:INFO: Substance-Related Disorders Recall-at-100: 2.91%
2018-05-28 12:42:33,344:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-28 12:42:33,803:INFO: Anemia, Hemolytic Recall-at-100: 25.00%
2018-05-28 12:42:33,803:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-28 12:42:36,619:INFO: Rheumatoid Arthritis Recall-at-100: 2.84%
2018-05-28 12:42:36,619:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-28 12:42:37,082:INFO: Arthritis, Psoriatic Recall-at-100: 10.00%
2018-05-28 12:42:37,082:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-28 12:42:37,667:INFO: Anemia Recall-at-100: 3.33%
2018-05-28 12:42:37,667:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-28 12:42:38,234:INFO: Cholangiocarcinoma Recall-at-100: 16.67%
2018-05-28 12:42:38,234:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-28 12:42:38,650:INFO: Neuroendocrine Tumors Recall-at-100: 30.00%
2018-05-28 12:42:38,650:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-28 12:42:39,177:INFO: Malaria Recall-at-100: 5.00%
2018-05-28 12:42:39,178:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-28 12:42:39,612:INFO: Hyperhomocysteinemia Recall-at-100: 15.00%
2018-05-28 12:42:39,612:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-28 12:42:41,053:INFO: HIV Infections Recall-at-100: 19.00%
2018-05-28 12:42:41,053:INFO: Experiment Progress: 3.0% -- 18/519
2018-05-28 12:42:41,564:INFO: Ankylosing spondylitis Recall-at-100: 20.00%
2018-05-28 12:42:41,564:INFO: Experiment Progress: 3.0% -- 19/519
2018-05-28 12:42:43,061:INFO: Adenoid Cystic Carcinoma Recall-at-100: 9.11%
2018-05-28 12:42:43,061:INFO: Experiment Progress: 3.0% -- 20/519
2018-05-28 12:42:44,854:INFO: Juvenile arthritis Recall-at-100: 5.00%
2018-05-28 12:42:44,855:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-28 12:42:45,584:INFO: Neoplasms, Experimental Recall-at-100: 12.50%
2018-05-28 12:42:45,584:INFO: Experiment Progress: 4.0% -- 22/519
2018-05-28 12:42:46,067:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 20.00%
2018-05-28 12:42:46,067:INFO: Experiment Progress: 4.0% -- 23/519
2018-05-28 12:42:46,444:INFO: Alopecia Areata Recall-at-100: 33.33%
2018-05-28 12:42:46,444:INFO: Experiment Progress: 4.0% -- 24/519
2018-05-28 12:42:46,958:INFO: Alopecia Recall-at-100: 5.00%
2018-05-28 12:42:46,958:INFO: Experiment Progress: 4.0% -- 25/519
2018-05-28 12:42:47,554:INFO: Bradycardia Recall-at-100: 50.00%
2018-05-28 12:42:47,554:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-28 12:42:48,084:INFO: Common Variable Immunodeficiency Recall-at-100: 65.00%
2018-05-28 12:42:48,084:INFO: Experiment Progress: 5.0% -- 27/519
2018-05-28 12:42:48,707:INFO: Glomerulonephritis Recall-at-100: 31.67%
2018-05-28 12:42:48,708:INFO: Experiment Progress: 5.0% -- 28/519
2018-05-28 12:42:49,448:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 0.00%
2018-05-28 12:42:49,449:INFO: Experiment Progress: 5.0% -- 29/519
2018-05-28 12:42:50,116:INFO: Lung Injury Recall-at-100: 30.00%
2018-05-28 12:42:50,117:INFO: Experiment Progress: 5.0% -- 30/519
2018-05-28 12:42:50,737:INFO: Hypercalcemia Recall-at-100: 20.00%
2018-05-28 12:42:50,737:INFO: Experiment Progress: 5.0% -- 31/519
2018-05-28 12:42:51,712:INFO: Cerebrovascular accident Recall-at-100: 22.50%
2018-05-28 12:42:51,713:INFO: Experiment Progress: 6.0% -- 32/519
2018-05-28 12:42:52,682:INFO: Diaphragmatic Hernia Recall-at-100: 15.00%
2018-05-28 12:42:52,682:INFO: Experiment Progress: 6.0% -- 33/519
2018-05-28 12:42:53,257:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 30.00%
2018-05-28 12:42:53,257:INFO: Experiment Progress: 6.0% -- 34/519
2018-05-28 12:42:53,951:INFO: Migraine Disorders Recall-at-100: 0.00%
2018-05-28 12:42:53,951:INFO: Experiment Progress: 6.0% -- 35/519
2018-05-28 12:42:54,179:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-05-28 12:42:54,179:INFO: Experiment Progress: 6.0% -- 36/519
2018-05-28 12:42:54,700:INFO: Brugada Syndrome (disorder) Recall-at-100: 15.00%
2018-05-28 12:42:54,700:INFO: Experiment Progress: 7.0% -- 37/519
2018-05-28 12:42:55,172:INFO: Pathological accumulation of air in tissues Recall-at-100: 30.00%
2018-05-28 12:42:55,172:INFO: Experiment Progress: 7.0% -- 38/519
2018-05-28 12:42:55,691:INFO: Craniosynostosis Recall-at-100: 15.00%
2018-05-28 12:42:55,691:INFO: Experiment Progress: 7.0% -- 39/519
2018-05-28 12:42:56,388:INFO: Head and Neck Neoplasms Recall-at-100: 13.33%
2018-05-28 12:42:56,388:INFO: Experiment Progress: 7.0% -- 40/519
2018-05-28 12:42:57,009:INFO: Brain Neoplasms Recall-at-100: 18.33%
2018-05-28 12:42:57,009:INFO: Experiment Progress: 7.0% -- 41/519
2018-05-28 12:42:57,621:INFO: Hearing Loss, Partial Recall-at-100: 0.00%
2018-05-28 12:42:57,622:INFO: Experiment Progress: 8.0% -- 42/519
2018-05-28 12:42:58,153:INFO: Chromosome Aberrations Recall-at-100: 10.00%
2018-05-28 12:42:58,154:INFO: Experiment Progress: 8.0% -- 43/519
2018-05-28 12:42:59,047:INFO: Chronic Lymphocytic Leukemia Recall-at-100: 8.00%
2018-05-28 12:42:59,047:INFO: Experiment Progress: 8.0% -- 44/519
2018-05-28 12:42:59,540:INFO: Refractive Errors Recall-at-100: 0.00%
2018-05-28 12:42:59,540:INFO: Experiment Progress: 8.0% -- 45/519
2018-05-28 12:42:59,978:INFO: Hepatitis C Recall-at-100: 10.00%
2018-05-28 12:42:59,978:INFO: Experiment Progress: 8.0% -- 46/519
2018-05-28 12:43:01,199:INFO: Mesothelioma Recall-at-100: 5.00%
2018-05-28 12:43:01,200:INFO: Experiment Progress: 9.0% -- 47/519
2018-05-28 12:43:01,483:INFO: Noise-induced hearing loss Recall-at-100: 20.00%
2018-05-28 12:43:01,483:INFO: Experiment Progress: 9.0% -- 48/519
2018-05-28 12:43:02,246:INFO: Inflammatory dermatosis Recall-at-100: 0.00%
2018-05-28 12:43:02,246:INFO: Experiment Progress: 9.0% -- 49/519
2018-05-28 12:43:02,757:INFO: Kallmann Syndrome Recall-at-100: 15.00%
2018-05-28 12:43:02,758:INFO: Experiment Progress: 9.0% -- 50/519
2018-05-28 12:43:03,274:INFO: Lipoidosis Recall-at-100: 10.00%
2018-05-28 12:43:03,274:INFO: Experiment Progress: 9.0% -- 51/519
2018-05-28 12:43:03,898:INFO: Diabetes Mellitus Recall-at-100: 3.33%
2018-05-28 12:43:03,898:INFO: Experiment Progress: 10.0% -- 52/519
2018-05-28 12:43:04,678:INFO: Fibrosis Recall-at-100: 20.00%
2018-05-28 12:43:04,678:INFO: Experiment Progress: 10.0% -- 53/519
2018-05-28 12:43:05,206:INFO: Hypercholesterolemia Recall-at-100: 5.00%
2018-05-28 12:43:05,206:INFO: Experiment Progress: 10.0% -- 54/519
2018-05-28 12:43:05,762:INFO: Microcephaly Recall-at-100: 15.00%
2018-05-28 12:43:05,762:INFO: Experiment Progress: 10.0% -- 55/519
2018-05-28 12:43:06,131:INFO: Tongue Neoplasms Recall-at-100: 0.00%
2018-05-28 12:43:06,131:INFO: Experiment Progress: 10.0% -- 56/519
2018-05-28 12:43:06,567:INFO: Common Migraine Recall-at-100: 0.00%
2018-05-28 12:43:06,567:INFO: Experiment Progress: 10.0% -- 57/519
2018-05-28 12:43:07,005:INFO: Carotid Artery Diseases Recall-at-100: 0.00%
2018-05-28 12:43:07,005:INFO: Experiment Progress: 11.0% -- 58/519
2018-05-28 12:43:07,651:INFO: Growth Disorders Recall-at-100: 2.50%
2018-05-28 12:43:07,651:INFO: Experiment Progress: 11.0% -- 59/519
2018-05-28 12:43:08,004:INFO: Absence Epilepsy Recall-at-100: 22.22%
2018-05-28 12:43:08,004:INFO: Experiment Progress: 11.0% -- 60/519
2018-05-28 12:43:08,567:INFO: Epilepsy, Temporal Lobe Recall-at-100: 45.00%
2018-05-28 12:43:08,567:INFO: Experiment Progress: 11.0% -- 61/519
2018-05-28 12:43:09,282:INFO: Memory Disorders Recall-at-100: 7.50%
2018-05-28 12:43:09,282:INFO: Experiment Progress: 11.0% -- 62/519
2018-05-28 12:43:09,740:INFO: Catalepsy Recall-at-100: 45.00%
2018-05-28 12:43:09,740:INFO: Experiment Progress: 12.0% -- 63/519
2018-05-28 12:43:10,195:INFO: Hereditary Nonpolyposis Colorectal Cancer Recall-at-100: 35.00%
2018-05-28 12:43:10,195:INFO: Experiment Progress: 12.0% -- 64/519
2018-05-28 12:43:11,092:INFO: Acute Promyelocytic Leukemia Recall-at-100: 18.33%
2018-05-28 12:43:11,092:INFO: Experiment Progress: 12.0% -- 65/519
2018-05-28 12:43:11,652:INFO: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 10.00%
2018-05-28 12:43:11,652:INFO: Experiment Progress: 12.0% -- 66/519
2018-05-28 12:43:12,102:INFO: Gout Recall-at-100: 0.00%
2018-05-28 12:43:12,102:INFO: Experiment Progress: 12.0% -- 67/519
2018-05-28 12:43:13,564:INFO: Coronary Artery Disease Recall-at-100: 3.10%
2018-05-28 12:43:13,564:INFO: Experiment Progress: 13.0% -- 68/519
2018-05-28 12:43:14,195:INFO: Venous Thromboembolism Recall-at-100: 30.00%
2018-05-28 12:43:14,196:INFO: Experiment Progress: 13.0% -- 69/519
2018-05-28 12:43:15,208:INFO: Precancerous Conditions Recall-at-100: 8.81%
2018-05-28 12:43:15,208:INFO: Experiment Progress: 13.0% -- 70/519
2018-05-28 12:43:16,394:INFO: Crohn Disease Recall-at-100: 3.47%
2018-05-28 12:43:16,394:INFO: Experiment Progress: 13.0% -- 71/519
2018-05-28 12:43:16,924:INFO: Uterine Cervical Neoplasm Recall-at-100: 20.00%
2018-05-28 12:43:16,925:INFO: Experiment Progress: 13.0% -- 72/519
2018-05-28 12:43:17,366:INFO: Dyskinesia, Drug-Induced Recall-at-100: 20.00%
2018-05-28 12:43:17,366:INFO: Experiment Progress: 14.0% -- 73/519
2018-05-28 12:43:17,812:INFO: Ataxia, Spinocerebellar Recall-at-100: 30.00%
2018-05-28 12:43:17,812:INFO: Experiment Progress: 14.0% -- 74/519
2018-05-28 12:43:18,236:INFO: Optic Atrophy, Hereditary, Leber Recall-at-100: 70.00%
2018-05-28 12:43:18,236:INFO: Experiment Progress: 14.0% -- 75/519
2018-05-28 12:43:18,716:INFO: Liver Cirrhosis, Alcoholic Recall-at-100: 0.00%
2018-05-28 12:43:18,717:INFO: Experiment Progress: 14.0% -- 76/519
2018-05-28 12:43:19,173:INFO: Acute Lung Injury Recall-at-100: 5.00%
2018-05-28 12:43:19,173:INFO: Experiment Progress: 14.0% -- 77/519
2018-05-28 12:43:20,540:INFO: Liver Cirrhosis, Experimental Recall-at-100: 7.27%
2018-05-28 12:43:20,541:INFO: Experiment Progress: 15.0% -- 78/519
2018-05-28 12:43:21,161:INFO: Chloracne Recall-at-100: 11.67%
2018-05-28 12:43:21,161:INFO: Experiment Progress: 15.0% -- 79/519
2018-05-28 12:43:22,136:INFO: Liver diseases Recall-at-100: 1.43%
2018-05-28 12:43:22,136:INFO: Experiment Progress: 15.0% -- 80/519
2018-05-28 12:43:22,928:INFO: Kidney Failure, Chronic Recall-at-100: 13.50%
2018-05-28 12:43:22,929:INFO: Experiment Progress: 15.0% -- 81/519
2018-05-28 12:43:23,463:INFO: Weight decreased Recall-at-100: 0.00%
2018-05-28 12:43:23,464:INFO: Experiment Progress: 15.0% -- 82/519
2018-05-28 12:43:24,169:INFO: Leigh Disease Recall-at-100: 59.17%
2018-05-28 12:43:24,169:INFO: Experiment Progress: 15.0% -- 83/519
2018-05-28 12:43:24,913:INFO: Celiac Disease Recall-at-100: 15.00%
2018-05-28 12:43:24,913:INFO: Experiment Progress: 16.0% -- 84/519
2018-05-28 12:43:25,448:INFO: Glaucoma Recall-at-100: 0.00%
2018-05-28 12:43:25,449:INFO: Experiment Progress: 16.0% -- 85/519
2018-05-28 12:43:25,959:INFO: Tachycardia Recall-at-100: 40.00%
2018-05-28 12:43:25,959:INFO: Experiment Progress: 16.0% -- 86/519
2018-05-28 12:43:26,412:INFO: Breast Cancer, Familial Recall-at-100: 70.00%
2018-05-28 12:43:26,412:INFO: Experiment Progress: 16.0% -- 87/519
2018-05-28 12:43:27,022:INFO: Ischemia Recall-at-100: 11.67%
2018-05-28 12:43:27,022:INFO: Experiment Progress: 16.0% -- 88/519
2018-05-28 12:43:27,419:INFO: Adenomatous Polyposis Coli Recall-at-100: 0.00%
2018-05-28 12:43:27,419:INFO: Experiment Progress: 17.0% -- 89/519
2018-05-28 12:43:27,882:INFO: Thyroid Diseases Recall-at-100: 10.00%
2018-05-28 12:43:27,882:INFO: Experiment Progress: 17.0% -- 90/519
2018-05-28 12:43:28,197:INFO: Panic Disorder Recall-at-100: 0.00%
2018-05-28 12:43:28,197:INFO: Experiment Progress: 17.0% -- 91/519
2018-05-28 12:43:31,129:INFO: Colorectal Neoplasms Recall-at-100: 3.81%
2018-05-28 12:43:31,130:INFO: Experiment Progress: 17.0% -- 92/519
2018-05-28 12:43:31,679:INFO: Adrenal Gland Neoplasms Recall-at-100: 60.00%
2018-05-28 12:43:31,680:INFO: Experiment Progress: 17.0% -- 93/519
2018-05-28 12:43:32,383:INFO: Sudden infant death syndrome Recall-at-100: 25.00%
2018-05-28 12:43:32,384:INFO: Experiment Progress: 18.0% -- 94/519
2018-05-28 12:43:33,258:INFO: Neuroblastoma Recall-at-100: 9.00%
2018-05-28 12:43:33,258:INFO: Experiment Progress: 18.0% -- 95/519
2018-05-28 12:43:33,706:INFO: Prostate cancer, familial Recall-at-100: 15.00%
2018-05-28 12:43:33,706:INFO: Experiment Progress: 18.0% -- 96/519
2018-05-28 12:43:35,428:INFO: Animal Mammary Neoplasms Recall-at-100: 8.02%
2018-05-28 12:43:35,428:INFO: Experiment Progress: 18.0% -- 97/519
2018-05-28 12:43:35,880:INFO: Osteochondrodysplasias Recall-at-100: 30.00%
2018-05-28 12:43:35,881:INFO: Experiment Progress: 18.0% -- 98/519
2018-05-28 12:43:36,440:INFO: Hepatolenticular Degeneration Recall-at-100: 18.33%
2018-05-28 12:43:36,440:INFO: Experiment Progress: 19.0% -- 99/519
2018-05-28 12:43:36,929:INFO: Fanconi Anemia Recall-at-100: 70.00%
2018-05-28 12:43:36,930:INFO: Experiment Progress: 19.0% -- 100/519
2018-05-28 12:43:37,374:INFO: Eye Abnormalities Recall-at-100: 30.00%
2018-05-28 12:43:37,374:INFO: Experiment Progress: 19.0% -- 101/519
2018-05-28 12:43:37,844:INFO: Limb Deformities, Congenital Recall-at-100: 20.00%
2018-05-28 12:43:37,845:INFO: Experiment Progress: 19.0% -- 102/519
2018-05-28 12:43:38,223:INFO: Electrocardiogram: P-R interval Recall-at-100: 0.00%
2018-05-28 12:43:38,224:INFO: Experiment Progress: 19.0% -- 103/519
2018-05-28 12:43:40,214:INFO: Mammary Neoplasms, Experimental Recall-at-100: 5.96%
2018-05-28 12:43:40,214:INFO: Experiment Progress: 20.0% -- 104/519
2018-05-28 12:43:40,801:INFO: Heart valve disease Recall-at-100: 3.33%
2018-05-28 12:43:40,802:INFO: Experiment Progress: 20.0% -- 105/519
2018-05-28 12:43:41,566:INFO: Diffuse Large B-Cell Lymphoma Recall-at-100: 5.00%
2018-05-28 12:43:41,566:INFO: Experiment Progress: 20.0% -- 106/519
2018-05-28 12:43:42,121:INFO: Hepatitis Recall-at-100: 5.00%
2018-05-28 12:43:42,121:INFO: Experiment Progress: 20.0% -- 107/519
2018-05-28 12:43:42,554:INFO: Impaired glucose tolerance Recall-at-100: 15.00%
2018-05-28 12:43:42,555:INFO: Experiment Progress: 20.0% -- 108/519
2018-05-28 12:43:43,050:INFO: Mitochondrial Encephalomyopathies Recall-at-100: 25.00%
2018-05-28 12:43:43,050:INFO: Experiment Progress: 21.0% -- 109/519
2018-05-28 12:43:43,668:INFO: Colon Carcinoma Recall-at-100: 20.00%
2018-05-28 12:43:43,668:INFO: Experiment Progress: 21.0% -- 110/519
2018-05-28 12:43:44,130:INFO: Hepatic Encephalopathy Recall-at-100: 30.00%
2018-05-28 12:43:44,131:INFO: Experiment Progress: 21.0% -- 111/519
2018-05-28 12:43:45,485:INFO: Multiple Sclerosis Recall-at-100: 5.69%
2018-05-28 12:43:45,485:INFO: Experiment Progress: 21.0% -- 112/519
2018-05-28 12:43:45,950:INFO: Neurogenic Inflammation Recall-at-100: 20.00%
2018-05-28 12:43:45,951:INFO: Experiment Progress: 21.0% -- 113/519
2018-05-28 12:43:47,108:INFO: Lupus Erythematosus, Systemic Recall-at-100: 3.93%
2018-05-28 12:43:47,108:INFO: Experiment Progress: 21.0% -- 114/519
2018-05-28 12:43:47,544:INFO: Ceroid lipofuscinosis, neuronal 1, infantile Recall-at-100: 10.00%
2018-05-28 12:43:47,544:INFO: Experiment Progress: 22.0% -- 115/519
2018-05-28 12:43:48,363:INFO: Adenocarcinoma of lung (disorder) Recall-at-100: 7.00%
2018-05-28 12:43:48,363:INFO: Experiment Progress: 22.0% -- 116/519
2018-05-28 12:43:48,968:INFO: Charcot-Marie-Tooth Disease Recall-at-100: 5.00%
2018-05-28 12:43:48,968:INFO: Experiment Progress: 22.0% -- 117/519
2018-05-28 12:43:49,398:INFO: Osteogenesis imperfecta type III (disorder) Recall-at-100: 45.00%
2018-05-28 12:43:49,399:INFO: Experiment Progress: 22.0% -- 118/519
2018-05-28 12:43:49,807:INFO: Osteogenesis imperfecta type IV (disorder) Recall-at-100: 30.00%
2018-05-28 12:43:49,807:INFO: Experiment Progress: 22.0% -- 119/519
2018-05-28 12:43:50,267:INFO: Hepatitis, Autoimmune Recall-at-100: 30.00%
2018-05-28 12:43:50,268:INFO: Experiment Progress: 23.0% -- 120/519
2018-05-28 12:43:55,671:INFO: Prostatic Neoplasms Recall-at-100: 6.41%
2018-05-28 12:43:55,671:INFO: Experiment Progress: 23.0% -- 121/519
2018-05-28 12:43:56,300:INFO: NADH:Q(1) Oxidoreductase deficiency Recall-at-100: 85.00%
2018-05-28 12:43:56,300:INFO: Experiment Progress: 23.0% -- 122/519
2018-05-28 12:43:56,800:INFO: Hypospadias Recall-at-100: 0.00%
2018-05-28 12:43:56,800:INFO: Experiment Progress: 23.0% -- 123/519
2018-05-28 12:43:57,558:INFO: Multiple Myeloma Recall-at-100: 13.33%
2018-05-28 12:43:57,558:INFO: Experiment Progress: 23.0% -- 124/519
2018-05-28 12:43:58,383:INFO: Fatty Liver Recall-at-100: 8.00%
2018-05-28 12:43:58,383:INFO: Experiment Progress: 24.0% -- 125/519
2018-05-28 12:43:58,818:INFO: Leishmaniasis, Visceral Recall-at-100: 30.00%
2018-05-28 12:43:58,818:INFO: Experiment Progress: 24.0% -- 126/519
2018-05-28 12:43:59,315:INFO: Early infantile epileptic encephalopathy with suppression bursts Recall-at-100: 0.00%
2018-05-28 12:43:59,318:INFO: Experiment Progress: 24.0% -- 127/519
2018-05-28 12:43:59,859:INFO: Kartagener Syndrome Recall-at-100: 0.00%
2018-05-28 12:43:59,859:INFO: Experiment Progress: 24.0% -- 128/519
2018-05-28 12:44:00,289:INFO: Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse Recall-at-100: 45.00%
2018-05-28 12:44:00,292:INFO: Experiment Progress: 24.0% -- 129/519
2018-05-28 12:44:01,275:INFO: Bipolar Disorder Recall-at-100: 5.00%
2018-05-28 12:44:01,276:INFO: Experiment Progress: 25.0% -- 130/519
2018-05-28 12:44:01,662:INFO: Erectile dysfunction Recall-at-100: 30.00%
2018-05-28 12:44:01,662:INFO: Experiment Progress: 25.0% -- 131/519
2018-05-28 12:44:02,130:INFO: Meckel-Gruber syndrome Recall-at-100: 80.00%
2018-05-28 12:44:02,130:INFO: Experiment Progress: 25.0% -- 132/519
2018-05-28 12:44:03,666:INFO: Colonic Neoplasms Recall-at-100: 11.99%
2018-05-28 12:44:03,666:INFO: Experiment Progress: 25.0% -- 133/519
2018-05-28 12:44:06,214:INFO: Autistic Disorder Recall-at-100: 2.97%
2018-05-28 12:44:06,214:INFO: Experiment Progress: 25.0% -- 134/519
2018-05-28 12:44:07,069:INFO: Liver Neoplasms, Experimental Recall-at-100: 7.33%
2018-05-28 12:44:07,069:INFO: Experiment Progress: 26.0% -- 135/519
2018-05-28 12:44:07,564:INFO: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 5.00%
2018-05-28 12:44:07,564:INFO: Experiment Progress: 26.0% -- 136/519
2018-05-28 12:44:08,033:INFO: Narcolepsy Recall-at-100: 15.00%
2018-05-28 12:44:08,034:INFO: Experiment Progress: 26.0% -- 137/519
2018-05-28 12:44:08,527:INFO: Fever Recall-at-100: 10.00%
2018-05-28 12:44:08,528:INFO: Experiment Progress: 26.0% -- 138/519
2018-05-28 12:44:09,957:INFO: Adenocarcinoma Recall-at-100: 9.45%
2018-05-28 12:44:09,957:INFO: Experiment Progress: 26.0% -- 139/519
2018-05-28 12:44:10,409:INFO: Aortic Valve Insufficiency Recall-at-100: 70.00%
2018-05-28 12:44:10,409:INFO: Experiment Progress: 26.0% -- 140/519
2018-05-28 12:44:10,931:INFO: Carcinoma, Pancreatic Ductal Recall-at-100: 45.00%
2018-05-28 12:44:10,931:INFO: Experiment Progress: 27.0% -- 141/519
2018-05-28 12:44:11,522:INFO: Infarction, Middle Cerebral Artery Recall-at-100: 18.33%
2018-05-28 12:44:11,522:INFO: Experiment Progress: 27.0% -- 142/519
2018-05-28 12:44:13,750:INFO: Hypertensive disease Recall-at-100: 6.87%
2018-05-28 12:44:13,751:INFO: Experiment Progress: 27.0% -- 143/519
2018-05-28 12:44:14,267:INFO: Juvenile Myelomonocytic Leukemia Recall-at-100: 35.00%
2018-05-28 12:44:14,268:INFO: Experiment Progress: 27.0% -- 144/519
2018-05-28 12:44:14,770:INFO: Leprosy Recall-at-100: 0.00%
2018-05-28 12:44:14,771:INFO: Experiment Progress: 27.0% -- 145/519
2018-05-28 12:44:15,987:INFO: Myocardial Infarction Recall-at-100: 4.58%
2018-05-28 12:44:15,987:INFO: Experiment Progress: 28.0% -- 146/519
2018-05-28 12:44:16,469:INFO: Urticaria Recall-at-100: 10.00%
2018-05-28 12:44:16,469:INFO: Experiment Progress: 28.0% -- 147/519
2018-05-28 12:44:17,120:INFO: Cardiac Arrhythmia Recall-at-100: 10.00%
2018-05-28 12:44:17,120:INFO: Experiment Progress: 28.0% -- 148/519
2018-05-28 12:44:17,540:INFO: Hemochromatosis Recall-at-100: 50.00%
2018-05-28 12:44:17,540:INFO: Experiment Progress: 28.0% -- 149/519
2018-05-28 12:44:18,775:INFO: Pancreatic Neoplasm Recall-at-100: 16.25%
2018-05-28 12:44:18,775:INFO: Experiment Progress: 28.0% -- 150/519
2018-05-28 12:44:19,822:INFO: Cardiomyopathy, Dilated Recall-at-100: 22.00%
2018-05-28 12:44:19,822:INFO: Experiment Progress: 29.0% -- 151/519
2018-05-28 12:44:20,340:INFO: Papilloma Recall-at-100: 20.00%
2018-05-28 12:44:20,341:INFO: Experiment Progress: 29.0% -- 152/519
2018-05-28 12:44:21,235:INFO: Pain Recall-at-100: 16.50%
2018-05-28 12:44:21,235:INFO: Experiment Progress: 29.0% -- 153/519
2018-05-28 12:44:21,774:INFO: Congenital Abnormality Recall-at-100: 30.00%
2018-05-28 12:44:21,774:INFO: Experiment Progress: 29.0% -- 154/519
2018-05-28 12:44:22,304:INFO: MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) Recall-at-100: 40.00%
2018-05-28 12:44:22,305:INFO: Experiment Progress: 29.0% -- 155/519
2018-05-28 12:44:23,591:INFO: Kidney Diseases Recall-at-100: 1.11%
2018-05-28 12:44:23,591:INFO: Experiment Progress: 30.0% -- 156/519
2018-05-28 12:44:24,062:INFO: Lung Diseases, Interstitial Recall-at-100: 0.00%
2018-05-28 12:44:24,062:INFO: Experiment Progress: 30.0% -- 157/519
2018-05-28 12:44:24,760:INFO: Basal cell carcinoma Recall-at-100: 15.00%
2018-05-28 12:44:24,760:INFO: Experiment Progress: 30.0% -- 158/519
2018-05-28 12:44:27,788:INFO: Liver carcinoma Recall-at-100: 9.68%
2018-05-28 12:44:27,789:INFO: Experiment Progress: 30.0% -- 159/519
2018-05-28 12:44:28,253:INFO: gliosarcoma Recall-at-100: 25.00%
2018-05-28 12:44:28,253:INFO: Experiment Progress: 30.0% -- 160/519
2018-05-28 12:44:28,877:INFO: Acute Coronary Syndrome Recall-at-100: 22.50%
2018-05-28 12:44:28,877:INFO: Experiment Progress: 31.0% -- 161/519
2018-05-28 12:44:29,526:INFO: Ovarian Cysts Recall-at-100: 0.00%
2018-05-28 12:44:29,526:INFO: Experiment Progress: 31.0% -- 162/519
2018-05-28 12:44:30,010:INFO: Schizophrenia, Childhood Recall-at-100: 0.00%
2018-05-28 12:44:30,011:INFO: Experiment Progress: 31.0% -- 163/519
2018-05-28 12:44:30,521:INFO: Adrenocortical carcinoma Recall-at-100: 30.00%
2018-05-28 12:44:30,522:INFO: Experiment Progress: 31.0% -- 164/519
2018-05-28 12:44:33,293:INFO: Schizophrenia Recall-at-100: 2.10%
2018-05-28 12:44:33,293:INFO: Experiment Progress: 31.0% -- 165/519
2018-05-28 12:44:33,702:INFO: Atrophic Recall-at-100: 0.00%
2018-05-28 12:44:33,703:INFO: Experiment Progress: 31.0% -- 166/519
2018-05-28 12:44:34,153:INFO: Idiopathic Pulmonary Fibrosis Recall-at-100: 10.00%
2018-05-28 12:44:34,153:INFO: Experiment Progress: 32.0% -- 167/519
2018-05-28 12:44:34,574:INFO: Lobar Holoprosencephaly Recall-at-100: 25.00%
2018-05-28 12:44:34,575:INFO: Experiment Progress: 32.0% -- 168/519
2018-05-28 12:44:34,997:INFO: Alobar Holoprosencephaly Recall-at-100: 25.00%
2018-05-28 12:44:34,997:INFO: Experiment Progress: 32.0% -- 169/519
2018-05-28 12:44:35,430:INFO: Immunologic Deficiency Syndromes Recall-at-100: 40.00%
2018-05-28 12:44:35,430:INFO: Experiment Progress: 32.0% -- 170/519
2018-05-28 12:44:35,850:INFO: Ataxia Recall-at-100: 20.00%
2018-05-28 12:44:35,851:INFO: Experiment Progress: 32.0% -- 171/519
2018-05-28 12:44:36,291:INFO: Adenocarcinoma Of Esophagus Recall-at-100: 10.00%
2018-05-28 12:44:36,291:INFO: Experiment Progress: 33.0% -- 172/519
2018-05-28 12:44:37,297:INFO: Retinitis Pigmentosa Recall-at-100: 8.57%
2018-05-28 12:44:37,297:INFO: Experiment Progress: 33.0% -- 173/519
2018-05-28 12:44:38,501:INFO: Squamous cell carcinoma of esophagus Recall-at-100: 8.61%
2018-05-28 12:44:38,501:INFO: Experiment Progress: 33.0% -- 174/519
2018-05-28 12:44:39,178:INFO: Autoimmune Diseases Recall-at-100: 0.00%
2018-05-28 12:44:39,178:INFO: Experiment Progress: 33.0% -- 175/519
2018-05-28 12:44:39,546:INFO: Diarrhea Recall-at-100: 20.00%
2018-05-28 12:44:39,546:INFO: Experiment Progress: 33.0% -- 176/519
2018-05-28 12:44:41,694:INFO: Myocardial Ischemia Recall-at-100: 3.60%
2018-05-28 12:44:41,694:INFO: Experiment Progress: 34.0% -- 177/519
2018-05-28 12:44:42,119:INFO: Essential Hypertension Recall-at-100: 0.00%
2018-05-28 12:44:42,120:INFO: Experiment Progress: 34.0% -- 178/519
2018-05-28 12:44:42,455:INFO: Hepatomegaly Recall-at-100: 33.33%
2018-05-28 12:44:42,455:INFO: Experiment Progress: 34.0% -- 179/519
2018-05-28 12:44:43,045:INFO: Myopathy Recall-at-100: 0.00%
2018-05-28 12:44:43,046:INFO: Experiment Progress: 34.0% -- 180/519
2018-05-28 12:44:43,863:INFO: Adverse reaction to drug Recall-at-100: 10.67%
2018-05-28 12:44:43,863:INFO: Experiment Progress: 34.0% -- 181/519
2018-05-28 12:44:44,267:INFO: Myoclonic Epilepsies, Progressive Recall-at-100: 15.00%
2018-05-28 12:44:44,268:INFO: Experiment Progress: 35.0% -- 182/519
2018-05-28 12:44:44,692:INFO: Muscular Atrophy Recall-at-100: 15.00%
2018-05-28 12:44:44,692:INFO: Experiment Progress: 35.0% -- 183/519
2018-05-28 12:44:45,152:INFO: Basal Ganglia Diseases Recall-at-100: 20.00%
2018-05-28 12:44:45,152:INFO: Experiment Progress: 35.0% -- 184/519
2018-05-28 12:44:45,594:INFO: Hepatitis B Recall-at-100: 35.00%
2018-05-28 12:44:45,594:INFO: Experiment Progress: 35.0% -- 185/519
2018-05-28 12:44:46,489:INFO: Lung diseases Recall-at-100: 4.00%
2018-05-28 12:44:46,490:INFO: Experiment Progress: 35.0% -- 186/519
2018-05-28 12:44:47,246:INFO: Chronic Obstructive Airway Disease Recall-at-100: 5.00%
2018-05-28 12:44:47,246:INFO: Experiment Progress: 36.0% -- 187/519
2018-05-28 12:44:50,415:INFO: Peripheral Neuropathy Recall-at-100: 2.88%
2018-05-28 12:44:50,415:INFO: Experiment Progress: 36.0% -- 188/519
2018-05-28 12:44:51,712:INFO: Weight Gain Recall-at-100: 4.58%
2018-05-28 12:44:51,712:INFO: Experiment Progress: 36.0% -- 189/519
2018-05-28 12:44:52,362:INFO: Deafness Recall-at-100: 0.00%
2018-05-28 12:44:52,363:INFO: Experiment Progress: 36.0% -- 190/519
2018-05-28 12:44:52,776:INFO: Renal dysplasia and retinal aplasia (disorder) Recall-at-100: 50.00%
2018-05-28 12:44:52,776:INFO: Experiment Progress: 36.0% -- 191/519
2018-05-28 12:44:53,445:INFO: Attention deficit hyperactivity disorder Recall-at-100: 16.67%
2018-05-28 12:44:53,445:INFO: Experiment Progress: 36.0% -- 192/519
2018-05-28 12:44:53,906:INFO: Tetralogy of Fallot Recall-at-100: 45.00%
2018-05-28 12:44:53,906:INFO: Experiment Progress: 37.0% -- 193/519
2018-05-28 12:44:54,711:INFO: Neurodegenerative Disorders Recall-at-100: 15.00%
2018-05-28 12:44:54,712:INFO: Experiment Progress: 37.0% -- 194/519
2018-05-28 12:44:55,203:INFO: Barrett Esophagus Recall-at-100: 10.00%
2018-05-28 12:44:55,203:INFO: Experiment Progress: 37.0% -- 195/519
2018-05-28 12:44:57,298:INFO: Craniofacial Abnormalities Recall-at-100: 6.95%
2018-05-28 12:44:57,298:INFO: Experiment Progress: 37.0% -- 196/519
2018-05-28 12:44:57,789:INFO: Necrotizing Enterocolitis Recall-at-100: 30.00%
2018-05-28 12:44:57,790:INFO: Experiment Progress: 37.0% -- 197/519
2018-05-28 12:44:58,319:INFO: Hyperlipidemia Recall-at-100: 30.00%
2018-05-28 12:44:58,320:INFO: Experiment Progress: 38.0% -- 198/519
2018-05-28 12:44:58,939:INFO: MYELODYSPLASTIC SYNDROME Recall-at-100: 0.00%
2018-05-28 12:44:58,939:INFO: Experiment Progress: 38.0% -- 199/519
2018-05-28 12:44:59,689:INFO: Anoxia Recall-at-100: 2.50%
2018-05-28 12:44:59,689:INFO: Experiment Progress: 38.0% -- 200/519
2018-05-28 12:45:00,396:INFO: Small cell carcinoma of lung Recall-at-100: 15.00%
2018-05-28 12:45:00,396:INFO: Experiment Progress: 38.0% -- 201/519
2018-05-28 12:45:01,315:INFO: Epilepsy Recall-at-100: 7.86%
2018-05-28 12:45:01,315:INFO: Experiment Progress: 38.0% -- 202/519
2018-05-28 12:45:01,800:INFO: Liver Failure, Acute Recall-at-100: 21.67%
2018-05-28 12:45:01,800:INFO: Experiment Progress: 39.0% -- 203/519
2018-05-28 12:45:02,299:INFO: Micronuclei, Chromosome-Defective Recall-at-100: 10.00%
2018-05-28 12:45:02,299:INFO: Experiment Progress: 39.0% -- 204/519
2018-05-28 12:45:02,829:INFO: Cognition Disorders Recall-at-100: 5.00%
2018-05-28 12:45:02,829:INFO: Experiment Progress: 39.0% -- 205/519
2018-05-28 12:45:03,223:INFO: Tonic-Clonic Epilepsy Recall-at-100: 30.00%
2018-05-28 12:45:03,223:INFO: Experiment Progress: 39.0% -- 206/519
2018-05-28 12:45:04,078:INFO: Heart Diseases Recall-at-100: 7.00%
2018-05-28 12:45:04,078:INFO: Experiment Progress: 39.0% -- 207/519
2018-05-28 12:45:04,845:INFO: Adult T-Cell Lymphoma/Leukemia Recall-at-100: 13.33%
2018-05-28 12:45:04,845:INFO: Experiment Progress: 40.0% -- 208/519
2018-05-28 12:45:05,389:INFO: Primary biliary cirrhosis Recall-at-100: 30.00%
2018-05-28 12:45:05,389:INFO: Experiment Progress: 40.0% -- 209/519
2018-05-28 12:45:05,890:INFO: beta Thalassemia Recall-at-100: 20.00%
2018-05-28 12:45:05,890:INFO: Experiment Progress: 40.0% -- 210/519
2018-05-28 12:45:06,301:INFO: Marijuana Abuse Recall-at-100: 20.00%
2018-05-28 12:45:06,301:INFO: Experiment Progress: 40.0% -- 211/519
2018-05-28 12:45:06,820:INFO: Long QT Syndrome Recall-at-100: 60.00%
2018-05-28 12:45:06,820:INFO: Experiment Progress: 40.0% -- 212/519
2018-05-28 12:45:07,284:INFO: Burkitt Lymphoma Recall-at-100: 20.00%
2018-05-28 12:45:07,284:INFO: Experiment Progress: 41.0% -- 213/519
2018-05-28 12:45:07,653:INFO: TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) Recall-at-100: 30.00%
2018-05-28 12:45:07,653:INFO: Experiment Progress: 41.0% -- 214/519
2018-05-28 12:45:08,471:INFO: Insulin Resistance Recall-at-100: 14.50%
2018-05-28 12:45:08,472:INFO: Experiment Progress: 41.0% -- 215/519
2018-05-28 12:45:08,991:INFO: Left Ventricular Hypertrophy Recall-at-100: 26.67%
2018-05-28 12:45:08,992:INFO: Experiment Progress: 41.0% -- 216/519
2018-05-28 12:45:09,417:INFO: Bronchial Hyperreactivity Recall-at-100: 5.00%
2018-05-28 12:45:09,417:INFO: Experiment Progress: 41.0% -- 217/519
2018-05-28 12:45:10,381:INFO: AMYOTROPHIC LATERAL SCLEROSIS 1 Recall-at-100: 8.50%
2018-05-28 12:45:10,381:INFO: Experiment Progress: 42.0% -- 218/519
2018-05-28 12:45:10,759:INFO: Fetal Growth Retardation Recall-at-100: 10.00%
2018-05-28 12:45:10,760:INFO: Experiment Progress: 42.0% -- 219/519
2018-05-28 12:45:11,030:INFO: Holoprosencephaly Recall-at-100: 25.00%
2018-05-28 12:45:11,030:INFO: Experiment Progress: 42.0% -- 220/519
2018-05-28 12:45:11,714:INFO: Arthritis, Experimental Recall-at-100: 20.00%
2018-05-28 12:45:11,714:INFO: Experiment Progress: 42.0% -- 221/519
2018-05-28 12:45:12,359:INFO: Congenital Heart Defects Recall-at-100: 11.67%
2018-05-28 12:45:12,360:INFO: Experiment Progress: 42.0% -- 222/519
2018-05-28 12:45:12,741:INFO: Pseudohypoaldosteronism Recall-at-100: 66.67%
2018-05-28 12:45:12,741:INFO: Experiment Progress: 42.0% -- 223/519
2018-05-28 12:45:13,255:INFO: Cataract Recall-at-100: 31.67%
2018-05-28 12:45:13,255:INFO: Experiment Progress: 43.0% -- 224/519
2018-05-28 12:45:13,694:INFO: Giant Cell Glioblastoma Recall-at-100: 35.00%
2018-05-28 12:45:13,695:INFO: Experiment Progress: 43.0% -- 225/519
2018-05-28 12:45:14,220:INFO: Seizure Adverse Event Recall-at-100: 0.00%
2018-05-28 12:45:14,221:INFO: Experiment Progress: 43.0% -- 226/519
2018-05-28 12:45:14,776:INFO: Body Weight Recall-at-100: 0.00%
2018-05-28 12:45:14,776:INFO: Experiment Progress: 43.0% -- 227/519
2018-05-28 12:45:15,219:INFO: Huntington Disease Recall-at-100: 0.00%
2018-05-28 12:45:15,219:INFO: Experiment Progress: 43.0% -- 228/519
2018-05-28 12:45:16,280:INFO: Glioblastoma Recall-at-100: 11.43%
2018-05-28 12:45:16,281:INFO: Experiment Progress: 44.0% -- 229/519
2018-05-28 12:45:16,679:INFO: Congenital diaphragmatic hernia Recall-at-100: 20.00%
2018-05-28 12:45:16,679:INFO: Experiment Progress: 44.0% -- 230/519
2018-05-28 12:45:17,202:INFO: Systemic Scleroderma Recall-at-100: 0.00%
2018-05-28 12:45:17,202:INFO: Experiment Progress: 44.0% -- 231/519
2018-05-28 12:45:18,145:INFO: Acute kidney injury Recall-at-100: 10.24%
2018-05-28 12:45:18,145:INFO: Experiment Progress: 44.0% -- 232/519
2018-05-28 12:45:18,589:INFO: Copper-Overload Cirrhosis Recall-at-100: 10.00%
2018-05-28 12:45:18,589:INFO: Experiment Progress: 44.0% -- 233/519
2018-05-28 12:45:20,089:INFO: Spontaneous abortion Recall-at-100: 6.82%
2018-05-28 12:45:20,089:INFO: Experiment Progress: 45.0% -- 234/519
2018-05-28 12:45:21,080:INFO: Glioma Recall-at-100: 7.38%
2018-05-28 12:45:21,080:INFO: Experiment Progress: 45.0% -- 235/519
2018-05-28 12:45:21,560:INFO: Gliosis Recall-at-100: 60.00%
2018-05-28 12:45:21,560:INFO: Experiment Progress: 45.0% -- 236/519
2018-05-28 12:45:22,019:INFO: LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 80.00%
2018-05-28 12:45:22,019:INFO: Experiment Progress: 45.0% -- 237/519
2018-05-28 12:45:22,515:INFO: Dementia Recall-at-100: 0.00%
2018-05-28 12:45:22,515:INFO: Experiment Progress: 45.0% -- 238/519
2018-05-28 12:45:23,082:INFO: Pancreatitis Recall-at-100: 10.00%
2018-05-28 12:45:23,083:INFO: Experiment Progress: 46.0% -- 239/519
2018-05-28 12:45:23,532:INFO: Amino Acid Metabolism, Inborn Errors Recall-at-100: 0.00%
2018-05-28 12:45:23,532:INFO: Experiment Progress: 46.0% -- 240/519
2018-05-28 12:45:24,214:INFO: Thyroid Neoplasm Recall-at-100: 10.00%
2018-05-28 12:45:24,214:INFO: Experiment Progress: 46.0% -- 241/519
2018-05-28 12:45:25,913:INFO: Neoplasm Invasiveness Recall-at-100: 13.53%
2018-05-28 12:45:25,913:INFO: Experiment Progress: 46.0% -- 242/519
2018-05-28 12:45:27,875:INFO: Neoplasm Metastasis Recall-at-100: 12.25%
2018-05-28 12:45:27,875:INFO: Experiment Progress: 46.0% -- 243/519
2018-05-28 12:45:28,621:INFO: Albuminuria Recall-at-100: 20.00%
2018-05-28 12:45:28,621:INFO: Experiment Progress: 47.0% -- 244/519
2018-05-28 12:45:29,122:INFO: Pre-Eclampsia Recall-at-100: 10.00%
2018-05-28 12:45:29,122:INFO: Experiment Progress: 47.0% -- 245/519
2018-05-28 12:45:30,356:INFO: Nerve Degeneration Recall-at-100: 11.96%
2018-05-28 12:45:30,356:INFO: Experiment Progress: 47.0% -- 246/519
2018-05-28 12:45:30,861:INFO: Thromboembolism Recall-at-100: 75.00%
2018-05-28 12:45:30,862:INFO: Experiment Progress: 47.0% -- 247/519
2018-05-28 12:45:32,795:INFO: Polycystic Ovary Syndrome Recall-at-100: 2.05%
2018-05-28 12:45:32,795:INFO: Experiment Progress: 47.0% -- 248/519
2018-05-28 12:45:33,209:INFO: Transient Ischemic Attack Recall-at-100: 30.00%
2018-05-28 12:45:33,210:INFO: Experiment Progress: 47.0% -- 249/519
2018-05-28 12:45:34,177:INFO: Brain Ischemia Recall-at-100: 20.00%
2018-05-28 12:45:34,178:INFO: Experiment Progress: 48.0% -- 250/519
2018-05-28 12:45:34,627:INFO: Cerebral Infarction Recall-at-100: 40.00%
2018-05-28 12:45:34,627:INFO: Experiment Progress: 48.0% -- 251/519
2018-05-28 12:45:35,125:INFO: Malignant neoplasm of esophagus Recall-at-100: 20.00%
2018-05-28 12:45:35,126:INFO: Experiment Progress: 48.0% -- 252/519
2018-05-28 12:45:36,401:INFO: Degenerative polyarthritis Recall-at-100: 6.44%
2018-05-28 12:45:36,401:INFO: Experiment Progress: 48.0% -- 253/519
2018-05-28 12:45:36,722:INFO: Osteitis Deformans Recall-at-100: 0.00%
2018-05-28 12:45:36,722:INFO: Experiment Progress: 48.0% -- 254/519
2018-05-28 12:45:37,129:INFO: Diabetic Cardiomyopathies Recall-at-100: 20.00%
2018-05-28 12:45:37,129:INFO: Experiment Progress: 49.0% -- 255/519
2018-05-28 12:45:37,562:INFO: Nuclear cataract Recall-at-100: 50.00%
2018-05-28 12:45:37,562:INFO: Experiment Progress: 49.0% -- 256/519
2018-05-28 12:45:38,044:INFO: Anorexia Recall-at-100: 65.00%
2018-05-28 12:45:38,044:INFO: Experiment Progress: 49.0% -- 257/519
2018-05-28 12:45:39,344:INFO: Cocaine-Related Disorders Recall-at-100: 11.81%
2018-05-28 12:45:39,345:INFO: Experiment Progress: 49.0% -- 258/519
2018-05-28 12:45:39,955:INFO: MELAS Syndrome Recall-at-100: 60.00%
2018-05-28 12:45:39,955:INFO: Experiment Progress: 49.0% -- 259/519
2018-05-28 12:45:40,147:INFO: Mitochondrial Myopathies Recall-at-100: 33.33%
2018-05-28 12:45:40,147:INFO: Experiment Progress: 50.0% -- 260/519
2018-05-28 12:45:41,118:INFO: Amphetamine-Related Disorders Recall-at-100: 3.93%
2018-05-28 12:45:41,118:INFO: Experiment Progress: 50.0% -- 261/519
2018-05-28 12:45:41,483:INFO: Birth Weight Recall-at-100: 0.00%
2018-05-28 12:45:41,484:INFO: Experiment Progress: 50.0% -- 262/519
2018-05-28 12:45:42,031:INFO: Brain Diseases Recall-at-100: 0.00%
2018-05-28 12:45:42,031:INFO: Experiment Progress: 50.0% -- 263/519
2018-05-28 12:45:42,524:INFO: Dyslipidemias Recall-at-100: 30.00%
2018-05-28 12:45:42,524:INFO: Experiment Progress: 50.0% -- 264/519
2018-05-28 12:45:42,938:INFO: Berylliosis Recall-at-100: 0.00%
2018-05-28 12:45:42,938:INFO: Experiment Progress: 51.0% -- 265/519
2018-05-28 12:45:43,579:INFO: Mental Retardation, X-Linked Recall-at-100: 0.00%
2018-05-28 12:45:43,579:INFO: Experiment Progress: 51.0% -- 266/519
2018-05-28 12:45:43,884:INFO: Sarcoidosis Recall-at-100: 0.00%
2018-05-28 12:45:43,884:INFO: Experiment Progress: 51.0% -- 267/519
2018-05-28 12:45:45,759:INFO: Liver neoplasms Recall-at-100: 8.64%
2018-05-28 12:45:45,759:INFO: Experiment Progress: 51.0% -- 268/519
2018-05-28 12:45:46,615:INFO: Myocardial Reperfusion Injury Recall-at-100: 18.33%
2018-05-28 12:45:46,615:INFO: Experiment Progress: 51.0% -- 269/519
2018-05-28 12:45:47,050:INFO: Microsatellite Instability Recall-at-100: 0.00%
2018-05-28 12:45:47,050:INFO: Experiment Progress: 52.0% -- 270/519
2018-05-28 12:45:47,532:INFO: Night blindness, congenital stationary Recall-at-100: 25.00%
2018-05-28 12:45:47,533:INFO: Experiment Progress: 52.0% -- 271/519
2018-05-28 12:45:48,121:INFO: Stevens-Johnson Syndrome Recall-at-100: 26.67%
2018-05-28 12:45:48,121:INFO: Experiment Progress: 52.0% -- 272/519
2018-05-28 12:45:48,519:INFO: Leukemia, Lymphocytic, Acute, L1 Recall-at-100: 0.00%
2018-05-28 12:45:48,519:INFO: Experiment Progress: 52.0% -- 273/519
2018-05-28 12:45:49,328:INFO: Systemic arterial pressure Recall-at-100: 0.00%
2018-05-28 12:45:49,329:INFO: Experiment Progress: 52.0% -- 274/519
2018-05-28 12:45:49,853:INFO: Learning Disorders Recall-at-100: 10.00%
2018-05-28 12:45:49,853:INFO: Experiment Progress: 52.0% -- 275/519
2018-05-28 12:45:50,276:INFO: Walker-Warburg congenital muscular dystrophy Recall-at-100: 30.00%
2018-05-28 12:45:50,276:INFO: Experiment Progress: 53.0% -- 276/519
2018-05-28 12:45:50,674:INFO: Marfan Syndrome Recall-at-100: 50.00%
2018-05-28 12:45:50,674:INFO: Experiment Progress: 53.0% -- 277/519
2018-05-28 12:45:51,239:INFO: Congenital ocular coloboma (disorder) Recall-at-100: 10.00%
2018-05-28 12:45:51,240:INFO: Experiment Progress: 53.0% -- 278/519
2018-05-28 12:45:53,389:INFO: Lung Neoplasms Recall-at-100: 10.42%
2018-05-28 12:45:53,389:INFO: Experiment Progress: 53.0% -- 279/519
2018-05-28 12:45:53,627:INFO: Myoclonic Epilepsy, Juvenile Recall-at-100: 0.00%
2018-05-28 12:45:53,627:INFO: Experiment Progress: 53.0% -- 280/519
2018-05-28 12:45:54,778:INFO: Inflammatory Bowel Diseases Recall-at-100: 2.50%
2018-05-28 12:45:54,778:INFO: Experiment Progress: 54.0% -- 281/519
2018-05-28 12:45:59,327:INFO: Mammary Neoplasms Recall-at-100: 6.87%
2018-05-28 12:45:59,327:INFO: Experiment Progress: 54.0% -- 282/519
2018-05-28 12:45:59,516:INFO: Idiopathic generalized epilepsy Recall-at-100: 0.00%
2018-05-28 12:45:59,516:INFO: Experiment Progress: 54.0% -- 283/519
2018-05-28 12:45:59,913:INFO: Neuralgia Recall-at-100: 0.00%
2018-05-28 12:45:59,913:INFO: Experiment Progress: 54.0% -- 284/519
2018-05-28 12:46:00,443:INFO: Neural Tube Defects Recall-at-100: 0.00%
2018-05-28 12:46:00,443:INFO: Experiment Progress: 54.0% -- 285/519
2018-05-28 12:46:01,357:INFO: Dermatitis, Allergic Contact Recall-at-100: 0.00%
2018-05-28 12:46:01,357:INFO: Experiment Progress: 55.0% -- 286/519
2018-05-28 12:46:01,779:INFO: Inborn Errors of Metabolism Recall-at-100: 10.00%
2018-05-28 12:46:01,779:INFO: Experiment Progress: 55.0% -- 287/519
2018-05-28 12:46:02,333:INFO: Platelet mean volume finding Recall-at-100: 0.00%
2018-05-28 12:46:02,333:INFO: Experiment Progress: 55.0% -- 288/519
2018-05-28 12:46:02,726:INFO: Intestinal Neoplasms Recall-at-100: 55.00%
2018-05-28 12:46:02,726:INFO: Experiment Progress: 55.0% -- 289/519
2018-05-28 12:46:03,116:INFO: Allergic rhinitis (disorder) Recall-at-100: 0.00%
2018-05-28 12:46:03,116:INFO: Experiment Progress: 55.0% -- 290/519
2018-05-28 12:46:03,930:INFO: Blood pressure finding Recall-at-100: 0.00%
2018-05-28 12:46:03,930:INFO: Experiment Progress: 56.0% -- 291/519
2018-05-28 12:46:04,656:INFO: Age related macular degeneration Recall-at-100: 14.17%
2018-05-28 12:46:04,656:INFO: Experiment Progress: 56.0% -- 292/519
2018-05-28 12:46:05,283:INFO: Hyperplasia Recall-at-100: 6.67%
2018-05-28 12:46:05,283:INFO: Experiment Progress: 56.0% -- 293/519
2018-05-28 12:46:06,013:INFO: Pulmonary function (finding) Recall-at-100: 0.00%
2018-05-28 12:46:06,013:INFO: Experiment Progress: 56.0% -- 294/519
2018-05-28 12:46:06,430:INFO: Spina Bifida Recall-at-100: 20.00%
2018-05-28 12:46:06,430:INFO: Experiment Progress: 56.0% -- 295/519
2018-05-28 12:46:07,060:INFO: Hypertrophic Cardiomyopathy Recall-at-100: 8.33%
2018-05-28 12:46:07,060:INFO: Experiment Progress: 57.0% -- 296/519
2018-05-28 12:46:07,597:INFO: Bardet-Biedl Syndrome Recall-at-100: 71.67%
2018-05-28 12:46:07,597:INFO: Experiment Progress: 57.0% -- 297/519
2018-05-28 12:46:08,243:INFO: Keloid Recall-at-100: 18.33%
2018-05-28 12:46:08,243:INFO: Experiment Progress: 57.0% -- 298/519
2018-05-28 12:46:10,829:INFO: melanoma Recall-at-100: 3.13%
2018-05-28 12:46:10,829:INFO: Experiment Progress: 57.0% -- 299/519
2018-05-28 12:46:11,402:INFO: LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3 Recall-at-100: 15.00%
2018-05-28 12:46:11,404:INFO: Experiment Progress: 57.0% -- 300/519
2018-05-28 12:46:12,206:INFO: Pneumonia Recall-at-100: 44.00%
2018-05-28 12:46:12,206:INFO: Experiment Progress: 57.0% -- 301/519
2018-05-28 12:46:13,722:INFO: Disease Progression Recall-at-100: 5.71%
2018-05-28 12:46:13,722:INFO: Experiment Progress: 58.0% -- 302/519
2018-05-28 12:46:14,167:INFO: Nephroblastoma Recall-at-100: 0.00%
2018-05-28 12:46:14,167:INFO: Experiment Progress: 58.0% -- 303/519
2018-05-28 12:46:14,544:INFO: Severe Combined Immunodeficiency Recall-at-100: 30.00%
2018-05-28 12:46:14,544:INFO: Experiment Progress: 58.0% -- 304/519
2018-05-28 12:46:14,973:INFO: Malignant neoplasm of ovary Recall-at-100: 10.00%
2018-05-28 12:46:14,973:INFO: Experiment Progress: 58.0% -- 305/519
2018-05-28 12:46:15,446:INFO: Pheochromocytoma Recall-at-100: 20.00%
2018-05-28 12:46:15,446:INFO: Experiment Progress: 58.0% -- 306/519
2018-05-28 12:46:16,149:INFO: Testicular Germ Cell Tumor Recall-at-100: 0.00%
2018-05-28 12:46:16,149:INFO: Experiment Progress: 59.0% -- 307/519
2018-05-28 12:46:16,625:INFO: Hypogonadism Recall-at-100: 55.00%
2018-05-28 12:46:16,625:INFO: Experiment Progress: 59.0% -- 308/519
2018-05-28 12:46:17,169:INFO: Movement Disorders Recall-at-100: 23.33%
2018-05-28 12:46:17,169:INFO: Experiment Progress: 59.0% -- 309/519
2018-05-28 12:46:17,649:INFO: Sarcoma Recall-at-100: 15.00%
2018-05-28 12:46:17,649:INFO: Experiment Progress: 59.0% -- 310/519
2018-05-28 12:46:18,128:INFO: Lymphatic Metastasis Recall-at-100: 0.00%
2018-05-28 12:46:18,128:INFO: Experiment Progress: 59.0% -- 311/519
2018-05-28 12:46:18,534:INFO: Hypoglycemia Recall-at-100: 30.00%
2018-05-28 12:46:18,534:INFO: Experiment Progress: 60.0% -- 312/519
2018-05-28 12:46:18,950:INFO: Anemia, Sickle Cell Recall-at-100: 0.00%
2018-05-28 12:46:18,950:INFO: Experiment Progress: 60.0% -- 313/519
2018-05-28 12:46:19,388:INFO: Muscular Dystrophy, Facioscapulohumeral Recall-at-100: 0.00%
2018-05-28 12:46:19,388:INFO: Experiment Progress: 60.0% -- 314/519
2018-05-28 12:46:20,014:INFO: Colorectal Cancer Recall-at-100: 6.67%
2018-05-28 12:46:20,014:INFO: Experiment Progress: 60.0% -- 315/519
2018-05-28 12:46:20,940:INFO: Atherosclerosis Recall-at-100: 10.67%
2018-05-28 12:46:20,940:INFO: Experiment Progress: 60.0% -- 316/519
2018-05-28 12:46:22,315:INFO: Asthma Recall-at-100: 2.91%
2018-05-28 12:46:22,315:INFO: Experiment Progress: 61.0% -- 317/519
2018-05-28 12:46:22,862:INFO: Cardiomyopathy, Hypertrophic, Familial Recall-at-100: 38.33%
2018-05-28 12:46:22,862:INFO: Experiment Progress: 61.0% -- 318/519
2018-05-28 12:46:23,724:INFO: Skin Neoplasms Recall-at-100: 14.50%
2018-05-28 12:46:23,724:INFO: Experiment Progress: 61.0% -- 319/519
2018-05-28 12:46:25,083:INFO: Seizures Recall-at-100: 6.44%
2018-05-28 12:46:25,083:INFO: Experiment Progress: 61.0% -- 320/519
2018-05-28 12:46:27,000:INFO: Alzheimer's Disease Recall-at-100: 5.52%
2018-05-28 12:46:27,000:INFO: Experiment Progress: 61.0% -- 321/519
2018-05-28 12:46:27,492:INFO: Menopause present (finding) Recall-at-100: 0.00%
2018-05-28 12:46:27,493:INFO: Experiment Progress: 62.0% -- 322/519
2018-05-28 12:46:28,287:INFO: Neoplastic Syndromes, Hereditary Recall-at-100: 28.50%
2018-05-28 12:46:28,288:INFO: Experiment Progress: 62.0% -- 323/519
2018-05-28 12:46:28,711:INFO: Gastrointestinal Diseases Recall-at-100: 20.00%
2018-05-28 12:46:28,711:INFO: Experiment Progress: 62.0% -- 324/519
2018-05-28 12:46:29,174:INFO: Cytochrome-c Oxidase Deficiency Recall-at-100: 40.00%
2018-05-28 12:46:29,175:INFO: Experiment Progress: 62.0% -- 325/519
2018-05-28 12:46:29,658:INFO: Retinal Degeneration Recall-at-100: 5.00%
2018-05-28 12:46:29,658:INFO: Experiment Progress: 62.0% -- 326/519
2018-05-28 12:46:30,410:INFO: Retinal Diseases Recall-at-100: 8.33%
2018-05-28 12:46:30,410:INFO: Experiment Progress: 63.0% -- 327/519
2018-05-28 12:46:30,833:INFO: Methylmalonic acidemia Recall-at-100: 40.00%
2018-05-28 12:46:30,833:INFO: Experiment Progress: 63.0% -- 328/519
2018-05-28 12:46:32,037:INFO: Contact Dermatitis Recall-at-100: 5.71%
2018-05-28 12:46:32,037:INFO: Experiment Progress: 63.0% -- 329/519
2018-05-28 12:46:32,966:INFO: Dermatitis, Atopic Recall-at-100: 35.00%
2018-05-28 12:46:32,966:INFO: Experiment Progress: 63.0% -- 330/519
2018-05-28 12:46:33,979:INFO: Coronary heart disease Recall-at-100: 5.00%
2018-05-28 12:46:33,979:INFO: Experiment Progress: 63.0% -- 331/519
2018-05-28 12:46:34,859:INFO: Osteoporosis Recall-at-100: 9.29%
2018-05-28 12:46:34,859:INFO: Experiment Progress: 63.0% -- 332/519
2018-05-28 12:46:35,724:INFO: Cardiomegaly Recall-at-100: 15.00%
2018-05-28 12:46:35,724:INFO: Experiment Progress: 64.0% -- 333/519
2018-05-28 12:46:36,774:INFO: Heart failure Recall-at-100: 6.25%
2018-05-28 12:46:36,774:INFO: Experiment Progress: 64.0% -- 334/519
2018-05-28 12:46:37,199:INFO: Hereditary Breast and Ovarian Cancer Syndrome Recall-at-100: 95.00%
2018-05-28 12:46:37,199:INFO: Experiment Progress: 64.0% -- 335/519
2018-05-28 12:46:37,792:INFO: Major Depressive Disorder Recall-at-100: 0.00%
2018-05-28 12:46:37,792:INFO: Experiment Progress: 64.0% -- 336/519
2018-05-28 12:46:38,691:INFO: Dermatologic disorders Recall-at-100: 0.00%
2018-05-28 12:46:38,691:INFO: Experiment Progress: 64.0% -- 337/519
2018-05-28 12:46:39,999:INFO: Inflammation Recall-at-100: 9.27%
2018-05-28 12:46:39,999:INFO: Experiment Progress: 65.0% -- 338/519
2018-05-28 12:46:40,404:INFO: Diabetic Neuropathies Recall-at-100: 25.00%
2018-05-28 12:46:40,404:INFO: Experiment Progress: 65.0% -- 339/519
2018-05-28 12:46:41,098:INFO: Male infertility Recall-at-100: 12.50%
2018-05-28 12:46:41,099:INFO: Experiment Progress: 65.0% -- 340/519
2018-05-28 12:46:41,529:INFO: Vascular Diseases Recall-at-100: 0.00%
2018-05-28 12:46:41,529:INFO: Experiment Progress: 65.0% -- 341/519
2018-05-28 12:46:42,070:INFO: Female infertility Recall-at-100: 35.00%
2018-05-28 12:46:42,070:INFO: Experiment Progress: 65.0% -- 342/519
2018-05-28 12:46:42,655:INFO: leukemia Recall-at-100: 22.50%
2018-05-28 12:46:42,656:INFO: Experiment Progress: 66.0% -- 343/519
2018-05-28 12:46:43,800:INFO: Ulcerative Colitis Recall-at-100: 7.50%
2018-05-28 12:46:43,801:INFO: Experiment Progress: 66.0% -- 344/519
2018-05-28 12:46:44,680:INFO: Influenza Recall-at-100: 20.00%
2018-05-28 12:46:44,680:INFO: Experiment Progress: 66.0% -- 345/519
2018-05-28 12:46:45,190:INFO: Nephritis, Interstitial Recall-at-100: 60.00%
2018-05-28 12:46:45,190:INFO: Experiment Progress: 66.0% -- 346/519
2018-05-28 12:46:45,659:INFO: Sjogren's Syndrome Recall-at-100: 20.00%
2018-05-28 12:46:45,660:INFO: Experiment Progress: 66.0% -- 347/519
2018-05-28 12:46:46,090:INFO: Infant length Recall-at-100: 0.00%
2018-05-28 12:46:46,090:INFO: Experiment Progress: 67.0% -- 348/519
2018-05-28 12:46:47,143:INFO: Child Development Disorders, Pervasive Recall-at-100: 15.67%
2018-05-28 12:46:47,143:INFO: Experiment Progress: 67.0% -- 349/519
2018-05-28 12:46:47,897:INFO: Substance Withdrawal Syndrome Recall-at-100: 23.67%
2018-05-28 12:46:47,898:INFO: Experiment Progress: 67.0% -- 350/519
2018-05-28 12:46:48,304:INFO: Malformations of Cortical Development Recall-at-100: 0.00%
2018-05-28 12:46:48,304:INFO: Experiment Progress: 67.0% -- 351/519
2018-05-28 12:46:49,229:INFO: Amyotrophic Lateral Sclerosis Recall-at-100: 8.10%
2018-05-28 12:46:49,229:INFO: Experiment Progress: 67.0% -- 352/519
2018-05-28 12:46:49,704:INFO: Developmental Disabilities Recall-at-100: 5.00%
2018-05-28 12:46:49,704:INFO: Experiment Progress: 68.0% -- 353/519
2018-05-28 12:46:50,086:INFO: Febrile Convulsions Recall-at-100: 0.00%
2018-05-28 12:46:50,086:INFO: Experiment Progress: 68.0% -- 354/519
2018-05-28 12:46:50,755:INFO: Cholestasis Recall-at-100: 7.50%
2018-05-28 12:46:50,755:INFO: Experiment Progress: 68.0% -- 355/519
2018-05-28 12:46:51,398:INFO: Pulmonary Hypertension Recall-at-100: 0.00%
2018-05-28 12:46:51,398:INFO: Experiment Progress: 68.0% -- 356/519
2018-05-28 12:46:52,091:INFO: Papillary thyroid carcinoma Recall-at-100: 10.00%
2018-05-28 12:46:52,091:INFO: Experiment Progress: 68.0% -- 357/519
2018-05-28 12:46:53,046:INFO: Salivary Gland Neoplasms Recall-at-100: 0.00%
2018-05-28 12:46:53,046:INFO: Experiment Progress: 68.0% -- 358/519
2018-05-28 12:46:53,805:INFO: Non-alcoholic Fatty Liver Disease Recall-at-100: 0.00%
2018-05-28 12:46:53,805:INFO: Experiment Progress: 69.0% -- 359/519
2018-05-28 12:46:54,223:INFO: Hay fever Recall-at-100: 0.00%
2018-05-28 12:46:54,223:INFO: Experiment Progress: 69.0% -- 360/519
2018-05-28 12:46:54,739:INFO: Hypercholesterolemia, Familial Recall-at-100: 55.00%
2018-05-28 12:46:54,740:INFO: Experiment Progress: 69.0% -- 361/519
2018-05-28 12:46:56,263:INFO: Down Syndrome Recall-at-100: 1.11%
2018-05-28 12:46:56,263:INFO: Experiment Progress: 69.0% -- 362/519
2018-05-28 12:46:56,673:INFO: Arrhythmogenic Right Ventricular Dysplasia Recall-at-100: 40.00%
2018-05-28 12:46:56,673:INFO: Experiment Progress: 69.0% -- 363/519
2018-05-28 12:46:57,098:INFO: Semilobar Holoprosencephaly Recall-at-100: 25.00%
2018-05-28 12:46:57,098:INFO: Experiment Progress: 70.0% -- 364/519
2018-05-28 12:46:57,551:INFO: Hypertriglyceridemia Recall-at-100: 20.00%
2018-05-28 12:46:57,551:INFO: Experiment Progress: 70.0% -- 365/519
2018-05-28 12:46:57,962:INFO: Sensorineural Hearing Loss (disorder) Recall-at-100: 22.22%
2018-05-28 12:46:57,962:INFO: Experiment Progress: 70.0% -- 366/519
2018-05-28 12:46:58,999:INFO: Metabolic Syndrome X Recall-at-100: 7.50%
2018-05-28 12:46:58,999:INFO: Experiment Progress: 70.0% -- 367/519
2018-05-28 12:46:59,512:INFO: Malignant neoplasm of lung Recall-at-100: 0.00%
2018-05-28 12:46:59,512:INFO: Experiment Progress: 70.0% -- 368/519
2018-05-28 12:47:01,083:INFO: Leukemia, Myelocytic, Acute Recall-at-100: 5.30%
2018-05-28 12:47:01,083:INFO: Experiment Progress: 71.0% -- 369/519
2018-05-28 12:47:02,154:INFO: Malignant neoplasm of prostate Recall-at-100: 4.76%
2018-05-28 12:47:02,154:INFO: Experiment Progress: 71.0% -- 370/519
2018-05-28 12:47:02,645:INFO: Renal Insufficiency Recall-at-100: 40.00%
2018-05-28 12:47:02,645:INFO: Experiment Progress: 71.0% -- 371/519
2018-05-28 12:47:03,009:INFO: Jeune thoracic dystrophy Recall-at-100: 66.67%
2018-05-28 12:47:03,009:INFO: Experiment Progress: 71.0% -- 372/519
2018-05-28 12:47:04,692:INFO: Renal Cell Carcinoma Recall-at-100: 5.77%
2018-05-28 12:47:04,693:INFO: Experiment Progress: 71.0% -- 373/519
2018-05-28 12:47:05,783:INFO: Squamous cell carcinoma Recall-at-100: 17.22%
2018-05-28 12:47:05,783:INFO: Experiment Progress: 72.0% -- 374/519
2018-05-28 12:47:07,069:INFO: Non-Small Cell Lung Carcinoma Recall-at-100: 7.12%
2018-05-28 12:47:07,069:INFO: Experiment Progress: 72.0% -- 375/519
2018-05-28 12:47:07,478:INFO: Manganese Poisoning Recall-at-100: 20.00%
2018-05-28 12:47:07,478:INFO: Experiment Progress: 72.0% -- 376/519
2018-05-28 12:47:07,905:INFO: Ventricular Dysfunction, Left Recall-at-100: 10.00%
2018-05-28 12:47:07,905:INFO: Experiment Progress: 72.0% -- 377/519
2018-05-28 12:47:08,484:INFO: Carcinoma, Transitional Cell Recall-at-100: 18.33%
2018-05-28 12:47:08,484:INFO: Experiment Progress: 72.0% -- 378/519
2018-05-28 12:47:08,865:INFO: Mucocutaneous Lymph Node Syndrome Recall-at-100: 0.00%
2018-05-28 12:47:08,865:INFO: Experiment Progress: 73.0% -- 379/519
2018-05-28 12:47:09,255:INFO: Tobacco Use Disorder Recall-at-100: 20.00%
2018-05-28 12:47:09,255:INFO: Experiment Progress: 73.0% -- 380/519
2018-05-28 12:47:09,907:INFO: Proteinuria Recall-at-100: 13.33%
2018-05-28 12:47:09,907:INFO: Experiment Progress: 73.0% -- 381/519
2018-05-28 12:47:10,559:INFO: Diabetic Nephropathy Recall-at-100: 0.00%
2018-05-28 12:47:10,560:INFO: Experiment Progress: 73.0% -- 382/519
2018-05-28 12:47:10,934:INFO: Williams Syndrome Recall-at-100: 10.00%
2018-05-28 12:47:10,934:INFO: Experiment Progress: 73.0% -- 383/519
2018-05-28 12:47:11,345:INFO: Oral Submucous Fibrosis Recall-at-100: 50.00%
2018-05-28 12:47:11,345:INFO: Experiment Progress: 73.0% -- 384/519
2018-05-28 12:47:11,962:INFO: Adenoma Recall-at-100: 6.67%
2018-05-28 12:47:11,963:INFO: Experiment Progress: 74.0% -- 385/519
2018-05-28 12:47:12,392:INFO: Neutropenia Recall-at-100: 10.00%
2018-05-28 12:47:12,392:INFO: Experiment Progress: 74.0% -- 386/519
2018-05-28 12:47:12,852:INFO: Poor school performance Recall-at-100: 0.00%
2018-05-28 12:47:12,852:INFO: Experiment Progress: 74.0% -- 387/519
2018-05-28 12:47:13,273:INFO: Pneumoconiosis Recall-at-100: 0.00%
2018-05-28 12:47:13,273:INFO: Experiment Progress: 74.0% -- 388/519
2018-05-28 12:47:14,073:INFO: Cardiovascular Diseases Recall-at-100: 12.00%
2018-05-28 12:47:14,073:INFO: Experiment Progress: 74.0% -- 389/519
2018-05-28 12:47:14,542:INFO: Fibrinogen Adverse Event Recall-at-100: 10.00%
2018-05-28 12:47:14,542:INFO: Experiment Progress: 75.0% -- 390/519
2018-05-28 12:47:16,338:INFO: Diabetes Mellitus, Non-Insulin-Dependent Recall-at-100: 6.46%
2018-05-28 12:47:16,339:INFO: Experiment Progress: 75.0% -- 391/519
2018-05-28 12:47:16,841:INFO: Thrombocytopenia Recall-at-100: 15.00%
2018-05-28 12:47:16,841:INFO: Experiment Progress: 75.0% -- 392/519
2018-05-28 12:47:17,394:INFO: Sezary Syndrome Recall-at-100: 25.00%
2018-05-28 12:47:17,394:INFO: Experiment Progress: 75.0% -- 393/519
2018-05-28 12:47:17,768:INFO: Nuclear non-senile cataract Recall-at-100: 50.00%
2018-05-28 12:47:17,768:INFO: Experiment Progress: 75.0% -- 394/519
2018-05-28 12:47:18,204:INFO: Diabetic Retinopathy Recall-at-100: 0.00%
2018-05-28 12:47:18,204:INFO: Experiment Progress: 76.0% -- 395/519
2018-05-28 12:47:18,836:INFO: hearing impairment Recall-at-100: 0.00%
2018-05-28 12:47:18,836:INFO: Experiment Progress: 76.0% -- 396/519
2018-05-28 12:47:19,325:INFO: Psychotic Disorders Recall-at-100: 25.00%
2018-05-28 12:47:19,326:INFO: Experiment Progress: 76.0% -- 397/519
2018-05-28 12:47:19,970:INFO: Anxiety Disorders Recall-at-100: 8.33%
2018-05-28 12:47:19,970:INFO: Experiment Progress: 76.0% -- 398/519
2018-05-28 12:47:20,651:INFO: Finding of Mean Corpuscular Hemoglobin Recall-at-100: 15.00%
2018-05-28 12:47:20,652:INFO: Experiment Progress: 76.0% -- 399/519
2018-05-28 12:47:21,111:INFO: Motion Sickness Recall-at-100: 0.00%
2018-05-28 12:47:21,111:INFO: Experiment Progress: 77.0% -- 400/519
2018-05-28 12:47:21,646:INFO: Lymphoma, Non-Hodgkin Recall-at-100: 28.33%
2018-05-28 12:47:21,646:INFO: Experiment Progress: 77.0% -- 401/519
2018-05-28 12:47:22,163:INFO: Lymphoma, Follicular Recall-at-100: 5.00%
2018-05-28 12:47:22,163:INFO: Experiment Progress: 77.0% -- 402/519
2018-05-28 12:47:22,608:INFO: Thrombocythemia, Essential Recall-at-100: 25.00%
2018-05-28 12:47:22,608:INFO: Experiment Progress: 77.0% -- 403/519
2018-05-28 12:47:22,943:INFO: Arthritis Recall-at-100: 0.00%
2018-05-28 12:47:22,943:INFO: Experiment Progress: 77.0% -- 404/519
2018-05-28 12:47:24,351:INFO: Hypotension Recall-at-100: 28.33%
2018-05-28 12:47:24,352:INFO: Experiment Progress: 78.0% -- 405/519
2018-05-28 12:47:25,976:INFO: Reperfusion Injury Recall-at-100: 15.14%
2018-05-28 12:47:25,976:INFO: Experiment Progress: 78.0% -- 406/519
2018-05-28 12:47:26,498:INFO: Heat Stroke Recall-at-100: 70.00%
2018-05-28 12:47:26,499:INFO: Experiment Progress: 78.0% -- 407/519
2018-05-28 12:47:27,132:INFO: Hemangiosarcoma Recall-at-100: 55.00%
2018-05-28 12:47:27,132:INFO: Experiment Progress: 78.0% -- 408/519
2018-05-28 12:47:28,018:INFO: Drug Allergy Recall-at-100: 11.67%
2018-05-28 12:47:28,019:INFO: Experiment Progress: 78.0% -- 409/519
2018-05-28 12:47:28,462:INFO: SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR Recall-at-100: 25.00%
2018-05-28 12:47:28,463:INFO: Experiment Progress: 78.0% -- 410/519
2018-05-28 12:47:29,275:INFO: Medulloblastoma Recall-at-100: 9.50%
2018-05-28 12:47:29,276:INFO: Experiment Progress: 79.0% -- 411/519
2018-05-28 12:47:29,828:INFO: Cleft Lip Recall-at-100: 50.00%
2018-05-28 12:47:29,828:INFO: Experiment Progress: 79.0% -- 412/519
2018-05-28 12:47:30,526:INFO: Cleft Palate Recall-at-100: 22.50%
2018-05-28 12:47:30,527:INFO: Experiment Progress: 79.0% -- 413/519
2018-05-28 12:47:31,921:INFO: Muscle Weakness Recall-at-100: 0.00%
2018-05-28 12:47:31,921:INFO: Experiment Progress: 79.0% -- 414/519
2018-05-28 12:47:32,309:INFO: Mental disorders Recall-at-100: 10.00%
2018-05-28 12:47:32,309:INFO: Experiment Progress: 79.0% -- 415/519
2018-05-28 12:47:32,867:INFO: Astrocytoma Recall-at-100: 36.67%
2018-05-28 12:47:32,867:INFO: Experiment Progress: 80.0% -- 416/519
2018-05-28 12:47:33,340:INFO: Anemia, Diamond-Blackfan Recall-at-100: 85.00%
2018-05-28 12:47:33,340:INFO: Experiment Progress: 80.0% -- 417/519
2018-05-28 12:47:33,809:INFO: Asthma, Aspirin-Induced Recall-at-100: 20.00%
2018-05-28 12:47:33,809:INFO: Experiment Progress: 80.0% -- 418/519
2018-05-28 12:47:34,441:INFO: Leber Congenital Amaurosis Recall-at-100: 10.00%
2018-05-28 12:47:34,441:INFO: Experiment Progress: 80.0% -- 419/519
2018-05-28 12:47:34,869:INFO: Cachexia Recall-at-100: 0.00%
2018-05-28 12:47:34,870:INFO: Experiment Progress: 80.0% -- 420/519
2018-05-28 12:47:35,316:INFO: Respiratory Insufficiency Recall-at-100: 0.00%
2018-05-28 12:47:35,317:INFO: Experiment Progress: 81.0% -- 421/519
2018-05-28 12:47:35,834:INFO: Respiratory Hypersensitivity Recall-at-100: 10.00%
2018-05-28 12:47:35,834:INFO: Experiment Progress: 81.0% -- 422/519
2018-05-28 12:47:36,412:INFO: Nasopharyngeal carcinoma Recall-at-100: 10.00%
2018-05-28 12:47:36,412:INFO: Experiment Progress: 81.0% -- 423/519
2018-05-28 12:47:37,398:INFO: Hyperalgesia Recall-at-100: 20.00%
2018-05-28 12:47:37,398:INFO: Experiment Progress: 81.0% -- 424/519
2018-05-28 12:47:37,829:INFO: Meningioma Recall-at-100: 35.00%
2018-05-28 12:47:37,829:INFO: Experiment Progress: 81.0% -- 425/519
2018-05-28 12:47:38,366:INFO: Sudden Cardiac Arrest Recall-at-100: 0.00%
2018-05-28 12:47:38,366:INFO: Experiment Progress: 82.0% -- 426/519
2018-05-28 12:47:40,009:INFO: Intellectual Disability Recall-at-100: 0.77%
2018-05-28 12:47:40,012:INFO: Experiment Progress: 82.0% -- 427/519
2018-05-28 12:47:40,437:INFO: Graves Disease Recall-at-100: 10.00%
2018-05-28 12:47:40,437:INFO: Experiment Progress: 82.0% -- 428/519
2018-05-28 12:47:41,060:INFO: Neurotoxicity Syndromes Recall-at-100: 0.00%
2018-05-28 12:47:41,061:INFO: Experiment Progress: 82.0% -- 429/519
2018-05-28 12:47:41,451:INFO: Cardiomyopathy, Familial Hypertrophic, 1 (disorder) Recall-at-100: 70.00%
2018-05-28 12:47:41,451:INFO: Experiment Progress: 82.0% -- 430/519
2018-05-28 12:47:42,022:INFO: Atrial Fibrillation Recall-at-100: 8.33%
2018-05-28 12:47:42,022:INFO: Experiment Progress: 83.0% -- 431/519
2018-05-28 12:47:42,545:INFO: Hepatitis, Chronic Recall-at-100: 28.33%
2018-05-28 12:47:42,545:INFO: Experiment Progress: 83.0% -- 432/519
2018-05-28 12:47:43,079:INFO: Behcet Syndrome Recall-at-100: 16.67%
2018-05-28 12:47:43,079:INFO: Experiment Progress: 83.0% -- 433/519
2018-05-28 12:47:44,102:INFO: Diabetes Mellitus, Insulin-Dependent Recall-at-100: 5.71%
2018-05-28 12:47:44,102:INFO: Experiment Progress: 83.0% -- 434/519
2018-05-28 12:47:45,500:INFO: Diabetes Mellitus, Experimental Recall-at-100: 8.55%
2018-05-28 12:47:45,500:INFO: Experiment Progress: 83.0% -- 435/519
2018-05-28 12:47:46,088:INFO: Parkinsonian Disorders Recall-at-100: 21.67%
2018-05-28 12:47:46,089:INFO: Experiment Progress: 84.0% -- 436/519
2018-05-28 12:47:47,121:INFO: Necrosis Recall-at-100: 12.00%
2018-05-28 12:47:47,122:INFO: Experiment Progress: 84.0% -- 437/519
2018-05-28 12:47:47,610:INFO: Gestational Diabetes Recall-at-100: 0.00%
2018-05-28 12:47:47,610:INFO: Experiment Progress: 84.0% -- 438/519
2018-05-28 12:47:48,185:INFO: Idiopathic Membranous Glomerulonephritis Recall-at-100: 0.00%
2018-05-28 12:47:48,185:INFO: Experiment Progress: 84.0% -- 439/519
2018-05-28 12:47:49,378:INFO: Hypersensitivity Recall-at-100: 32.14%
2018-05-28 12:47:49,378:INFO: Experiment Progress: 84.0% -- 440/519
2018-05-28 12:47:50,085:INFO: Myopia Recall-at-100: 3.33%
2018-05-28 12:47:50,085:INFO: Experiment Progress: 84.0% -- 441/519
2018-05-28 12:47:50,499:INFO: Hyperemia Recall-at-100: 20.00%
2018-05-28 12:47:50,499:INFO: Experiment Progress: 85.0% -- 442/519
2018-05-28 12:47:50,892:INFO: Tooth Abnormalities Recall-at-100: 10.00%
2018-05-28 12:47:50,892:INFO: Experiment Progress: 85.0% -- 443/519
2018-05-28 12:47:51,392:INFO: Hyperglycemia Recall-at-100: 10.00%
2018-05-28 12:47:51,393:INFO: Experiment Progress: 85.0% -- 444/519
2018-05-28 12:47:51,856:INFO: Noonan Syndrome Recall-at-100: 70.00%
2018-05-28 12:47:51,856:INFO: Experiment Progress: 85.0% -- 445/519
2018-05-28 12:47:52,278:INFO: Hyperinsulinism Recall-at-100: 25.00%
2018-05-28 12:47:52,278:INFO: Experiment Progress: 85.0% -- 446/519
2018-05-28 12:47:52,846:INFO: Edema Recall-at-100: 16.67%
2018-05-28 12:47:52,847:INFO: Experiment Progress: 86.0% -- 447/519
2018-05-28 12:47:53,347:INFO: Hodgkin Disease Recall-at-100: 0.00%
2018-05-28 12:47:53,347:INFO: Experiment Progress: 86.0% -- 448/519
2018-05-28 12:47:53,773:INFO: Metabolic Bone Disorder Recall-at-100: 0.00%
2018-05-28 12:47:53,773:INFO: Experiment Progress: 86.0% -- 449/519
2018-05-28 12:47:54,304:INFO: Bone Diseases, Developmental Recall-at-100: 0.00%
2018-05-28 12:47:54,305:INFO: Experiment Progress: 86.0% -- 450/519
2018-05-28 12:47:54,709:INFO: Tachycardia, Ventricular Recall-at-100: 10.00%
2018-05-28 12:47:54,709:INFO: Experiment Progress: 86.0% -- 451/519
2018-05-28 12:47:55,146:INFO: Dystonia Recall-at-100: 0.00%
2018-05-28 12:47:55,146:INFO: Experiment Progress: 87.0% -- 452/519
2018-05-28 12:47:55,761:INFO: Squamous cell carcinoma of the head and neck Recall-at-100: 13.33%
2018-05-28 12:47:55,761:INFO: Experiment Progress: 87.0% -- 453/519
2018-05-28 12:47:56,150:INFO: Pulmonary Embolism Recall-at-100: 35.00%
2018-05-28 12:47:56,151:INFO: Experiment Progress: 87.0% -- 454/519
2018-05-28 12:47:56,868:INFO: Pulmonary Fibrosis Recall-at-100: 35.00%
2018-05-28 12:47:56,869:INFO: Experiment Progress: 87.0% -- 455/519
2018-05-28 12:47:57,306:INFO: West Syndrome Recall-at-100: 0.00%
2018-05-28 12:47:57,307:INFO: Experiment Progress: 87.0% -- 456/519
2018-05-28 12:47:57,858:INFO: Cerebral Hemorrhage Recall-at-100: 53.33%
2018-05-28 12:47:57,859:INFO: Experiment Progress: 88.0% -- 457/519
2018-05-28 12:47:58,292:INFO: Romano-Ward Syndrome Recall-at-100: 45.00%
2018-05-28 12:47:58,292:INFO: Experiment Progress: 88.0% -- 458/519
2018-05-28 12:47:59,065:INFO: Mouth Neoplasms Recall-at-100: 17.00%
2018-05-28 12:47:59,066:INFO: Experiment Progress: 88.0% -- 459/519
2018-05-28 12:47:59,947:INFO: Liver Cirrhosis Recall-at-100: 21.33%
2018-05-28 12:47:59,947:INFO: Experiment Progress: 88.0% -- 460/519
2018-05-28 12:48:00,488:INFO: Neoplasm Recurrence, Local Recall-at-100: 13.33%
2018-05-28 12:48:00,488:INFO: Experiment Progress: 88.0% -- 461/519
2018-05-28 12:48:03,707:INFO: Obesity Recall-at-100: 3.51%
2018-05-28 12:48:03,708:INFO: Experiment Progress: 89.0% -- 462/519
2018-05-28 12:48:04,360:INFO: Biliary cirrhosis Recall-at-100: 15.00%
2018-05-28 12:48:04,360:INFO: Experiment Progress: 89.0% -- 463/519
2018-05-28 12:48:05,135:INFO: Precursor Cell Lymphoblastic Leukemia Lymphoma Recall-at-100: 12.00%
2018-05-28 12:48:05,135:INFO: Experiment Progress: 89.0% -- 464/519
2018-05-28 12:48:06,447:INFO: Cardiomyopathies Recall-at-100: 7.78%
2018-05-28 12:48:06,448:INFO: Experiment Progress: 89.0% -- 465/519
2018-05-28 12:48:06,843:INFO: Peroxisome biogenesis disorders Recall-at-100: 100.00%
2018-05-28 12:48:06,843:INFO: Experiment Progress: 89.0% -- 466/519
2018-05-28 12:48:07,291:INFO: Dyskeratosis Congenita Recall-at-100: 55.00%
2018-05-28 12:48:07,292:INFO: Experiment Progress: 89.0% -- 467/519
2018-05-28 12:48:07,775:INFO: Uremia Recall-at-100: 15.00%
2018-05-28 12:48:07,776:INFO: Experiment Progress: 90.0% -- 468/519
2018-05-28 12:48:08,494:INFO: Depressive disorder Recall-at-100: 6.67%
2018-05-28 12:48:08,494:INFO: Experiment Progress: 90.0% -- 469/519
2018-05-28 12:48:09,193:INFO: Thrombosis Recall-at-100: 40.00%
2018-05-28 12:48:09,194:INFO: Experiment Progress: 90.0% -- 470/519
2018-05-28 12:48:10,108:INFO: nervous system disorder Recall-at-100: 5.67%
2018-05-28 12:48:10,109:INFO: Experiment Progress: 90.0% -- 471/519
2018-05-28 12:48:10,610:INFO: Lymphoma Recall-at-100: 0.00%
2018-05-28 12:48:10,610:INFO: Experiment Progress: 90.0% -- 472/519
2018-05-28 12:48:15,460:INFO: IGA Glomerulonephritis Recall-at-100: 1.40%
2018-05-28 12:48:15,461:INFO: Experiment Progress: 91.0% -- 473/519
2018-05-28 12:48:16,160:INFO: Kidney Neoplasm Recall-at-100: 16.67%
2018-05-28 12:48:16,160:INFO: Experiment Progress: 91.0% -- 474/519
2018-05-28 12:48:16,569:INFO: Hypothermia, natural Recall-at-100: 25.00%
2018-05-28 12:48:16,569:INFO: Experiment Progress: 91.0% -- 475/519
2018-05-28 12:48:17,197:INFO: Focal glomerulosclerosis Recall-at-100: 21.67%
2018-05-28 12:48:17,197:INFO: Experiment Progress: 91.0% -- 476/519
2018-05-28 12:48:17,785:INFO: Hepatitis B, Chronic Recall-at-100: 0.00%
2018-05-28 12:48:17,785:INFO: Experiment Progress: 91.0% -- 477/519
2018-05-28 12:48:18,371:INFO: Drug Eruptions Recall-at-100: 0.00%
2018-05-28 12:48:18,371:INFO: Experiment Progress: 92.0% -- 478/519
2018-05-28 12:48:18,882:INFO: Malignant neoplasm of pancreas Recall-at-100: 0.00%
2018-05-28 12:48:18,882:INFO: Experiment Progress: 92.0% -- 479/519
2018-05-28 12:48:22,521:INFO: Stomach Neoplasms Recall-at-100: 3.88%
2018-05-28 12:48:22,521:INFO: Experiment Progress: 92.0% -- 480/519
2018-05-28 12:48:23,249:INFO: Osteosarcoma Recall-at-100: 14.17%
2018-05-28 12:48:23,249:INFO: Experiment Progress: 92.0% -- 481/519
2018-05-28 12:48:23,891:INFO: Vitiligo Recall-at-100: 6.67%
2018-05-28 12:48:23,891:INFO: Experiment Progress: 92.0% -- 482/519
2018-05-28 12:48:24,383:INFO: Gastric ulcer Recall-at-100: 0.00%
2018-05-28 12:48:24,384:INFO: Experiment Progress: 93.0% -- 483/519
2018-05-28 12:48:25,394:INFO: Malignant neoplasm of breast Recall-at-100: 9.76%
2018-05-28 12:48:25,394:INFO: Experiment Progress: 93.0% -- 484/519
2018-05-28 12:48:26,934:INFO: Drug-Induced Liver Injury Recall-at-100: 9.24%
2018-05-28 12:48:26,935:INFO: Experiment Progress: 93.0% -- 485/519
2018-05-28 12:48:27,515:INFO: Colitis Recall-at-100: 6.67%
2018-05-28 12:48:27,515:INFO: Experiment Progress: 93.0% -- 486/519
2018-05-28 12:48:28,055:INFO: Lymphoma, T-Cell, Cutaneous Recall-at-100: 5.00%
2018-05-28 12:48:28,055:INFO: Experiment Progress: 93.0% -- 487/519
2018-05-28 12:48:28,575:INFO: T-Cell Lymphoma Recall-at-100: 40.00%
2018-05-28 12:48:28,575:INFO: Experiment Progress: 94.0% -- 488/519
2018-05-28 12:48:29,307:INFO: Hyperactive behavior Recall-at-100: 26.67%
2018-05-28 12:48:29,307:INFO: Experiment Progress: 94.0% -- 489/519
2018-05-28 12:48:29,724:INFO: Skin Abnormalities Recall-at-100: 0.00%
2018-05-28 12:48:29,725:INFO: Experiment Progress: 94.0% -- 490/519
2018-05-28 12:48:30,223:INFO: Epithelial ovarian cancer Recall-at-100: 0.00%
2018-05-28 12:48:30,223:INFO: Experiment Progress: 94.0% -- 491/519
2018-05-28 12:48:30,629:INFO: Infantile Refsum Disease (disorder) Recall-at-100: 100.00%
2018-05-28 12:48:30,629:INFO: Experiment Progress: 94.0% -- 492/519
2018-05-28 12:48:31,203:INFO: Adrenoleukodystrophy, Neonatal Recall-at-100: 100.00%
2018-05-28 12:48:31,204:INFO: Experiment Progress: 94.0% -- 493/519
2018-05-28 12:48:31,610:INFO: Hirschsprung Disease Recall-at-100: 30.00%
2018-05-28 12:48:31,610:INFO: Experiment Progress: 95.0% -- 494/519
2018-05-28 12:48:32,093:INFO: Female Urogenital Diseases Recall-at-100: 10.00%
2018-05-28 12:48:32,093:INFO: Experiment Progress: 95.0% -- 495/519
2018-05-28 12:48:33,516:INFO: ovarian neoplasm Recall-at-100: 12.33%
2018-05-28 12:48:33,517:INFO: Experiment Progress: 95.0% -- 496/519
2018-05-28 12:48:33,962:INFO: Aortic Aneurysm, Abdominal Recall-at-100: 15.00%
2018-05-28 12:48:33,962:INFO: Experiment Progress: 95.0% -- 497/519
2018-05-28 12:48:34,673:INFO: Venous Thrombosis Recall-at-100: 75.00%
2018-05-28 12:48:34,673:INFO: Experiment Progress: 95.0% -- 498/519
2018-05-28 12:48:35,317:INFO: Amnesia Recall-at-100: 20.00%
2018-05-28 12:48:35,318:INFO: Experiment Progress: 96.0% -- 499/519
2018-05-28 12:48:37,284:INFO: Bladder Neoplasm Recall-at-100: 9.55%
2018-05-28 12:48:37,284:INFO: Experiment Progress: 96.0% -- 500/519
2018-05-28 12:48:37,848:INFO: Hemorrhage Recall-at-100: 15.00%
2018-05-28 12:48:37,848:INFO: Experiment Progress: 96.0% -- 501/519
2018-05-28 12:48:39,113:INFO: Status Epilepticus Recall-at-100: 25.71%
2018-05-28 12:48:39,113:INFO: Experiment Progress: 96.0% -- 502/519
2018-05-28 12:48:39,620:INFO: Chronic Kidney Diseases Recall-at-100: 0.00%
2018-05-28 12:48:39,621:INFO: Experiment Progress: 96.0% -- 503/519
2018-05-28 12:48:40,234:INFO: Myeloid Leukemia, Chronic Recall-at-100: 26.67%
2018-05-28 12:48:40,234:INFO: Experiment Progress: 97.0% -- 504/519
2018-05-28 12:48:40,726:INFO: Myeloid Leukemia Recall-at-100: 35.00%
2018-05-28 12:48:40,726:INFO: Experiment Progress: 97.0% -- 505/519
2018-05-28 12:48:41,526:INFO: Calcinosis Recall-at-100: 12.50%
2018-05-28 12:48:41,526:INFO: Experiment Progress: 97.0% -- 506/519
2018-05-28 12:48:41,996:INFO: Creutzfeldt-Jakob disease Recall-at-100: 0.00%
2018-05-28 12:48:41,997:INFO: Experiment Progress: 97.0% -- 507/519
2018-05-28 12:48:42,426:INFO: Left ventricular noncompaction Recall-at-100: 10.00%
2018-05-28 12:48:42,426:INFO: Experiment Progress: 97.0% -- 508/519
2018-05-28 12:48:43,780:INFO: Parkinson Disease Recall-at-100: 4.22%
2018-05-28 12:48:43,780:INFO: Experiment Progress: 98.0% -- 509/519
2018-05-28 12:48:44,694:INFO: Endometrial Neoplasms Recall-at-100: 12.00%
2018-05-28 12:48:44,695:INFO: Experiment Progress: 98.0% -- 510/519
2018-05-28 12:48:45,239:INFO: Sepsis Recall-at-100: 20.00%
2018-05-28 12:48:45,239:INFO: Experiment Progress: 98.0% -- 511/519
2018-05-28 12:48:47,403:INFO: Endometriosis Recall-at-100: 14.42%
2018-05-28 12:48:47,403:INFO: Experiment Progress: 98.0% -- 512/519
2018-05-28 12:48:48,653:INFO: Esophageal Neoplasms Recall-at-100: 8.81%
2018-05-28 12:48:48,653:INFO: Experiment Progress: 98.0% -- 513/519
2018-05-28 12:48:49,143:INFO: Eosinophilic esophagitis Recall-at-100: 0.00%
2018-05-28 12:48:49,144:INFO: Experiment Progress: 99.0% -- 514/519
2018-05-28 12:48:49,624:INFO: Malignant neoplasm of urinary bladder Recall-at-100: 15.00%
2018-05-28 12:48:49,624:INFO: Experiment Progress: 99.0% -- 515/519
2018-05-28 12:48:50,170:INFO: Lewy Body Disease Recall-at-100: 30.00%
2018-05-28 12:48:50,170:INFO: Experiment Progress: 99.0% -- 516/519
2018-05-28 12:48:50,646:INFO: PARKINSON DISEASE, LATE-ONSET Recall-at-100: 10.00%
2018-05-28 12:48:50,646:INFO: Experiment Progress: 99.0% -- 517/519
2018-05-28 12:48:51,868:INFO: Neoplastic Cell Transformation Recall-at-100: 14.44%
2018-05-28 12:48:51,868:INFO: Experiment Progress: 99.0% -- 518/519
2018-05-28 12:48:52,828:INFO: Arsenic Poisoning Recall-at-100: 1.67%
2018-05-28 14:17:16,156:INFO: Disease Protein Prediction in the PPI Network
2018-05-28 14:17:16,158:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-28 14:17:16,159:INFO: ======================================
2018-05-28 14:17:16,160:INFO: Loading PPI Network...
2018-05-28 14:17:20,350:INFO: Disease Protein Prediction in the PPI Network
2018-05-28 14:17:20,351:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-28 14:17:20,351:INFO: ======================================
2018-05-28 14:17:20,351:INFO: Loading PPI Network...
2018-05-28 14:17:34,508:INFO: Loading Disease Associations...
2018-05-28 14:17:34,548:INFO: Loading PPI Matrix...
2018-05-28 14:17:43,249:INFO: Running Experiment...
2018-05-28 14:17:43,250:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-28 14:19:24,509:INFO: Disease Protein Prediction in the PPI Network
2018-05-28 14:19:24,509:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-28 14:19:24,509:INFO: ======================================
2018-05-28 14:19:24,509:INFO: Loading PPI Network...
2018-05-28 14:19:36,967:INFO: Loading Disease Associations...
2018-05-28 14:19:37,005:INFO: Loading PPI Matrix...
2018-05-28 14:19:43,259:INFO: Running Experiment...
2018-05-28 14:19:43,260:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-28 14:19:45,333:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 40.00%
2018-05-28 14:19:45,334:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-28 14:19:54,951:INFO: Disease Protein Prediction in the PPI Network
2018-05-28 14:19:54,951:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-28 14:19:54,952:INFO: ======================================
2018-05-28 14:19:54,952:INFO: Loading PPI Network...
2018-05-28 14:20:09,183:INFO: Loading Disease Associations...
2018-05-28 14:20:09,228:INFO: Loading PPI Matrix...
2018-05-28 14:20:14,705:INFO: Running Experiment...
2018-05-28 14:20:14,706:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-28 14:20:16,193:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 40.00%
2018-05-28 14:20:16,193:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-28 14:20:17,918:INFO: Psychoses, Substance-Induced Recall-at-100: 5.00%
2018-05-28 14:20:17,918:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-28 14:20:18,664:INFO: Zellweger Syndrome Recall-at-100: 100.00%
2018-05-28 14:20:18,664:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-28 14:20:22,472:INFO: Psoriasis Recall-at-100: 12.38%
2018-05-28 14:20:22,474:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-28 14:20:23,037:INFO: Nephrotic Syndrome Recall-at-100: 18.33%
2018-05-28 14:20:23,037:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-28 14:20:23,606:INFO: Nephrosis Recall-at-100: 20.00%
2018-05-28 14:20:23,606:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-28 14:20:24,135:INFO: Mouth Diseases Recall-at-100: 20.00%
2018-05-28 14:20:24,135:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-28 14:20:25,033:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 86.67%
2018-05-28 14:20:25,033:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-28 14:20:27,071:INFO: Substance-Related Disorders Recall-at-100: 2.91%
2018-05-28 14:20:27,071:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-28 14:20:27,559:INFO: Anemia, Hemolytic Recall-at-100: 25.00%
2018-05-28 14:20:27,560:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-28 14:20:30,109:INFO: Rheumatoid Arthritis Recall-at-100: 2.84%
2018-05-28 14:20:30,109:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-28 14:20:30,611:INFO: Arthritis, Psoriatic Recall-at-100: 10.00%
2018-05-28 14:20:30,611:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-28 14:20:31,252:INFO: Anemia Recall-at-100: 3.33%
2018-05-28 14:20:31,253:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-28 14:20:31,832:INFO: Cholangiocarcinoma Recall-at-100: 16.67%
2018-05-28 14:20:31,833:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-28 14:20:32,272:INFO: Neuroendocrine Tumors Recall-at-100: 30.00%
2018-05-28 14:20:32,272:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-28 14:20:32,776:INFO: Malaria Recall-at-100: 5.00%
2018-05-28 14:20:32,776:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-28 14:20:33,193:INFO: Hyperhomocysteinemia Recall-at-100: 15.00%
2018-05-28 14:20:33,194:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-28 14:20:34,595:INFO: HIV Infections Recall-at-100: 19.00%
2018-05-28 14:20:34,595:INFO: Experiment Progress: 3.0% -- 18/519
2018-05-28 14:20:35,150:INFO: Ankylosing spondylitis Recall-at-100: 20.00%
2018-05-28 14:20:35,151:INFO: Experiment Progress: 3.0% -- 19/519
2018-05-28 14:20:36,552:INFO: Adenoid Cystic Carcinoma Recall-at-100: 9.11%
2018-05-28 14:20:36,553:INFO: Experiment Progress: 3.0% -- 20/519
2018-05-28 14:20:38,113:INFO: Juvenile arthritis Recall-at-100: 5.00%
2018-05-28 14:20:38,113:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-28 14:20:38,747:INFO: Neoplasms, Experimental Recall-at-100: 12.50%
2018-05-28 14:20:38,748:INFO: Experiment Progress: 4.0% -- 22/519
2018-05-28 14:20:39,177:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 20.00%
2018-05-28 14:20:39,177:INFO: Experiment Progress: 4.0% -- 23/519
2018-05-28 14:20:39,514:INFO: Alopecia Areata Recall-at-100: 33.33%
2018-05-28 14:20:39,514:INFO: Experiment Progress: 4.0% -- 24/519
2018-05-28 14:20:39,980:INFO: Alopecia Recall-at-100: 5.00%
2018-05-28 14:20:39,980:INFO: Experiment Progress: 4.0% -- 25/519
2018-05-28 14:20:40,503:INFO: Bradycardia Recall-at-100: 50.00%
2018-05-28 14:20:40,503:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-28 14:20:40,984:INFO: Common Variable Immunodeficiency Recall-at-100: 65.00%
2018-05-28 14:20:40,984:INFO: Experiment Progress: 5.0% -- 27/519
2018-05-28 14:20:41,579:INFO: Glomerulonephritis Recall-at-100: 31.67%
2018-05-28 14:20:41,579:INFO: Experiment Progress: 5.0% -- 28/519
2018-05-28 14:20:42,296:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 0.00%
2018-05-28 14:20:42,296:INFO: Experiment Progress: 5.0% -- 29/519
2018-05-28 14:20:42,812:INFO: Lung Injury Recall-at-100: 30.00%
2018-05-28 14:20:42,812:INFO: Experiment Progress: 5.0% -- 30/519
2018-05-28 14:20:43,213:INFO: Hypercalcemia Recall-at-100: 20.00%
2018-05-28 14:20:43,213:INFO: Experiment Progress: 5.0% -- 31/519
2018-05-28 14:20:43,912:INFO: Cerebrovascular accident Recall-at-100: 22.50%
2018-05-28 14:20:43,913:INFO: Experiment Progress: 6.0% -- 32/519
2018-05-28 14:20:44,660:INFO: Diaphragmatic Hernia Recall-at-100: 15.00%
2018-05-28 14:20:44,660:INFO: Experiment Progress: 6.0% -- 33/519
2018-05-28 14:20:45,118:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 30.00%
2018-05-28 14:20:45,118:INFO: Experiment Progress: 6.0% -- 34/519
2018-05-28 14:20:45,834:INFO: Migraine Disorders Recall-at-100: 0.00%
2018-05-28 14:20:45,834:INFO: Experiment Progress: 6.0% -- 35/519
2018-05-28 14:20:46,091:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-05-28 14:20:46,092:INFO: Experiment Progress: 6.0% -- 36/519
2018-05-28 14:20:46,740:INFO: Brugada Syndrome (disorder) Recall-at-100: 15.00%
2018-05-28 14:20:46,740:INFO: Experiment Progress: 7.0% -- 37/519
2018-05-28 14:20:47,174:INFO: Pathological accumulation of air in tissues Recall-at-100: 30.00%
2018-05-28 14:20:47,174:INFO: Experiment Progress: 7.0% -- 38/519
2018-05-28 14:20:47,606:INFO: Craniosynostosis Recall-at-100: 15.00%
2018-05-28 14:20:47,606:INFO: Experiment Progress: 7.0% -- 39/519
2018-05-28 14:20:48,193:INFO: Head and Neck Neoplasms Recall-at-100: 13.33%
2018-05-28 14:20:48,194:INFO: Experiment Progress: 7.0% -- 40/519
2018-05-28 14:20:48,910:INFO: Brain Neoplasms Recall-at-100: 18.33%
2018-05-28 14:20:48,910:INFO: Experiment Progress: 7.0% -- 41/519
2018-05-28 14:20:49,475:INFO: Hearing Loss, Partial Recall-at-100: 0.00%
2018-05-28 14:20:49,475:INFO: Experiment Progress: 8.0% -- 42/519
2018-05-28 14:20:50,056:INFO: Chromosome Aberrations Recall-at-100: 10.00%
2018-05-28 14:20:50,056:INFO: Experiment Progress: 8.0% -- 43/519
2018-05-28 14:20:51,195:INFO: Chronic Lymphocytic Leukemia Recall-at-100: 8.00%
2018-05-28 14:20:51,195:INFO: Experiment Progress: 8.0% -- 44/519
2018-05-28 14:20:51,712:INFO: Refractive Errors Recall-at-100: 0.00%
2018-05-28 14:20:51,712:INFO: Experiment Progress: 8.0% -- 45/519
2018-05-28 14:20:52,186:INFO: Hepatitis C Recall-at-100: 10.00%
2018-05-28 14:20:52,186:INFO: Experiment Progress: 8.0% -- 46/519
2018-05-28 14:20:52,945:INFO: Mesothelioma Recall-at-100: 5.00%
2018-05-28 14:20:52,945:INFO: Experiment Progress: 9.0% -- 47/519
2018-05-28 14:20:53,128:INFO: Noise-induced hearing loss Recall-at-100: 20.00%
2018-05-28 14:20:53,131:INFO: Experiment Progress: 9.0% -- 48/519
2018-05-28 14:20:53,887:INFO: Inflammatory dermatosis Recall-at-100: 0.00%
2018-05-28 14:20:53,887:INFO: Experiment Progress: 9.0% -- 49/519
2018-05-28 14:20:54,758:INFO: Kallmann Syndrome Recall-at-100: 15.00%
2018-05-28 14:20:54,758:INFO: Experiment Progress: 9.0% -- 50/519
2018-05-28 14:20:55,682:INFO: Lipoidosis Recall-at-100: 10.00%
2018-05-28 14:20:55,683:INFO: Experiment Progress: 9.0% -- 51/519
2018-05-28 14:20:56,376:INFO: Diabetes Mellitus Recall-at-100: 3.33%
2018-05-28 14:20:56,376:INFO: Experiment Progress: 10.0% -- 52/519
2018-05-28 14:20:57,129:INFO: Fibrosis Recall-at-100: 20.00%
2018-05-28 14:20:57,129:INFO: Experiment Progress: 10.0% -- 53/519
2018-05-28 14:20:57,646:INFO: Hypercholesterolemia Recall-at-100: 5.00%
2018-05-28 14:20:57,646:INFO: Experiment Progress: 10.0% -- 54/519
2018-05-28 14:20:58,187:INFO: Microcephaly Recall-at-100: 15.00%
2018-05-28 14:20:58,187:INFO: Experiment Progress: 10.0% -- 55/519
2018-05-28 14:20:58,540:INFO: Tongue Neoplasms Recall-at-100: 0.00%
2018-05-28 14:20:58,540:INFO: Experiment Progress: 10.0% -- 56/519
2018-05-28 14:20:58,959:INFO: Common Migraine Recall-at-100: 0.00%
2018-05-28 14:20:58,959:INFO: Experiment Progress: 10.0% -- 57/519
2018-05-28 14:20:59,385:INFO: Carotid Artery Diseases Recall-at-100: 0.00%
2018-05-28 14:20:59,385:INFO: Experiment Progress: 11.0% -- 58/519
2018-05-28 14:21:00,080:INFO: Growth Disorders Recall-at-100: 2.50%
2018-05-28 14:21:00,080:INFO: Experiment Progress: 11.0% -- 59/519
2018-05-28 14:21:00,471:INFO: Absence Epilepsy Recall-at-100: 22.22%
2018-05-28 14:21:00,471:INFO: Experiment Progress: 11.0% -- 60/519
2018-05-28 14:21:01,068:INFO: Epilepsy, Temporal Lobe Recall-at-100: 45.00%
2018-05-28 14:21:01,069:INFO: Experiment Progress: 11.0% -- 61/519
2018-05-28 14:21:02,043:INFO: Memory Disorders Recall-at-100: 7.50%
2018-05-28 14:21:02,043:INFO: Experiment Progress: 11.0% -- 62/519
2018-05-28 14:21:02,539:INFO: Catalepsy Recall-at-100: 45.00%
2018-05-28 14:21:02,539:INFO: Experiment Progress: 12.0% -- 63/519
2018-05-28 14:21:02,981:INFO: Hereditary Nonpolyposis Colorectal Cancer Recall-at-100: 35.00%
2018-05-28 14:21:02,983:INFO: Experiment Progress: 12.0% -- 64/519
2018-05-28 14:21:03,572:INFO: Acute Promyelocytic Leukemia Recall-at-100: 18.33%
2018-05-28 14:21:03,572:INFO: Experiment Progress: 12.0% -- 65/519
2018-05-28 14:21:04,077:INFO: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 10.00%
2018-05-28 14:21:04,077:INFO: Experiment Progress: 12.0% -- 66/519
2018-05-28 14:21:04,490:INFO: Gout Recall-at-100: 0.00%
2018-05-28 14:21:04,491:INFO: Experiment Progress: 12.0% -- 67/519
2018-05-28 14:21:05,497:INFO: Coronary Artery Disease Recall-at-100: 3.10%
2018-05-28 14:21:05,498:INFO: Experiment Progress: 13.0% -- 68/519
2018-05-28 14:21:06,274:INFO: Venous Thromboembolism Recall-at-100: 30.00%
2018-05-28 14:21:06,275:INFO: Experiment Progress: 13.0% -- 69/519
2018-05-28 14:21:07,434:INFO: Precancerous Conditions Recall-at-100: 8.81%
2018-05-28 14:21:07,435:INFO: Experiment Progress: 13.0% -- 70/519
2018-05-28 14:21:08,715:INFO: Crohn Disease Recall-at-100: 3.47%
2018-05-28 14:21:08,716:INFO: Experiment Progress: 13.0% -- 71/519
2018-05-28 14:21:09,285:INFO: Uterine Cervical Neoplasm Recall-at-100: 20.00%
2018-05-28 14:21:09,286:INFO: Experiment Progress: 13.0% -- 72/519
2018-05-28 14:21:09,755:INFO: Dyskinesia, Drug-Induced Recall-at-100: 20.00%
2018-05-28 14:21:09,755:INFO: Experiment Progress: 14.0% -- 73/519
2018-05-28 14:21:10,248:INFO: Ataxia, Spinocerebellar Recall-at-100: 30.00%
2018-05-28 14:21:10,248:INFO: Experiment Progress: 14.0% -- 74/519
2018-05-28 14:21:10,678:INFO: Optic Atrophy, Hereditary, Leber Recall-at-100: 70.00%
2018-05-28 14:21:10,678:INFO: Experiment Progress: 14.0% -- 75/519
2018-05-28 14:21:11,166:INFO: Liver Cirrhosis, Alcoholic Recall-at-100: 0.00%
2018-05-28 14:21:11,166:INFO: Experiment Progress: 14.0% -- 76/519
2018-05-28 14:21:11,647:INFO: Acute Lung Injury Recall-at-100: 5.00%
2018-05-28 14:21:11,649:INFO: Experiment Progress: 14.0% -- 77/519
2018-05-28 14:21:13,046:INFO: Liver Cirrhosis, Experimental Recall-at-100: 7.27%
2018-05-28 14:21:13,046:INFO: Experiment Progress: 15.0% -- 78/519
2018-05-28 14:21:13,770:INFO: Chloracne Recall-at-100: 11.67%
2018-05-28 14:21:13,771:INFO: Experiment Progress: 15.0% -- 79/519
2018-05-28 14:21:14,824:INFO: Liver diseases Recall-at-100: 1.43%
2018-05-28 14:21:14,824:INFO: Experiment Progress: 15.0% -- 80/519
2018-05-28 14:21:16,020:INFO: Kidney Failure, Chronic Recall-at-100: 13.50%
2018-05-28 14:21:16,020:INFO: Experiment Progress: 15.0% -- 81/519
2018-05-28 14:21:16,526:INFO: Weight decreased Recall-at-100: 0.00%
2018-05-28 14:21:16,526:INFO: Experiment Progress: 15.0% -- 82/519
2018-05-28 14:21:17,143:INFO: Leigh Disease Recall-at-100: 59.17%
2018-05-28 14:21:17,144:INFO: Experiment Progress: 15.0% -- 83/519
2018-05-28 14:21:17,907:INFO: Celiac Disease Recall-at-100: 15.00%
2018-05-28 14:21:17,907:INFO: Experiment Progress: 16.0% -- 84/519
2018-05-28 14:21:18,506:INFO: Glaucoma Recall-at-100: 0.00%
2018-05-28 14:21:18,506:INFO: Experiment Progress: 16.0% -- 85/519
2018-05-28 14:21:19,174:INFO: Tachycardia Recall-at-100: 40.00%
2018-05-28 14:21:19,174:INFO: Experiment Progress: 16.0% -- 86/519
2018-05-28 14:21:19,683:INFO: Breast Cancer, Familial Recall-at-100: 70.00%
2018-05-28 14:21:19,683:INFO: Experiment Progress: 16.0% -- 87/519
2018-05-28 14:21:20,333:INFO: Ischemia Recall-at-100: 11.67%
2018-05-28 14:21:20,334:INFO: Experiment Progress: 16.0% -- 88/519
2018-05-28 14:21:20,867:INFO: Adenomatous Polyposis Coli Recall-at-100: 0.00%
2018-05-28 14:21:20,867:INFO: Experiment Progress: 17.0% -- 89/519
2018-05-28 14:21:21,584:INFO: Thyroid Diseases Recall-at-100: 10.00%
2018-05-28 14:21:21,584:INFO: Experiment Progress: 17.0% -- 90/519
2018-05-28 14:21:22,031:INFO: Panic Disorder Recall-at-100: 0.00%
2018-05-28 14:21:22,031:INFO: Experiment Progress: 17.0% -- 91/519
2018-05-28 14:21:25,875:INFO: Colorectal Neoplasms Recall-at-100: 3.81%
2018-05-28 14:21:25,876:INFO: Experiment Progress: 17.0% -- 92/519
2018-05-28 14:21:26,484:INFO: Adrenal Gland Neoplasms Recall-at-100: 60.00%
2018-05-28 14:21:26,485:INFO: Experiment Progress: 17.0% -- 93/519
2018-05-28 14:21:27,138:INFO: Sudden infant death syndrome Recall-at-100: 25.00%
2018-05-28 14:21:27,138:INFO: Experiment Progress: 18.0% -- 94/519
2018-05-28 14:21:28,250:INFO: Neuroblastoma Recall-at-100: 9.00%
2018-05-28 14:21:28,250:INFO: Experiment Progress: 18.0% -- 95/519
2018-05-28 14:21:28,789:INFO: Prostate cancer, familial Recall-at-100: 15.00%
2018-05-28 14:21:28,790:INFO: Experiment Progress: 18.0% -- 96/519
2018-05-28 14:21:30,754:INFO: Animal Mammary Neoplasms Recall-at-100: 8.02%
2018-05-28 14:21:30,754:INFO: Experiment Progress: 18.0% -- 97/519
2018-05-28 14:21:31,361:INFO: Osteochondrodysplasias Recall-at-100: 30.00%
2018-05-28 14:21:31,361:INFO: Experiment Progress: 18.0% -- 98/519
2018-05-28 14:21:31,991:INFO: Hepatolenticular Degeneration Recall-at-100: 18.33%
2018-05-28 14:21:31,991:INFO: Experiment Progress: 19.0% -- 99/519
2018-05-28 14:21:32,484:INFO: Fanconi Anemia Recall-at-100: 70.00%
2018-05-28 14:21:32,484:INFO: Experiment Progress: 19.0% -- 100/519
2018-05-28 14:21:32,929:INFO: Eye Abnormalities Recall-at-100: 30.00%
2018-05-28 14:21:32,929:INFO: Experiment Progress: 19.0% -- 101/519
2018-05-28 14:21:33,391:INFO: Limb Deformities, Congenital Recall-at-100: 20.00%
2018-05-28 14:21:33,391:INFO: Experiment Progress: 19.0% -- 102/519
2018-05-28 14:21:33,750:INFO: Electrocardiogram: P-R interval Recall-at-100: 0.00%
2018-05-28 14:21:33,750:INFO: Experiment Progress: 19.0% -- 103/519
2018-05-28 14:21:35,712:INFO: Mammary Neoplasms, Experimental Recall-at-100: 5.96%
2018-05-28 14:21:35,713:INFO: Experiment Progress: 20.0% -- 104/519
2018-05-28 14:21:36,294:INFO: Heart valve disease Recall-at-100: 3.33%
2018-05-28 14:21:36,295:INFO: Experiment Progress: 20.0% -- 105/519
2018-05-28 14:21:37,165:INFO: Diffuse Large B-Cell Lymphoma Recall-at-100: 5.00%
2018-05-28 14:21:37,165:INFO: Experiment Progress: 20.0% -- 106/519
2018-05-28 14:21:37,993:INFO: Hepatitis Recall-at-100: 5.00%
2018-05-28 14:21:37,993:INFO: Experiment Progress: 20.0% -- 107/519
2018-05-28 14:21:38,441:INFO: Impaired glucose tolerance Recall-at-100: 15.00%
2018-05-28 14:21:38,441:INFO: Experiment Progress: 20.0% -- 108/519
2018-05-28 14:21:38,896:INFO: Mitochondrial Encephalomyopathies Recall-at-100: 25.00%
2018-05-28 14:21:38,896:INFO: Experiment Progress: 21.0% -- 109/519
2018-05-28 14:21:39,481:INFO: Colon Carcinoma Recall-at-100: 20.00%
2018-05-28 14:21:39,481:INFO: Experiment Progress: 21.0% -- 110/519
2018-05-28 14:21:39,916:INFO: Hepatic Encephalopathy Recall-at-100: 30.00%
2018-05-28 14:21:39,917:INFO: Experiment Progress: 21.0% -- 111/519
2018-05-28 14:21:41,127:INFO: Multiple Sclerosis Recall-at-100: 5.69%
2018-05-28 14:21:41,128:INFO: Experiment Progress: 21.0% -- 112/519
2018-05-28 14:21:41,562:INFO: Neurogenic Inflammation Recall-at-100: 20.00%
2018-05-28 14:21:41,563:INFO: Experiment Progress: 21.0% -- 113/519
2018-05-28 14:21:42,612:INFO: Lupus Erythematosus, Systemic Recall-at-100: 3.93%
2018-05-28 14:21:42,612:INFO: Experiment Progress: 21.0% -- 114/519
2018-05-28 14:21:43,037:INFO: Ceroid lipofuscinosis, neuronal 1, infantile Recall-at-100: 10.00%
2018-05-28 14:21:43,037:INFO: Experiment Progress: 22.0% -- 115/519
2018-05-28 14:21:43,825:INFO: Adenocarcinoma of lung (disorder) Recall-at-100: 7.00%
2018-05-28 14:21:43,825:INFO: Experiment Progress: 22.0% -- 116/519
2018-05-28 14:21:44,446:INFO: Charcot-Marie-Tooth Disease Recall-at-100: 5.00%
2018-05-28 14:21:44,446:INFO: Experiment Progress: 22.0% -- 117/519
2018-05-28 14:21:44,880:INFO: Osteogenesis imperfecta type III (disorder) Recall-at-100: 45.00%
2018-05-28 14:21:44,880:INFO: Experiment Progress: 22.0% -- 118/519
2018-05-28 14:21:45,296:INFO: Osteogenesis imperfecta type IV (disorder) Recall-at-100: 30.00%
2018-05-28 14:21:45,296:INFO: Experiment Progress: 22.0% -- 119/519
2018-05-28 14:21:45,782:INFO: Hepatitis, Autoimmune Recall-at-100: 30.00%
2018-05-28 14:21:45,782:INFO: Experiment Progress: 23.0% -- 120/519
2018-05-28 14:21:50,636:INFO: Prostatic Neoplasms Recall-at-100: 6.41%
2018-05-28 14:21:50,636:INFO: Experiment Progress: 23.0% -- 121/519
2018-05-28 14:21:51,177:INFO: NADH:Q(1) Oxidoreductase deficiency Recall-at-100: 85.00%
2018-05-28 14:21:51,177:INFO: Experiment Progress: 23.0% -- 122/519
2018-05-28 14:21:51,623:INFO: Hypospadias Recall-at-100: 0.00%
2018-05-28 14:21:51,623:INFO: Experiment Progress: 23.0% -- 123/519
2018-05-28 14:21:52,325:INFO: Multiple Myeloma Recall-at-100: 13.33%
2018-05-28 14:21:52,326:INFO: Experiment Progress: 23.0% -- 124/519
2018-05-28 14:21:53,113:INFO: Fatty Liver Recall-at-100: 8.00%
2018-05-28 14:21:53,113:INFO: Experiment Progress: 24.0% -- 125/519
2018-05-28 14:21:53,530:INFO: Leishmaniasis, Visceral Recall-at-100: 30.00%
2018-05-28 14:21:53,530:INFO: Experiment Progress: 24.0% -- 126/519
2018-05-28 14:21:54,039:INFO: Early infantile epileptic encephalopathy with suppression bursts Recall-at-100: 0.00%
2018-05-28 14:21:54,039:INFO: Experiment Progress: 24.0% -- 127/519
2018-05-28 14:21:54,715:INFO: Kartagener Syndrome Recall-at-100: 0.00%
2018-05-28 14:21:54,715:INFO: Experiment Progress: 24.0% -- 128/519
2018-05-28 14:21:55,245:INFO: Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse Recall-at-100: 45.00%
2018-05-28 14:21:55,245:INFO: Experiment Progress: 24.0% -- 129/519
2018-05-28 14:21:56,237:INFO: Bipolar Disorder Recall-at-100: 5.00%
2018-05-28 14:21:56,238:INFO: Experiment Progress: 25.0% -- 130/519
2018-05-28 14:21:56,643:INFO: Erectile dysfunction Recall-at-100: 30.00%
2018-05-28 14:21:56,643:INFO: Experiment Progress: 25.0% -- 131/519
2018-05-28 14:21:57,113:INFO: Meckel-Gruber syndrome Recall-at-100: 80.00%
2018-05-28 14:21:57,113:INFO: Experiment Progress: 25.0% -- 132/519
2018-05-28 14:21:59,005:INFO: Colonic Neoplasms Recall-at-100: 11.99%
2018-05-28 14:21:59,005:INFO: Experiment Progress: 25.0% -- 133/519
2018-05-28 14:22:02,474:INFO: Autistic Disorder Recall-at-100: 2.97%
2018-05-28 14:22:02,474:INFO: Experiment Progress: 25.0% -- 134/519
2018-05-28 14:22:03,429:INFO: Liver Neoplasms, Experimental Recall-at-100: 7.33%
2018-05-28 14:22:03,430:INFO: Experiment Progress: 26.0% -- 135/519
2018-05-28 14:22:03,948:INFO: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 5.00%
2018-05-28 14:22:03,948:INFO: Experiment Progress: 26.0% -- 136/519
2018-05-28 14:22:04,427:INFO: Narcolepsy Recall-at-100: 15.00%
2018-05-28 14:22:04,427:INFO: Experiment Progress: 26.0% -- 137/519
2018-05-28 14:22:04,921:INFO: Fever Recall-at-100: 10.00%
2018-05-28 14:22:04,922:INFO: Experiment Progress: 26.0% -- 138/519
2018-05-28 14:22:06,166:INFO: Adenocarcinoma Recall-at-100: 9.45%
2018-05-28 14:22:06,166:INFO: Experiment Progress: 26.0% -- 139/519
2018-05-28 14:22:06,562:INFO: Aortic Valve Insufficiency Recall-at-100: 70.00%
2018-05-28 14:22:06,562:INFO: Experiment Progress: 26.0% -- 140/519
2018-05-28 14:22:07,102:INFO: Carcinoma, Pancreatic Ductal Recall-at-100: 45.00%
2018-05-28 14:22:07,102:INFO: Experiment Progress: 27.0% -- 141/519
2018-05-28 14:22:07,901:INFO: Infarction, Middle Cerebral Artery Recall-at-100: 18.33%
2018-05-28 14:22:07,902:INFO: Experiment Progress: 27.0% -- 142/519
2018-05-28 14:22:10,259:INFO: Hypertensive disease Recall-at-100: 6.87%
2018-05-28 14:22:10,259:INFO: Experiment Progress: 27.0% -- 143/519
2018-05-28 14:22:10,734:INFO: Juvenile Myelomonocytic Leukemia Recall-at-100: 35.00%
2018-05-28 14:22:10,734:INFO: Experiment Progress: 27.0% -- 144/519
2018-05-28 14:22:11,191:INFO: Leprosy Recall-at-100: 0.00%
2018-05-28 14:22:11,191:INFO: Experiment Progress: 27.0% -- 145/519
2018-05-28 14:22:12,401:INFO: Myocardial Infarction Recall-at-100: 4.58%
2018-05-28 14:22:12,401:INFO: Experiment Progress: 28.0% -- 146/519
2018-05-28 14:22:12,949:INFO: Urticaria Recall-at-100: 10.00%
2018-05-28 14:22:12,950:INFO: Experiment Progress: 28.0% -- 147/519
2018-05-28 14:22:13,442:INFO: Cardiac Arrhythmia Recall-at-100: 10.00%
2018-05-28 14:22:13,442:INFO: Experiment Progress: 28.0% -- 148/519
2018-05-28 14:22:13,838:INFO: Hemochromatosis Recall-at-100: 50.00%
2018-05-28 14:22:13,838:INFO: Experiment Progress: 28.0% -- 149/519
2018-05-28 14:22:14,857:INFO: Pancreatic Neoplasm Recall-at-100: 16.25%
2018-05-28 14:22:14,857:INFO: Experiment Progress: 28.0% -- 150/519
2018-05-28 14:22:15,578:INFO: Cardiomyopathy, Dilated Recall-at-100: 22.00%
2018-05-28 14:22:15,578:INFO: Experiment Progress: 29.0% -- 151/519
2018-05-28 14:22:15,969:INFO: Papilloma Recall-at-100: 20.00%
2018-05-28 14:22:15,969:INFO: Experiment Progress: 29.0% -- 152/519
2018-05-28 14:22:16,655:INFO: Pain Recall-at-100: 16.50%
2018-05-28 14:22:16,655:INFO: Experiment Progress: 29.0% -- 153/519
2018-05-28 14:22:17,056:INFO: Congenital Abnormality Recall-at-100: 30.00%
2018-05-28 14:22:17,056:INFO: Experiment Progress: 29.0% -- 154/519
2018-05-28 14:22:17,426:INFO: MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) Recall-at-100: 40.00%
2018-05-28 14:22:17,427:INFO: Experiment Progress: 29.0% -- 155/519
2018-05-28 14:22:18,624:INFO: Kidney Diseases Recall-at-100: 1.11%
2018-05-28 14:22:18,624:INFO: Experiment Progress: 30.0% -- 156/519
2018-05-28 14:22:19,059:INFO: Lung Diseases, Interstitial Recall-at-100: 0.00%
2018-05-28 14:22:19,060:INFO: Experiment Progress: 30.0% -- 157/519
2018-05-28 14:22:19,555:INFO: Basal cell carcinoma Recall-at-100: 15.00%
2018-05-28 14:22:19,556:INFO: Experiment Progress: 30.0% -- 158/519
2018-05-28 14:22:21,770:INFO: Liver carcinoma Recall-at-100: 9.68%
2018-05-28 14:22:21,770:INFO: Experiment Progress: 30.0% -- 159/519
2018-05-28 14:22:22,335:INFO: gliosarcoma Recall-at-100: 25.00%
2018-05-28 14:22:22,336:INFO: Experiment Progress: 30.0% -- 160/519
2018-05-28 14:22:22,987:INFO: Acute Coronary Syndrome Recall-at-100: 22.50%
2018-05-28 14:22:22,987:INFO: Experiment Progress: 31.0% -- 161/519
2018-05-28 14:22:23,568:INFO: Ovarian Cysts Recall-at-100: 0.00%
2018-05-28 14:22:23,568:INFO: Experiment Progress: 31.0% -- 162/519
2018-05-28 14:22:23,994:INFO: Schizophrenia, Childhood Recall-at-100: 0.00%
2018-05-28 14:22:23,994:INFO: Experiment Progress: 31.0% -- 163/519
2018-05-28 14:22:24,461:INFO: Adrenocortical carcinoma Recall-at-100: 30.00%
2018-05-28 14:22:24,461:INFO: Experiment Progress: 31.0% -- 164/519
2018-05-28 14:22:26,956:INFO: Schizophrenia Recall-at-100: 2.10%
2018-05-28 14:22:26,957:INFO: Experiment Progress: 31.0% -- 165/519
2018-05-28 14:22:27,343:INFO: Atrophic Recall-at-100: 0.00%
2018-05-28 14:22:27,343:INFO: Experiment Progress: 31.0% -- 166/519
2018-05-28 14:22:27,785:INFO: Idiopathic Pulmonary Fibrosis Recall-at-100: 10.00%
2018-05-28 14:22:27,785:INFO: Experiment Progress: 32.0% -- 167/519
2018-05-28 14:22:28,196:INFO: Lobar Holoprosencephaly Recall-at-100: 25.00%
2018-05-28 14:22:28,196:INFO: Experiment Progress: 32.0% -- 168/519
2018-05-28 14:22:28,606:INFO: Alobar Holoprosencephaly Recall-at-100: 25.00%
2018-05-28 14:22:28,606:INFO: Experiment Progress: 32.0% -- 169/519
2018-05-28 14:22:29,029:INFO: Immunologic Deficiency Syndromes Recall-at-100: 40.00%
2018-05-28 14:22:29,029:INFO: Experiment Progress: 32.0% -- 170/519
2018-05-28 14:22:29,434:INFO: Ataxia Recall-at-100: 20.00%
2018-05-28 14:22:29,434:INFO: Experiment Progress: 32.0% -- 171/519
2018-05-28 14:22:29,857:INFO: Adenocarcinoma Of Esophagus Recall-at-100: 10.00%
2018-05-28 14:22:29,857:INFO: Experiment Progress: 33.0% -- 172/519
2018-05-28 14:22:30,807:INFO: Retinitis Pigmentosa Recall-at-100: 8.57%
2018-05-28 14:22:30,807:INFO: Experiment Progress: 33.0% -- 173/519
2018-05-28 14:22:31,845:INFO: Squamous cell carcinoma of esophagus Recall-at-100: 8.61%
2018-05-28 14:22:31,846:INFO: Experiment Progress: 33.0% -- 174/519
2018-05-28 14:22:32,453:INFO: Autoimmune Diseases Recall-at-100: 0.00%
2018-05-28 14:22:32,453:INFO: Experiment Progress: 33.0% -- 175/519
2018-05-28 14:22:32,819:INFO: Diarrhea Recall-at-100: 20.00%
2018-05-28 14:22:32,819:INFO: Experiment Progress: 33.0% -- 176/519
2018-05-28 14:22:34,589:INFO: Myocardial Ischemia Recall-at-100: 3.60%
2018-05-28 14:22:34,589:INFO: Experiment Progress: 34.0% -- 177/519
2018-05-28 14:22:35,010:INFO: Essential Hypertension Recall-at-100: 0.00%
2018-05-28 14:22:35,010:INFO: Experiment Progress: 34.0% -- 178/519
2018-05-28 14:22:35,345:INFO: Hepatomegaly Recall-at-100: 33.33%
2018-05-28 14:22:35,345:INFO: Experiment Progress: 34.0% -- 179/519
2018-05-28 14:22:35,879:INFO: Myopathy Recall-at-100: 0.00%
2018-05-28 14:22:35,879:INFO: Experiment Progress: 34.0% -- 180/519
2018-05-28 14:22:36,649:INFO: Adverse reaction to drug Recall-at-100: 10.67%
2018-05-28 14:22:36,649:INFO: Experiment Progress: 34.0% -- 181/519
2018-05-28 14:22:37,048:INFO: Myoclonic Epilepsies, Progressive Recall-at-100: 15.00%
2018-05-28 14:22:37,048:INFO: Experiment Progress: 35.0% -- 182/519
2018-05-28 14:22:37,462:INFO: Muscular Atrophy Recall-at-100: 15.00%
2018-05-28 14:22:37,462:INFO: Experiment Progress: 35.0% -- 183/519
2018-05-28 14:22:37,847:INFO: Basal Ganglia Diseases Recall-at-100: 20.00%
2018-05-28 14:22:37,847:INFO: Experiment Progress: 35.0% -- 184/519
2018-05-28 14:22:38,267:INFO: Hepatitis B Recall-at-100: 35.00%
2018-05-28 14:22:38,267:INFO: Experiment Progress: 35.0% -- 185/519
2018-05-28 14:22:38,969:INFO: Lung diseases Recall-at-100: 4.00%
2018-05-28 14:22:38,969:INFO: Experiment Progress: 35.0% -- 186/519
2018-05-28 14:22:39,723:INFO: Chronic Obstructive Airway Disease Recall-at-100: 5.00%
2018-05-28 14:22:39,723:INFO: Experiment Progress: 36.0% -- 187/519
2018-05-28 14:22:42,506:INFO: Peripheral Neuropathy Recall-at-100: 2.88%
2018-05-28 14:22:42,506:INFO: Experiment Progress: 36.0% -- 188/519
2018-05-28 14:22:43,606:INFO: Weight Gain Recall-at-100: 4.58%
2018-05-28 14:22:43,606:INFO: Experiment Progress: 36.0% -- 189/519
2018-05-28 14:22:44,036:INFO: Deafness Recall-at-100: 0.00%
2018-05-28 14:22:44,036:INFO: Experiment Progress: 36.0% -- 190/519
2018-05-28 14:22:44,406:INFO: Renal dysplasia and retinal aplasia (disorder) Recall-at-100: 50.00%
2018-05-28 14:22:44,406:INFO: Experiment Progress: 36.0% -- 191/519
2018-05-28 14:22:45,008:INFO: Attention deficit hyperactivity disorder Recall-at-100: 16.67%
2018-05-28 14:22:45,008:INFO: Experiment Progress: 36.0% -- 192/519
2018-05-28 14:22:45,420:INFO: Tetralogy of Fallot Recall-at-100: 45.00%
2018-05-28 14:22:45,421:INFO: Experiment Progress: 37.0% -- 193/519
2018-05-28 14:22:46,071:INFO: Neurodegenerative Disorders Recall-at-100: 15.00%
2018-05-28 14:22:46,071:INFO: Experiment Progress: 37.0% -- 194/519
2018-05-28 14:22:46,485:INFO: Barrett Esophagus Recall-at-100: 10.00%
2018-05-28 14:22:46,486:INFO: Experiment Progress: 37.0% -- 195/519
2018-05-28 14:22:48,079:INFO: Craniofacial Abnormalities Recall-at-100: 6.95%
2018-05-28 14:22:48,080:INFO: Experiment Progress: 37.0% -- 196/519
2018-05-28 14:22:48,535:INFO: Necrotizing Enterocolitis Recall-at-100: 30.00%
2018-05-28 14:22:48,536:INFO: Experiment Progress: 37.0% -- 197/519
2018-05-28 14:22:48,983:INFO: Hyperlipidemia Recall-at-100: 30.00%
2018-05-28 14:22:48,984:INFO: Experiment Progress: 38.0% -- 198/519
2018-05-28 14:22:49,448:INFO: MYELODYSPLASTIC SYNDROME Recall-at-100: 0.00%
2018-05-28 14:22:49,448:INFO: Experiment Progress: 38.0% -- 199/519
2018-05-28 14:22:50,031:INFO: Anoxia Recall-at-100: 2.50%
2018-05-28 14:22:50,031:INFO: Experiment Progress: 38.0% -- 200/519
2018-05-28 14:22:50,707:INFO: Small cell carcinoma of lung Recall-at-100: 15.00%
2018-05-28 14:22:50,707:INFO: Experiment Progress: 38.0% -- 201/519
2018-05-28 14:22:51,585:INFO: Epilepsy Recall-at-100: 7.86%
2018-05-28 14:22:51,585:INFO: Experiment Progress: 38.0% -- 202/519
2018-05-28 14:22:52,069:INFO: Liver Failure, Acute Recall-at-100: 21.67%
2018-05-28 14:22:52,069:INFO: Experiment Progress: 39.0% -- 203/519
2018-05-28 14:22:52,523:INFO: Micronuclei, Chromosome-Defective Recall-at-100: 10.00%
2018-05-28 14:22:52,523:INFO: Experiment Progress: 39.0% -- 204/519
2018-05-28 14:22:53,025:INFO: Cognition Disorders Recall-at-100: 5.00%
2018-05-28 14:22:53,025:INFO: Experiment Progress: 39.0% -- 205/519
2018-05-28 14:22:53,385:INFO: Tonic-Clonic Epilepsy Recall-at-100: 30.00%
2018-05-28 14:22:53,385:INFO: Experiment Progress: 39.0% -- 206/519
2018-05-28 14:22:54,071:INFO: Heart Diseases Recall-at-100: 7.00%
2018-05-28 14:22:54,071:INFO: Experiment Progress: 39.0% -- 207/519
2018-05-28 14:22:54,655:INFO: Adult T-Cell Lymphoma/Leukemia Recall-at-100: 13.33%
2018-05-28 14:22:54,656:INFO: Experiment Progress: 40.0% -- 208/519
2018-05-28 14:22:55,142:INFO: Primary biliary cirrhosis Recall-at-100: 30.00%
2018-05-28 14:22:55,142:INFO: Experiment Progress: 40.0% -- 209/519
2018-05-28 14:22:55,517:INFO: beta Thalassemia Recall-at-100: 20.00%
2018-05-28 14:22:55,517:INFO: Experiment Progress: 40.0% -- 210/519
2018-05-28 14:22:55,893:INFO: Marijuana Abuse Recall-at-100: 20.00%
2018-05-28 14:22:55,894:INFO: Experiment Progress: 40.0% -- 211/519
2018-05-28 14:22:56,327:INFO: Long QT Syndrome Recall-at-100: 60.00%
2018-05-28 14:22:56,327:INFO: Experiment Progress: 40.0% -- 212/519
2018-05-28 14:22:56,756:INFO: Burkitt Lymphoma Recall-at-100: 20.00%
2018-05-28 14:22:56,756:INFO: Experiment Progress: 41.0% -- 213/519
2018-05-28 14:22:57,115:INFO: TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) Recall-at-100: 30.00%
2018-05-28 14:22:57,115:INFO: Experiment Progress: 41.0% -- 214/519
2018-05-28 14:22:57,832:INFO: Insulin Resistance Recall-at-100: 14.50%
2018-05-28 14:22:57,832:INFO: Experiment Progress: 41.0% -- 215/519
2018-05-28 14:22:58,323:INFO: Left Ventricular Hypertrophy Recall-at-100: 26.67%
2018-05-28 14:22:58,324:INFO: Experiment Progress: 41.0% -- 216/519
2018-05-28 14:22:58,706:INFO: Bronchial Hyperreactivity Recall-at-100: 5.00%
2018-05-28 14:22:58,706:INFO: Experiment Progress: 41.0% -- 217/519
2018-05-28 14:22:59,409:INFO: AMYOTROPHIC LATERAL SCLEROSIS 1 Recall-at-100: 8.50%
2018-05-28 14:22:59,409:INFO: Experiment Progress: 42.0% -- 218/519
2018-05-28 14:22:59,781:INFO: Fetal Growth Retardation Recall-at-100: 10.00%
2018-05-28 14:22:59,781:INFO: Experiment Progress: 42.0% -- 219/519
2018-05-28 14:23:00,052:INFO: Holoprosencephaly Recall-at-100: 25.00%
2018-05-28 14:23:00,052:INFO: Experiment Progress: 42.0% -- 220/519
2018-05-28 14:23:00,684:INFO: Arthritis, Experimental Recall-at-100: 20.00%
2018-05-28 14:23:00,684:INFO: Experiment Progress: 42.0% -- 221/519
2018-05-28 14:23:01,298:INFO: Congenital Heart Defects Recall-at-100: 11.67%
2018-05-28 14:23:01,298:INFO: Experiment Progress: 42.0% -- 222/519
2018-05-28 14:23:01,638:INFO: Pseudohypoaldosteronism Recall-at-100: 66.67%
2018-05-28 14:23:01,638:INFO: Experiment Progress: 42.0% -- 223/519
2018-05-28 14:23:02,120:INFO: Cataract Recall-at-100: 31.67%
2018-05-28 14:23:02,121:INFO: Experiment Progress: 43.0% -- 224/519
2018-05-28 14:23:02,522:INFO: Giant Cell Glioblastoma Recall-at-100: 35.00%
2018-05-28 14:23:02,522:INFO: Experiment Progress: 43.0% -- 225/519
2018-05-28 14:23:02,978:INFO: Seizure Adverse Event Recall-at-100: 0.00%
2018-05-28 14:23:02,979:INFO: Experiment Progress: 43.0% -- 226/519
2018-05-28 14:23:03,371:INFO: Body Weight Recall-at-100: 0.00%
2018-05-28 14:23:03,372:INFO: Experiment Progress: 43.0% -- 227/519
2018-05-28 14:23:03,764:INFO: Huntington Disease Recall-at-100: 0.00%
2018-05-28 14:23:03,764:INFO: Experiment Progress: 43.0% -- 228/519
2018-05-28 14:23:04,611:INFO: Glioblastoma Recall-at-100: 11.43%
2018-05-28 14:23:04,611:INFO: Experiment Progress: 44.0% -- 229/519
2018-05-28 14:23:04,995:INFO: Congenital diaphragmatic hernia Recall-at-100: 20.00%
2018-05-28 14:23:04,995:INFO: Experiment Progress: 44.0% -- 230/519
2018-05-28 14:23:05,484:INFO: Systemic Scleroderma Recall-at-100: 0.00%
2018-05-28 14:23:05,485:INFO: Experiment Progress: 44.0% -- 231/519
2018-05-28 14:23:06,357:INFO: Acute kidney injury Recall-at-100: 10.24%
2018-05-28 14:23:06,357:INFO: Experiment Progress: 44.0% -- 232/519
2018-05-28 14:23:06,766:INFO: Copper-Overload Cirrhosis Recall-at-100: 10.00%
2018-05-28 14:23:06,766:INFO: Experiment Progress: 44.0% -- 233/519
2018-05-28 14:23:07,978:INFO: Spontaneous abortion Recall-at-100: 6.82%
2018-05-28 14:23:07,978:INFO: Experiment Progress: 45.0% -- 234/519
2018-05-28 14:23:09,258:INFO: Glioma Recall-at-100: 7.38%
2018-05-28 14:23:09,259:INFO: Experiment Progress: 45.0% -- 235/519
2018-05-28 14:23:09,712:INFO: Gliosis Recall-at-100: 60.00%
2018-05-28 14:23:09,712:INFO: Experiment Progress: 45.0% -- 236/519
2018-05-28 14:23:10,139:INFO: LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 80.00%
2018-05-28 14:23:10,139:INFO: Experiment Progress: 45.0% -- 237/519
2018-05-28 14:23:10,537:INFO: Dementia Recall-at-100: 0.00%
2018-05-28 14:23:10,537:INFO: Experiment Progress: 45.0% -- 238/519
2018-05-28 14:23:11,014:INFO: Pancreatitis Recall-at-100: 10.00%
2018-05-28 14:23:11,014:INFO: Experiment Progress: 46.0% -- 239/519
2018-05-28 14:23:11,440:INFO: Amino Acid Metabolism, Inborn Errors Recall-at-100: 0.00%
2018-05-28 14:23:11,440:INFO: Experiment Progress: 46.0% -- 240/519
2018-05-28 14:23:12,123:INFO: Thyroid Neoplasm Recall-at-100: 10.00%
2018-05-28 14:23:12,123:INFO: Experiment Progress: 46.0% -- 241/519
2018-05-28 14:23:14,429:INFO: Neoplasm Invasiveness Recall-at-100: 13.53%
2018-05-28 14:23:14,429:INFO: Experiment Progress: 46.0% -- 242/519
2018-05-28 14:23:16,261:INFO: Neoplasm Metastasis Recall-at-100: 12.25%
2018-05-28 14:23:16,262:INFO: Experiment Progress: 46.0% -- 243/519
2018-05-28 14:23:16,793:INFO: Albuminuria Recall-at-100: 20.00%
2018-05-28 14:23:16,793:INFO: Experiment Progress: 47.0% -- 244/519
2018-05-28 14:23:17,309:INFO: Pre-Eclampsia Recall-at-100: 10.00%
2018-05-28 14:23:17,310:INFO: Experiment Progress: 47.0% -- 245/519
2018-05-28 14:23:18,443:INFO: Nerve Degeneration Recall-at-100: 11.96%
2018-05-28 14:23:18,443:INFO: Experiment Progress: 47.0% -- 246/519
2018-05-28 14:23:18,876:INFO: Thromboembolism Recall-at-100: 75.00%
2018-05-28 14:23:18,877:INFO: Experiment Progress: 47.0% -- 247/519
2018-05-28 14:23:20,705:INFO: Polycystic Ovary Syndrome Recall-at-100: 2.05%
2018-05-28 14:23:20,705:INFO: Experiment Progress: 47.0% -- 248/519
2018-05-28 14:23:21,128:INFO: Transient Ischemic Attack Recall-at-100: 30.00%
2018-05-28 14:23:21,128:INFO: Experiment Progress: 47.0% -- 249/519
2018-05-28 14:23:22,046:INFO: Brain Ischemia Recall-at-100: 20.00%
2018-05-28 14:23:22,046:INFO: Experiment Progress: 48.0% -- 250/519
2018-05-28 14:23:22,444:INFO: Cerebral Infarction Recall-at-100: 40.00%
2018-05-28 14:23:22,444:INFO: Experiment Progress: 48.0% -- 251/519
2018-05-28 14:23:22,920:INFO: Malignant neoplasm of esophagus Recall-at-100: 20.00%
2018-05-28 14:23:22,920:INFO: Experiment Progress: 48.0% -- 252/519
2018-05-28 14:23:24,103:INFO: Degenerative polyarthritis Recall-at-100: 6.44%
2018-05-28 14:23:24,103:INFO: Experiment Progress: 48.0% -- 253/519
2018-05-28 14:23:24,395:INFO: Osteitis Deformans Recall-at-100: 0.00%
2018-05-28 14:23:24,395:INFO: Experiment Progress: 48.0% -- 254/519
2018-05-28 14:23:24,802:INFO: Diabetic Cardiomyopathies Recall-at-100: 20.00%
2018-05-28 14:23:24,802:INFO: Experiment Progress: 49.0% -- 255/519
2018-05-28 14:23:25,193:INFO: Nuclear cataract Recall-at-100: 50.00%
2018-05-28 14:23:25,193:INFO: Experiment Progress: 49.0% -- 256/519
2018-05-28 14:23:25,648:INFO: Anorexia Recall-at-100: 65.00%
2018-05-28 14:23:25,648:INFO: Experiment Progress: 49.0% -- 257/519
2018-05-28 14:23:26,761:INFO: Cocaine-Related Disorders Recall-at-100: 11.81%
2018-05-28 14:23:26,761:INFO: Experiment Progress: 49.0% -- 258/519
2018-05-28 14:23:27,141:INFO: MELAS Syndrome Recall-at-100: 60.00%
2018-05-28 14:23:27,141:INFO: Experiment Progress: 49.0% -- 259/519
2018-05-28 14:23:27,351:INFO: Mitochondrial Myopathies Recall-at-100: 33.33%
2018-05-28 14:23:27,351:INFO: Experiment Progress: 50.0% -- 260/519
2018-05-28 14:23:28,345:INFO: Amphetamine-Related Disorders Recall-at-100: 3.93%
2018-05-28 14:23:28,345:INFO: Experiment Progress: 50.0% -- 261/519
2018-05-28 14:23:28,707:INFO: Birth Weight Recall-at-100: 0.00%
2018-05-28 14:23:28,707:INFO: Experiment Progress: 50.0% -- 262/519
2018-05-28 14:23:29,220:INFO: Brain Diseases Recall-at-100: 0.00%
2018-05-28 14:23:29,220:INFO: Experiment Progress: 50.0% -- 263/519
2018-05-28 14:23:29,655:INFO: Dyslipidemias Recall-at-100: 30.00%
2018-05-28 14:23:29,655:INFO: Experiment Progress: 50.0% -- 264/519
2018-05-28 14:23:29,990:INFO: Berylliosis Recall-at-100: 0.00%
2018-05-28 14:23:29,991:INFO: Experiment Progress: 51.0% -- 265/519
2018-05-28 14:23:30,458:INFO: Mental Retardation, X-Linked Recall-at-100: 0.00%
2018-05-28 14:23:30,459:INFO: Experiment Progress: 51.0% -- 266/519
2018-05-28 14:23:30,762:INFO: Sarcoidosis Recall-at-100: 0.00%
2018-05-28 14:23:30,762:INFO: Experiment Progress: 51.0% -- 267/519
2018-05-28 14:23:32,129:INFO: Liver neoplasms Recall-at-100: 8.64%
2018-05-28 14:23:32,129:INFO: Experiment Progress: 51.0% -- 268/519
2018-05-28 14:23:32,751:INFO: Myocardial Reperfusion Injury Recall-at-100: 18.33%
2018-05-28 14:23:32,751:INFO: Experiment Progress: 51.0% -- 269/519
2018-05-28 14:23:33,166:INFO: Microsatellite Instability Recall-at-100: 0.00%
2018-05-28 14:23:33,166:INFO: Experiment Progress: 52.0% -- 270/519
2018-05-28 14:23:33,522:INFO: Night blindness, congenital stationary Recall-at-100: 25.00%
2018-05-28 14:23:33,522:INFO: Experiment Progress: 52.0% -- 271/519
2018-05-28 14:23:34,125:INFO: Stevens-Johnson Syndrome Recall-at-100: 26.67%
2018-05-28 14:23:34,125:INFO: Experiment Progress: 52.0% -- 272/519
2018-05-28 14:23:34,562:INFO: Leukemia, Lymphocytic, Acute, L1 Recall-at-100: 0.00%
2018-05-28 14:23:34,562:INFO: Experiment Progress: 52.0% -- 273/519
2018-05-28 14:23:35,346:INFO: Systemic arterial pressure Recall-at-100: 0.00%
2018-05-28 14:23:35,346:INFO: Experiment Progress: 52.0% -- 274/519
2018-05-28 14:23:35,904:INFO: Learning Disorders Recall-at-100: 10.00%
2018-05-28 14:23:35,905:INFO: Experiment Progress: 52.0% -- 275/519
2018-05-28 14:23:36,318:INFO: Walker-Warburg congenital muscular dystrophy Recall-at-100: 30.00%
2018-05-28 14:23:36,318:INFO: Experiment Progress: 53.0% -- 276/519
2018-05-28 14:23:36,700:INFO: Marfan Syndrome Recall-at-100: 50.00%
2018-05-28 14:23:36,700:INFO: Experiment Progress: 53.0% -- 277/519
2018-05-28 14:23:37,144:INFO: Congenital ocular coloboma (disorder) Recall-at-100: 10.00%
2018-05-28 14:23:37,144:INFO: Experiment Progress: 53.0% -- 278/519
2018-05-28 14:23:39,039:INFO: Lung Neoplasms Recall-at-100: 10.42%
2018-05-28 14:23:39,039:INFO: Experiment Progress: 53.0% -- 279/519
2018-05-28 14:23:39,288:INFO: Myoclonic Epilepsy, Juvenile Recall-at-100: 0.00%
2018-05-28 14:23:39,288:INFO: Experiment Progress: 53.0% -- 280/519
2018-05-28 14:23:40,350:INFO: Inflammatory Bowel Diseases Recall-at-100: 2.50%
2018-05-28 14:23:40,351:INFO: Experiment Progress: 54.0% -- 281/519
2018-05-28 14:23:44,786:INFO: Mammary Neoplasms Recall-at-100: 6.87%
2018-05-28 14:23:44,787:INFO: Experiment Progress: 54.0% -- 282/519
2018-05-28 14:23:45,062:INFO: Idiopathic generalized epilepsy Recall-at-100: 0.00%
2018-05-28 14:23:45,062:INFO: Experiment Progress: 54.0% -- 283/519
2018-05-28 14:23:45,612:INFO: Neuralgia Recall-at-100: 0.00%
2018-05-28 14:23:45,612:INFO: Experiment Progress: 54.0% -- 284/519
2018-05-28 14:23:46,257:INFO: Neural Tube Defects Recall-at-100: 0.00%
2018-05-28 14:23:46,258:INFO: Experiment Progress: 54.0% -- 285/519
2018-05-28 14:23:47,399:INFO: Dermatitis, Allergic Contact Recall-at-100: 0.00%
2018-05-28 14:23:47,399:INFO: Experiment Progress: 55.0% -- 286/519
2018-05-28 14:23:47,836:INFO: Inborn Errors of Metabolism Recall-at-100: 10.00%
2018-05-28 14:23:47,837:INFO: Experiment Progress: 55.0% -- 287/519
2018-05-28 14:23:48,432:INFO: Platelet mean volume finding Recall-at-100: 0.00%
2018-05-28 14:23:48,432:INFO: Experiment Progress: 55.0% -- 288/519
2018-05-28 14:23:48,854:INFO: Intestinal Neoplasms Recall-at-100: 55.00%
2018-05-28 14:23:48,855:INFO: Experiment Progress: 55.0% -- 289/519
2018-05-28 14:23:49,252:INFO: Allergic rhinitis (disorder) Recall-at-100: 0.00%
2018-05-28 14:23:49,252:INFO: Experiment Progress: 55.0% -- 290/519
2018-05-28 14:23:50,047:INFO: Blood pressure finding Recall-at-100: 0.00%
2018-05-28 14:23:50,047:INFO: Experiment Progress: 56.0% -- 291/519
2018-05-28 14:23:50,694:INFO: Age related macular degeneration Recall-at-100: 14.17%
2018-05-28 14:23:50,694:INFO: Experiment Progress: 56.0% -- 292/519
2018-05-28 14:23:51,239:INFO: Hyperplasia Recall-at-100: 6.67%
2018-05-28 14:23:51,239:INFO: Experiment Progress: 56.0% -- 293/519
2018-05-28 14:23:51,838:INFO: Pulmonary function (finding) Recall-at-100: 0.00%
2018-05-28 14:23:51,839:INFO: Experiment Progress: 56.0% -- 294/519
2018-05-28 14:23:52,239:INFO: Spina Bifida Recall-at-100: 20.00%
2018-05-28 14:23:52,239:INFO: Experiment Progress: 56.0% -- 295/519
2018-05-28 14:23:52,752:INFO: Hypertrophic Cardiomyopathy Recall-at-100: 8.33%
2018-05-28 14:23:52,752:INFO: Experiment Progress: 57.0% -- 296/519
2018-05-28 14:23:53,258:INFO: Bardet-Biedl Syndrome Recall-at-100: 71.67%
2018-05-28 14:23:53,258:INFO: Experiment Progress: 57.0% -- 297/519
2018-05-28 14:23:53,879:INFO: Keloid Recall-at-100: 18.33%
2018-05-28 14:23:53,879:INFO: Experiment Progress: 57.0% -- 298/519
2018-05-28 14:23:55,992:INFO: melanoma Recall-at-100: 3.13%
2018-05-28 14:23:55,992:INFO: Experiment Progress: 57.0% -- 299/519
2018-05-28 14:23:56,514:INFO: LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3 Recall-at-100: 15.00%
2018-05-28 14:23:56,514:INFO: Experiment Progress: 57.0% -- 300/519
2018-05-28 14:23:57,233:INFO: Pneumonia Recall-at-100: 44.00%
2018-05-28 14:23:57,233:INFO: Experiment Progress: 57.0% -- 301/519
2018-05-28 14:23:58,762:INFO: Disease Progression Recall-at-100: 5.71%
2018-05-28 14:23:58,762:INFO: Experiment Progress: 58.0% -- 302/519
2018-05-28 14:23:59,231:INFO: Nephroblastoma Recall-at-100: 0.00%
2018-05-28 14:23:59,232:INFO: Experiment Progress: 58.0% -- 303/519
2018-05-28 14:23:59,629:INFO: Severe Combined Immunodeficiency Recall-at-100: 30.00%
2018-05-28 14:23:59,629:INFO: Experiment Progress: 58.0% -- 304/519
2018-05-28 14:24:00,047:INFO: Malignant neoplasm of ovary Recall-at-100: 10.00%
2018-05-28 14:24:00,047:INFO: Experiment Progress: 58.0% -- 305/519
2018-05-28 14:24:00,515:INFO: Pheochromocytoma Recall-at-100: 20.00%
2018-05-28 14:24:00,515:INFO: Experiment Progress: 58.0% -- 306/519
2018-05-28 14:24:01,015:INFO: Testicular Germ Cell Tumor Recall-at-100: 0.00%
2018-05-28 14:24:01,015:INFO: Experiment Progress: 59.0% -- 307/519
2018-05-28 14:24:01,410:INFO: Hypogonadism Recall-at-100: 55.00%
2018-05-28 14:24:01,411:INFO: Experiment Progress: 59.0% -- 308/519
2018-05-28 14:24:01,892:INFO: Movement Disorders Recall-at-100: 23.33%
2018-05-28 14:24:01,892:INFO: Experiment Progress: 59.0% -- 309/519
2018-05-28 14:24:02,314:INFO: Sarcoma Recall-at-100: 15.00%
2018-05-28 14:24:02,315:INFO: Experiment Progress: 59.0% -- 310/519
2018-05-28 14:24:02,740:INFO: Lymphatic Metastasis Recall-at-100: 0.00%
2018-05-28 14:24:02,741:INFO: Experiment Progress: 59.0% -- 311/519
2018-05-28 14:24:03,128:INFO: Hypoglycemia Recall-at-100: 30.00%
2018-05-28 14:24:03,129:INFO: Experiment Progress: 60.0% -- 312/519
2018-05-28 14:24:03,523:INFO: Anemia, Sickle Cell Recall-at-100: 0.00%
2018-05-28 14:24:03,523:INFO: Experiment Progress: 60.0% -- 313/519
2018-05-28 14:24:03,934:INFO: Muscular Dystrophy, Facioscapulohumeral Recall-at-100: 0.00%
2018-05-28 14:24:03,934:INFO: Experiment Progress: 60.0% -- 314/519
2018-05-28 14:24:04,520:INFO: Colorectal Cancer Recall-at-100: 6.67%
2018-05-28 14:24:04,520:INFO: Experiment Progress: 60.0% -- 315/519
2018-05-28 14:24:05,322:INFO: Atherosclerosis Recall-at-100: 10.67%
2018-05-28 14:24:05,322:INFO: Experiment Progress: 60.0% -- 316/519
2018-05-28 14:24:06,607:INFO: Asthma Recall-at-100: 2.91%
2018-05-28 14:24:06,607:INFO: Experiment Progress: 61.0% -- 317/519
2018-05-28 14:24:07,104:INFO: Cardiomyopathy, Hypertrophic, Familial Recall-at-100: 38.33%
2018-05-28 14:24:07,104:INFO: Experiment Progress: 61.0% -- 318/519
2018-05-28 14:24:07,835:INFO: Skin Neoplasms Recall-at-100: 14.50%
2018-05-28 14:24:07,835:INFO: Experiment Progress: 61.0% -- 319/519
2018-05-28 14:24:09,032:INFO: Seizures Recall-at-100: 6.44%
2018-05-28 14:24:09,032:INFO: Experiment Progress: 61.0% -- 320/519
2018-05-28 14:24:10,718:INFO: Alzheimer's Disease Recall-at-100: 5.52%
2018-05-28 14:24:10,718:INFO: Experiment Progress: 61.0% -- 321/519
2018-05-28 14:24:11,193:INFO: Menopause present (finding) Recall-at-100: 0.00%
2018-05-28 14:24:11,193:INFO: Experiment Progress: 62.0% -- 322/519
2018-05-28 14:24:11,969:INFO: Neoplastic Syndromes, Hereditary Recall-at-100: 28.50%
2018-05-28 14:24:11,969:INFO: Experiment Progress: 62.0% -- 323/519
2018-05-28 14:24:12,387:INFO: Gastrointestinal Diseases Recall-at-100: 20.00%
2018-05-28 14:24:12,387:INFO: Experiment Progress: 62.0% -- 324/519
2018-05-28 14:24:12,807:INFO: Cytochrome-c Oxidase Deficiency Recall-at-100: 40.00%
2018-05-28 14:24:12,807:INFO: Experiment Progress: 62.0% -- 325/519
2018-05-28 14:24:13,267:INFO: Retinal Degeneration Recall-at-100: 5.00%
2018-05-28 14:24:13,267:INFO: Experiment Progress: 62.0% -- 326/519
2018-05-28 14:24:13,779:INFO: Retinal Diseases Recall-at-100: 8.33%
2018-05-28 14:24:13,779:INFO: Experiment Progress: 63.0% -- 327/519
2018-05-28 14:24:14,168:INFO: Methylmalonic acidemia Recall-at-100: 40.00%
2018-05-28 14:24:14,168:INFO: Experiment Progress: 63.0% -- 328/519
2018-05-28 14:24:15,125:INFO: Contact Dermatitis Recall-at-100: 5.71%
2018-05-28 14:24:15,126:INFO: Experiment Progress: 63.0% -- 329/519
2018-05-28 14:24:15,792:INFO: Dermatitis, Atopic Recall-at-100: 35.00%
2018-05-28 14:24:15,792:INFO: Experiment Progress: 63.0% -- 330/519
2018-05-28 14:24:16,617:INFO: Coronary heart disease Recall-at-100: 5.00%
2018-05-28 14:24:16,617:INFO: Experiment Progress: 63.0% -- 331/519
2018-05-28 14:24:17,519:INFO: Osteoporosis Recall-at-100: 9.29%
2018-05-28 14:24:17,519:INFO: Experiment Progress: 63.0% -- 332/519
2018-05-28 14:24:18,408:INFO: Cardiomegaly Recall-at-100: 15.00%
2018-05-28 14:24:18,408:INFO: Experiment Progress: 64.0% -- 333/519
2018-05-28 14:24:19,400:INFO: Heart failure Recall-at-100: 6.25%
2018-05-28 14:24:19,401:INFO: Experiment Progress: 64.0% -- 334/519
2018-05-28 14:24:19,829:INFO: Hereditary Breast and Ovarian Cancer Syndrome Recall-at-100: 95.00%
2018-05-28 14:24:19,829:INFO: Experiment Progress: 64.0% -- 335/519
2018-05-28 14:24:20,421:INFO: Major Depressive Disorder Recall-at-100: 0.00%
2018-05-28 14:24:20,421:INFO: Experiment Progress: 64.0% -- 336/519
2018-05-28 14:24:21,307:INFO: Dermatologic disorders Recall-at-100: 0.00%
2018-05-28 14:24:21,307:INFO: Experiment Progress: 64.0% -- 337/519
2018-05-28 14:24:22,562:INFO: Inflammation Recall-at-100: 9.27%
2018-05-28 14:24:22,562:INFO: Experiment Progress: 65.0% -- 338/519
2018-05-28 14:24:22,973:INFO: Diabetic Neuropathies Recall-at-100: 25.00%
2018-05-28 14:24:22,973:INFO: Experiment Progress: 65.0% -- 339/519
2018-05-28 14:24:23,658:INFO: Male infertility Recall-at-100: 12.50%
2018-05-28 14:24:23,658:INFO: Experiment Progress: 65.0% -- 340/519
2018-05-28 14:24:24,099:INFO: Vascular Diseases Recall-at-100: 0.00%
2018-05-28 14:24:24,099:INFO: Experiment Progress: 65.0% -- 341/519
2018-05-28 14:24:24,651:INFO: Female infertility Recall-at-100: 35.00%
2018-05-28 14:24:24,651:INFO: Experiment Progress: 65.0% -- 342/519
2018-05-28 14:24:25,238:INFO: leukemia Recall-at-100: 22.50%
2018-05-28 14:24:25,239:INFO: Experiment Progress: 66.0% -- 343/519
2018-05-28 14:24:26,305:INFO: Ulcerative Colitis Recall-at-100: 7.50%
2018-05-28 14:24:26,305:INFO: Experiment Progress: 66.0% -- 344/519
2018-05-28 14:24:27,095:INFO: Influenza Recall-at-100: 20.00%
2018-05-28 14:24:27,096:INFO: Experiment Progress: 66.0% -- 345/519
2018-05-28 14:24:27,482:INFO: Nephritis, Interstitial Recall-at-100: 60.00%
2018-05-28 14:24:27,482:INFO: Experiment Progress: 66.0% -- 346/519
2018-05-28 14:24:27,885:INFO: Sjogren's Syndrome Recall-at-100: 20.00%
2018-05-28 14:24:27,885:INFO: Experiment Progress: 66.0% -- 347/519
2018-05-28 14:24:28,272:INFO: Infant length Recall-at-100: 0.00%
2018-05-28 14:24:28,272:INFO: Experiment Progress: 67.0% -- 348/519
2018-05-28 14:24:29,068:INFO: Child Development Disorders, Pervasive Recall-at-100: 15.67%
2018-05-28 14:24:29,069:INFO: Experiment Progress: 67.0% -- 349/519
2018-05-28 14:24:29,826:INFO: Substance Withdrawal Syndrome Recall-at-100: 23.67%
2018-05-28 14:24:29,826:INFO: Experiment Progress: 67.0% -- 350/519
2018-05-28 14:24:30,221:INFO: Malformations of Cortical Development Recall-at-100: 0.00%
2018-05-28 14:24:30,221:INFO: Experiment Progress: 67.0% -- 351/519
2018-05-28 14:24:31,134:INFO: Amyotrophic Lateral Sclerosis Recall-at-100: 8.10%
2018-05-28 14:24:31,134:INFO: Experiment Progress: 67.0% -- 352/519
2018-05-28 14:24:31,604:INFO: Developmental Disabilities Recall-at-100: 5.00%
2018-05-28 14:24:31,604:INFO: Experiment Progress: 68.0% -- 353/519
2018-05-28 14:24:31,990:INFO: Febrile Convulsions Recall-at-100: 0.00%
2018-05-28 14:24:31,990:INFO: Experiment Progress: 68.0% -- 354/519
2018-05-28 14:24:32,650:INFO: Cholestasis Recall-at-100: 7.50%
2018-05-28 14:24:32,651:INFO: Experiment Progress: 68.0% -- 355/519
2018-05-28 14:24:33,231:INFO: Pulmonary Hypertension Recall-at-100: 0.00%
2018-05-28 14:24:33,231:INFO: Experiment Progress: 68.0% -- 356/519
2018-05-28 14:24:33,763:INFO: Papillary thyroid carcinoma Recall-at-100: 10.00%
2018-05-28 14:24:33,763:INFO: Experiment Progress: 68.0% -- 357/519
2018-05-28 14:24:34,492:INFO: Salivary Gland Neoplasms Recall-at-100: 0.00%
2018-05-28 14:24:34,492:INFO: Experiment Progress: 68.0% -- 358/519
2018-05-28 14:24:35,181:INFO: Non-alcoholic Fatty Liver Disease Recall-at-100: 0.00%
2018-05-28 14:24:35,181:INFO: Experiment Progress: 69.0% -- 359/519
2018-05-28 14:24:35,582:INFO: Hay fever Recall-at-100: 0.00%
2018-05-28 14:24:35,582:INFO: Experiment Progress: 69.0% -- 360/519
2018-05-28 14:24:36,033:INFO: Hypercholesterolemia, Familial Recall-at-100: 55.00%
2018-05-28 14:24:36,033:INFO: Experiment Progress: 69.0% -- 361/519
2018-05-28 14:24:37,236:INFO: Down Syndrome Recall-at-100: 1.11%
2018-05-28 14:24:37,236:INFO: Experiment Progress: 69.0% -- 362/519
2018-05-28 14:24:37,625:INFO: Arrhythmogenic Right Ventricular Dysplasia Recall-at-100: 40.00%
2018-05-28 14:24:37,625:INFO: Experiment Progress: 69.0% -- 363/519
2018-05-28 14:24:38,039:INFO: Semilobar Holoprosencephaly Recall-at-100: 25.00%
2018-05-28 14:24:38,039:INFO: Experiment Progress: 70.0% -- 364/519
2018-05-28 14:24:38,441:INFO: Hypertriglyceridemia Recall-at-100: 20.00%
2018-05-28 14:24:38,441:INFO: Experiment Progress: 70.0% -- 365/519
2018-05-28 14:24:38,774:INFO: Sensorineural Hearing Loss (disorder) Recall-at-100: 22.22%
2018-05-28 14:24:38,774:INFO: Experiment Progress: 70.0% -- 366/519
2018-05-28 14:24:39,482:INFO: Metabolic Syndrome X Recall-at-100: 7.50%
2018-05-28 14:24:39,482:INFO: Experiment Progress: 70.0% -- 367/519
2018-05-28 14:24:39,940:INFO: Malignant neoplasm of lung Recall-at-100: 0.00%
2018-05-28 14:24:39,940:INFO: Experiment Progress: 70.0% -- 368/519
2018-05-28 14:24:41,547:INFO: Leukemia, Myelocytic, Acute Recall-at-100: 5.30%
2018-05-28 14:24:41,547:INFO: Experiment Progress: 71.0% -- 369/519
2018-05-28 14:24:42,640:INFO: Malignant neoplasm of prostate Recall-at-100: 4.76%
2018-05-28 14:24:42,641:INFO: Experiment Progress: 71.0% -- 370/519
2018-05-28 14:24:43,120:INFO: Renal Insufficiency Recall-at-100: 40.00%
2018-05-28 14:24:43,120:INFO: Experiment Progress: 71.0% -- 371/519
2018-05-28 14:24:43,806:INFO: Jeune thoracic dystrophy Recall-at-100: 66.67%
2018-05-28 14:24:43,806:INFO: Experiment Progress: 71.0% -- 372/519
2018-05-28 14:24:45,811:INFO: Renal Cell Carcinoma Recall-at-100: 5.77%
2018-05-28 14:24:45,811:INFO: Experiment Progress: 71.0% -- 373/519
2018-05-28 14:24:46,943:INFO: Squamous cell carcinoma Recall-at-100: 17.22%
2018-05-28 14:24:46,943:INFO: Experiment Progress: 72.0% -- 374/519
2018-05-28 14:24:48,373:INFO: Non-Small Cell Lung Carcinoma Recall-at-100: 7.12%
2018-05-28 14:24:48,373:INFO: Experiment Progress: 72.0% -- 375/519
2018-05-28 14:24:48,809:INFO: Manganese Poisoning Recall-at-100: 20.00%
2018-05-28 14:24:48,809:INFO: Experiment Progress: 72.0% -- 376/519
2018-05-28 14:24:49,277:INFO: Ventricular Dysfunction, Left Recall-at-100: 10.00%
2018-05-28 14:24:49,277:INFO: Experiment Progress: 72.0% -- 377/519
2018-05-28 14:24:49,931:INFO: Carcinoma, Transitional Cell Recall-at-100: 18.33%
2018-05-28 14:24:49,931:INFO: Experiment Progress: 72.0% -- 378/519
2018-05-28 14:24:50,361:INFO: Mucocutaneous Lymph Node Syndrome Recall-at-100: 0.00%
2018-05-28 14:24:50,361:INFO: Experiment Progress: 73.0% -- 379/519
2018-05-28 14:24:50,782:INFO: Tobacco Use Disorder Recall-at-100: 20.00%
2018-05-28 14:24:50,782:INFO: Experiment Progress: 73.0% -- 380/519
2018-05-28 14:24:51,506:INFO: Proteinuria Recall-at-100: 13.33%
2018-05-28 14:24:51,507:INFO: Experiment Progress: 73.0% -- 381/519
2018-05-28 14:24:52,347:INFO: Diabetic Nephropathy Recall-at-100: 0.00%
2018-05-28 14:24:52,347:INFO: Experiment Progress: 73.0% -- 382/519
2018-05-28 14:24:52,823:INFO: Williams Syndrome Recall-at-100: 10.00%
2018-05-28 14:24:52,824:INFO: Experiment Progress: 73.0% -- 383/519
2018-05-28 14:24:53,326:INFO: Oral Submucous Fibrosis Recall-at-100: 50.00%
2018-05-28 14:24:53,327:INFO: Experiment Progress: 73.0% -- 384/519
2018-05-28 14:24:54,018:INFO: Adenoma Recall-at-100: 6.67%
2018-05-28 14:24:54,018:INFO: Experiment Progress: 74.0% -- 385/519
2018-05-28 14:24:54,489:INFO: Neutropenia Recall-at-100: 10.00%
2018-05-28 14:24:54,489:INFO: Experiment Progress: 74.0% -- 386/519
2018-05-28 14:24:54,950:INFO: Poor school performance Recall-at-100: 0.00%
2018-05-28 14:24:54,950:INFO: Experiment Progress: 74.0% -- 387/519
2018-05-28 14:24:55,424:INFO: Pneumoconiosis Recall-at-100: 0.00%
2018-05-28 14:24:55,424:INFO: Experiment Progress: 74.0% -- 388/519
2018-05-28 14:24:56,349:INFO: Cardiovascular Diseases Recall-at-100: 12.00%
2018-05-28 14:24:56,350:INFO: Experiment Progress: 74.0% -- 389/519
2018-05-28 14:24:56,881:INFO: Fibrinogen Adverse Event Recall-at-100: 10.00%
2018-05-28 14:24:56,882:INFO: Experiment Progress: 75.0% -- 390/519
2018-05-28 14:24:58,870:INFO: Diabetes Mellitus, Non-Insulin-Dependent Recall-at-100: 6.46%
2018-05-28 14:24:58,870:INFO: Experiment Progress: 75.0% -- 391/519
2018-05-28 14:24:59,523:INFO: Thrombocytopenia Recall-at-100: 15.00%
2018-05-28 14:24:59,524:INFO: Experiment Progress: 75.0% -- 392/519
2018-05-28 14:25:00,108:INFO: Sezary Syndrome Recall-at-100: 25.00%
2018-05-28 14:25:00,109:INFO: Experiment Progress: 75.0% -- 393/519
2018-05-28 14:25:00,519:INFO: Nuclear non-senile cataract Recall-at-100: 50.00%
2018-05-28 14:25:00,519:INFO: Experiment Progress: 75.0% -- 394/519
2018-05-28 14:25:01,036:INFO: Diabetic Retinopathy Recall-at-100: 0.00%
2018-05-28 14:25:01,036:INFO: Experiment Progress: 76.0% -- 395/519
2018-05-28 14:25:01,816:INFO: hearing impairment Recall-at-100: 0.00%
2018-05-28 14:25:01,816:INFO: Experiment Progress: 76.0% -- 396/519
2018-05-28 14:25:02,346:INFO: Psychotic Disorders Recall-at-100: 25.00%
2018-05-28 14:25:02,346:INFO: Experiment Progress: 76.0% -- 397/519
2018-05-28 14:25:03,256:INFO: Anxiety Disorders Recall-at-100: 8.33%
2018-05-28 14:25:03,256:INFO: Experiment Progress: 76.0% -- 398/519
2018-05-28 14:25:04,021:INFO: Finding of Mean Corpuscular Hemoglobin Recall-at-100: 15.00%
2018-05-28 14:25:04,022:INFO: Experiment Progress: 76.0% -- 399/519
2018-05-28 14:25:04,753:INFO: Motion Sickness Recall-at-100: 0.00%
2018-05-28 14:25:04,753:INFO: Experiment Progress: 77.0% -- 400/519
2018-05-28 14:25:05,438:INFO: Lymphoma, Non-Hodgkin Recall-at-100: 28.33%
2018-05-28 14:25:05,438:INFO: Experiment Progress: 77.0% -- 401/519
2018-05-28 14:25:06,156:INFO: Lymphoma, Follicular Recall-at-100: 5.00%
2018-05-28 14:25:06,156:INFO: Experiment Progress: 77.0% -- 402/519
2018-05-28 14:25:06,587:INFO: Thrombocythemia, Essential Recall-at-100: 25.00%
2018-05-28 14:25:06,587:INFO: Experiment Progress: 77.0% -- 403/519
2018-05-28 14:25:07,016:INFO: Arthritis Recall-at-100: 0.00%
2018-05-28 14:25:07,016:INFO: Experiment Progress: 77.0% -- 404/519
2018-05-28 14:25:07,826:INFO: Hypotension Recall-at-100: 28.33%
2018-05-28 14:25:07,826:INFO: Experiment Progress: 78.0% -- 405/519
2018-05-28 14:25:08,962:INFO: Reperfusion Injury Recall-at-100: 15.14%
2018-05-28 14:25:08,962:INFO: Experiment Progress: 78.0% -- 406/519
2018-05-28 14:25:09,404:INFO: Heat Stroke Recall-at-100: 70.00%
2018-05-28 14:25:09,404:INFO: Experiment Progress: 78.0% -- 407/519
2018-05-28 14:25:09,907:INFO: Hemangiosarcoma Recall-at-100: 55.00%
2018-05-28 14:25:09,907:INFO: Experiment Progress: 78.0% -- 408/519
2018-05-28 14:25:10,563:INFO: Drug Allergy Recall-at-100: 11.67%
2018-05-28 14:25:10,563:INFO: Experiment Progress: 78.0% -- 409/519
2018-05-28 14:25:10,996:INFO: SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR Recall-at-100: 25.00%
2018-05-28 14:25:10,997:INFO: Experiment Progress: 78.0% -- 410/519
2018-05-28 14:25:11,763:INFO: Medulloblastoma Recall-at-100: 9.50%
2018-05-28 14:25:11,763:INFO: Experiment Progress: 79.0% -- 411/519
2018-05-28 14:25:12,299:INFO: Cleft Lip Recall-at-100: 50.00%
2018-05-28 14:25:12,299:INFO: Experiment Progress: 79.0% -- 412/519
2018-05-28 14:25:13,017:INFO: Cleft Palate Recall-at-100: 22.50%
2018-05-28 14:25:13,017:INFO: Experiment Progress: 79.0% -- 413/519
2018-05-28 14:25:14,264:INFO: Muscle Weakness Recall-at-100: 0.00%
2018-05-28 14:25:14,264:INFO: Experiment Progress: 79.0% -- 414/519
2018-05-28 14:25:14,679:INFO: Mental disorders Recall-at-100: 10.00%
2018-05-28 14:25:14,679:INFO: Experiment Progress: 79.0% -- 415/519
2018-05-28 14:25:15,244:INFO: Astrocytoma Recall-at-100: 36.67%
2018-05-28 14:25:15,244:INFO: Experiment Progress: 80.0% -- 416/519
2018-05-28 14:25:15,679:INFO: Anemia, Diamond-Blackfan Recall-at-100: 85.00%
2018-05-28 14:25:15,680:INFO: Experiment Progress: 80.0% -- 417/519
2018-05-28 14:25:16,106:INFO: Asthma, Aspirin-Induced Recall-at-100: 20.00%
2018-05-28 14:25:16,106:INFO: Experiment Progress: 80.0% -- 418/519
2018-05-28 14:25:16,622:INFO: Leber Congenital Amaurosis Recall-at-100: 10.00%
2018-05-28 14:25:16,622:INFO: Experiment Progress: 80.0% -- 419/519
2018-05-28 14:25:17,024:INFO: Cachexia Recall-at-100: 0.00%
2018-05-28 14:25:17,025:INFO: Experiment Progress: 80.0% -- 420/519
2018-05-28 14:25:17,442:INFO: Respiratory Insufficiency Recall-at-100: 0.00%
2018-05-28 14:25:17,442:INFO: Experiment Progress: 81.0% -- 421/519
2018-05-28 14:25:17,924:INFO: Respiratory Hypersensitivity Recall-at-100: 10.00%
2018-05-28 14:25:17,924:INFO: Experiment Progress: 81.0% -- 422/519
2018-05-28 14:25:18,429:INFO: Nasopharyngeal carcinoma Recall-at-100: 10.00%
2018-05-28 14:25:18,429:INFO: Experiment Progress: 81.0% -- 423/519
2018-05-28 14:25:19,465:INFO: Hyperalgesia Recall-at-100: 20.00%
2018-05-28 14:25:19,465:INFO: Experiment Progress: 81.0% -- 424/519
2018-05-28 14:25:19,884:INFO: Meningioma Recall-at-100: 35.00%
2018-05-28 14:25:19,884:INFO: Experiment Progress: 81.0% -- 425/519
2018-05-28 14:25:20,336:INFO: Sudden Cardiac Arrest Recall-at-100: 0.00%
2018-05-28 14:25:20,336:INFO: Experiment Progress: 82.0% -- 426/519
2018-05-28 14:25:22,341:INFO: Intellectual Disability Recall-at-100: 0.77%
2018-05-28 14:25:22,341:INFO: Experiment Progress: 82.0% -- 427/519
2018-05-28 14:25:22,790:INFO: Graves Disease Recall-at-100: 10.00%
2018-05-28 14:25:22,790:INFO: Experiment Progress: 82.0% -- 428/519
2018-05-28 14:25:23,395:INFO: Neurotoxicity Syndromes Recall-at-100: 0.00%
2018-05-28 14:25:23,395:INFO: Experiment Progress: 82.0% -- 429/519
2018-05-28 14:25:23,785:INFO: Cardiomyopathy, Familial Hypertrophic, 1 (disorder) Recall-at-100: 70.00%
2018-05-28 14:25:23,785:INFO: Experiment Progress: 82.0% -- 430/519
2018-05-28 14:25:24,317:INFO: Atrial Fibrillation Recall-at-100: 8.33%
2018-05-28 14:25:24,317:INFO: Experiment Progress: 83.0% -- 431/519
2018-05-28 14:25:24,837:INFO: Hepatitis, Chronic Recall-at-100: 28.33%
2018-05-28 14:25:24,837:INFO: Experiment Progress: 83.0% -- 432/519
2018-05-28 14:25:25,354:INFO: Behcet Syndrome Recall-at-100: 16.67%
2018-05-28 14:25:25,354:INFO: Experiment Progress: 83.0% -- 433/519
2018-05-28 14:25:26,352:INFO: Diabetes Mellitus, Insulin-Dependent Recall-at-100: 5.71%
2018-05-28 14:25:26,352:INFO: Experiment Progress: 83.0% -- 434/519
2018-05-28 14:25:27,602:INFO: Diabetes Mellitus, Experimental Recall-at-100: 8.55%
2018-05-28 14:25:27,602:INFO: Experiment Progress: 83.0% -- 435/519
2018-05-28 14:25:28,123:INFO: Parkinsonian Disorders Recall-at-100: 21.67%
2018-05-28 14:25:28,123:INFO: Experiment Progress: 84.0% -- 436/519
2018-05-28 14:25:28,924:INFO: Necrosis Recall-at-100: 12.00%
2018-05-28 14:25:28,924:INFO: Experiment Progress: 84.0% -- 437/519
2018-05-28 14:25:29,329:INFO: Gestational Diabetes Recall-at-100: 0.00%
2018-05-28 14:25:29,329:INFO: Experiment Progress: 84.0% -- 438/519
2018-05-28 14:25:29,770:INFO: Idiopathic Membranous Glomerulonephritis Recall-at-100: 0.00%
2018-05-28 14:25:29,770:INFO: Experiment Progress: 84.0% -- 439/519
2018-05-28 14:25:30,851:INFO: Hypersensitivity Recall-at-100: 32.14%
2018-05-28 14:25:30,851:INFO: Experiment Progress: 84.0% -- 440/519
2018-05-28 14:25:31,447:INFO: Myopia Recall-at-100: 3.33%
2018-05-28 14:25:31,447:INFO: Experiment Progress: 84.0% -- 441/519
2018-05-28 14:25:31,885:INFO: Hyperemia Recall-at-100: 20.00%
2018-05-28 14:25:31,885:INFO: Experiment Progress: 85.0% -- 442/519
2018-05-28 14:25:32,291:INFO: Tooth Abnormalities Recall-at-100: 10.00%
2018-05-28 14:25:32,291:INFO: Experiment Progress: 85.0% -- 443/519
2018-05-28 14:25:32,788:INFO: Hyperglycemia Recall-at-100: 10.00%
2018-05-28 14:25:32,788:INFO: Experiment Progress: 85.0% -- 444/519
2018-05-28 14:25:33,267:INFO: Noonan Syndrome Recall-at-100: 70.00%
2018-05-28 14:25:33,267:INFO: Experiment Progress: 85.0% -- 445/519
2018-05-28 14:25:33,719:INFO: Hyperinsulinism Recall-at-100: 25.00%
2018-05-28 14:25:33,719:INFO: Experiment Progress: 85.0% -- 446/519
2018-05-28 14:25:34,284:INFO: Edema Recall-at-100: 16.67%
2018-05-28 14:25:34,285:INFO: Experiment Progress: 86.0% -- 447/519
2018-05-28 14:25:34,731:INFO: Hodgkin Disease Recall-at-100: 0.00%
2018-05-28 14:25:34,731:INFO: Experiment Progress: 86.0% -- 448/519
2018-05-28 14:25:35,131:INFO: Metabolic Bone Disorder Recall-at-100: 0.00%
2018-05-28 14:25:35,131:INFO: Experiment Progress: 86.0% -- 449/519
2018-05-28 14:25:35,652:INFO: Bone Diseases, Developmental Recall-at-100: 0.00%
2018-05-28 14:25:35,652:INFO: Experiment Progress: 86.0% -- 450/519
2018-05-28 14:25:36,035:INFO: Tachycardia, Ventricular Recall-at-100: 10.00%
2018-05-28 14:25:36,035:INFO: Experiment Progress: 86.0% -- 451/519
2018-05-28 14:25:36,463:INFO: Dystonia Recall-at-100: 0.00%
2018-05-28 14:25:36,463:INFO: Experiment Progress: 87.0% -- 452/519
2018-05-28 14:25:36,993:INFO: Squamous cell carcinoma of the head and neck Recall-at-100: 13.33%
2018-05-28 14:25:36,993:INFO: Experiment Progress: 87.0% -- 453/519
2018-05-28 14:25:37,385:INFO: Pulmonary Embolism Recall-at-100: 35.00%
2018-05-28 14:25:37,385:INFO: Experiment Progress: 87.0% -- 454/519
2018-05-28 14:25:38,132:INFO: Pulmonary Fibrosis Recall-at-100: 35.00%
2018-05-28 14:25:38,132:INFO: Experiment Progress: 87.0% -- 455/519
2018-05-28 14:25:38,579:INFO: West Syndrome Recall-at-100: 0.00%
2018-05-28 14:25:38,579:INFO: Experiment Progress: 87.0% -- 456/519
2018-05-28 14:25:39,135:INFO: Cerebral Hemorrhage Recall-at-100: 53.33%
2018-05-28 14:25:39,135:INFO: Experiment Progress: 88.0% -- 457/519
2018-05-28 14:25:39,554:INFO: Romano-Ward Syndrome Recall-at-100: 45.00%
2018-05-28 14:25:39,554:INFO: Experiment Progress: 88.0% -- 458/519
2018-05-28 14:25:40,268:INFO: Mouth Neoplasms Recall-at-100: 17.00%
2018-05-28 14:25:40,268:INFO: Experiment Progress: 88.0% -- 459/519
2018-05-28 14:25:41,083:INFO: Liver Cirrhosis Recall-at-100: 21.33%
2018-05-28 14:25:41,083:INFO: Experiment Progress: 88.0% -- 460/519
2018-05-28 14:25:41,609:INFO: Neoplasm Recurrence, Local Recall-at-100: 13.33%
2018-05-28 14:25:41,609:INFO: Experiment Progress: 88.0% -- 461/519
2018-05-28 14:25:44,417:INFO: Obesity Recall-at-100: 3.51%
2018-05-28 14:25:44,417:INFO: Experiment Progress: 89.0% -- 462/519
2018-05-28 14:25:45,017:INFO: Biliary cirrhosis Recall-at-100: 15.00%
2018-05-28 14:25:45,018:INFO: Experiment Progress: 89.0% -- 463/519
2018-05-28 14:25:45,763:INFO: Precursor Cell Lymphoblastic Leukemia Lymphoma Recall-at-100: 12.00%
2018-05-28 14:25:45,763:INFO: Experiment Progress: 89.0% -- 464/519
2018-05-28 14:25:47,146:INFO: Cardiomyopathies Recall-at-100: 7.78%
2018-05-28 14:25:47,146:INFO: Experiment Progress: 89.0% -- 465/519
2018-05-28 14:25:47,516:INFO: Peroxisome biogenesis disorders Recall-at-100: 100.00%
2018-05-28 14:25:47,516:INFO: Experiment Progress: 89.0% -- 466/519
2018-05-28 14:25:47,937:INFO: Dyskeratosis Congenita Recall-at-100: 55.00%
2018-05-28 14:25:47,937:INFO: Experiment Progress: 89.0% -- 467/519
2018-05-28 14:25:48,597:INFO: Uremia Recall-at-100: 15.00%
2018-05-28 14:25:48,597:INFO: Experiment Progress: 90.0% -- 468/519
2018-05-28 14:25:49,331:INFO: Depressive disorder Recall-at-100: 6.67%
2018-05-28 14:25:49,332:INFO: Experiment Progress: 90.0% -- 469/519
2018-05-28 14:25:49,954:INFO: Thrombosis Recall-at-100: 40.00%
2018-05-28 14:25:49,954:INFO: Experiment Progress: 90.0% -- 470/519
2018-05-28 14:25:50,753:INFO: nervous system disorder Recall-at-100: 5.67%
2018-05-28 14:25:50,754:INFO: Experiment Progress: 90.0% -- 471/519
2018-05-28 14:25:51,265:INFO: Lymphoma Recall-at-100: 0.00%
2018-05-28 14:25:51,265:INFO: Experiment Progress: 90.0% -- 472/519
2018-05-28 14:25:55,743:INFO: IGA Glomerulonephritis Recall-at-100: 1.40%
2018-05-28 14:25:55,744:INFO: Experiment Progress: 91.0% -- 473/519
2018-05-28 14:25:56,289:INFO: Kidney Neoplasm Recall-at-100: 16.67%
2018-05-28 14:25:56,289:INFO: Experiment Progress: 91.0% -- 474/519
2018-05-28 14:25:56,678:INFO: Hypothermia, natural Recall-at-100: 25.00%
2018-05-28 14:25:56,678:INFO: Experiment Progress: 91.0% -- 475/519
2018-05-28 14:25:57,175:INFO: Focal glomerulosclerosis Recall-at-100: 21.67%
2018-05-28 14:25:57,175:INFO: Experiment Progress: 91.0% -- 476/519
2018-05-28 14:25:57,592:INFO: Hepatitis B, Chronic Recall-at-100: 0.00%
2018-05-28 14:25:57,592:INFO: Experiment Progress: 91.0% -- 477/519
2018-05-28 14:25:58,035:INFO: Drug Eruptions Recall-at-100: 0.00%
2018-05-28 14:25:58,035:INFO: Experiment Progress: 92.0% -- 478/519
2018-05-28 14:25:58,450:INFO: Malignant neoplasm of pancreas Recall-at-100: 0.00%
2018-05-28 14:25:58,450:INFO: Experiment Progress: 92.0% -- 479/519
2018-05-28 14:26:01,258:INFO: Stomach Neoplasms Recall-at-100: 3.88%
2018-05-28 14:26:01,259:INFO: Experiment Progress: 92.0% -- 480/519
2018-05-28 14:26:01,869:INFO: Osteosarcoma Recall-at-100: 14.17%
2018-05-28 14:26:01,869:INFO: Experiment Progress: 92.0% -- 481/519
2018-05-28 14:26:02,455:INFO: Vitiligo Recall-at-100: 6.67%
2018-05-28 14:26:02,456:INFO: Experiment Progress: 92.0% -- 482/519
2018-05-28 14:26:02,909:INFO: Gastric ulcer Recall-at-100: 0.00%
2018-05-28 14:26:02,909:INFO: Experiment Progress: 93.0% -- 483/519
2018-05-28 14:26:03,806:INFO: Malignant neoplasm of breast Recall-at-100: 9.76%
2018-05-28 14:26:03,806:INFO: Experiment Progress: 93.0% -- 484/519
2018-05-28 14:26:05,117:INFO: Drug-Induced Liver Injury Recall-at-100: 9.24%
2018-05-28 14:26:05,117:INFO: Experiment Progress: 93.0% -- 485/519
2018-05-28 14:26:05,617:INFO: Colitis Recall-at-100: 6.67%
2018-05-28 14:26:05,617:INFO: Experiment Progress: 93.0% -- 486/519
2018-05-28 14:26:06,098:INFO: Lymphoma, T-Cell, Cutaneous Recall-at-100: 5.00%
2018-05-28 14:26:06,099:INFO: Experiment Progress: 93.0% -- 487/519
2018-05-28 14:26:06,504:INFO: T-Cell Lymphoma Recall-at-100: 40.00%
2018-05-28 14:26:06,504:INFO: Experiment Progress: 94.0% -- 488/519
2018-05-28 14:26:07,067:INFO: Hyperactive behavior Recall-at-100: 26.67%
2018-05-28 14:26:07,068:INFO: Experiment Progress: 94.0% -- 489/519
2018-05-28 14:26:07,435:INFO: Skin Abnormalities Recall-at-100: 0.00%
2018-05-28 14:26:07,435:INFO: Experiment Progress: 94.0% -- 490/519
2018-05-28 14:26:07,907:INFO: Epithelial ovarian cancer Recall-at-100: 0.00%
2018-05-28 14:26:07,907:INFO: Experiment Progress: 94.0% -- 491/519
2018-05-28 14:26:08,288:INFO: Infantile Refsum Disease (disorder) Recall-at-100: 100.00%
2018-05-28 14:26:08,289:INFO: Experiment Progress: 94.0% -- 492/519
2018-05-28 14:26:08,674:INFO: Adrenoleukodystrophy, Neonatal Recall-at-100: 100.00%
2018-05-28 14:26:08,674:INFO: Experiment Progress: 94.0% -- 493/519
2018-05-28 14:26:09,087:INFO: Hirschsprung Disease Recall-at-100: 30.00%
2018-05-28 14:26:09,087:INFO: Experiment Progress: 95.0% -- 494/519
2018-05-28 14:26:09,587:INFO: Female Urogenital Diseases Recall-at-100: 10.00%
2018-05-28 14:26:09,587:INFO: Experiment Progress: 95.0% -- 495/519
2018-05-28 14:26:10,815:INFO: ovarian neoplasm Recall-at-100: 12.33%
2018-05-28 14:26:10,815:INFO: Experiment Progress: 95.0% -- 496/519
2018-05-28 14:26:11,209:INFO: Aortic Aneurysm, Abdominal Recall-at-100: 15.00%
2018-05-28 14:26:11,209:INFO: Experiment Progress: 95.0% -- 497/519
2018-05-28 14:26:11,666:INFO: Venous Thrombosis Recall-at-100: 75.00%
2018-05-28 14:26:11,666:INFO: Experiment Progress: 95.0% -- 498/519
2018-05-28 14:26:12,120:INFO: Amnesia Recall-at-100: 20.00%
2018-05-28 14:26:12,120:INFO: Experiment Progress: 96.0% -- 499/519
2018-05-28 14:26:13,400:INFO: Bladder Neoplasm Recall-at-100: 9.55%
2018-05-28 14:26:13,400:INFO: Experiment Progress: 96.0% -- 500/519
2018-05-28 14:26:13,830:INFO: Hemorrhage Recall-at-100: 15.00%
2018-05-28 14:26:13,830:INFO: Experiment Progress: 96.0% -- 501/519
2018-05-28 14:26:14,799:INFO: Status Epilepticus Recall-at-100: 25.71%
2018-05-28 14:26:14,800:INFO: Experiment Progress: 96.0% -- 502/519
2018-05-28 14:26:15,285:INFO: Chronic Kidney Diseases Recall-at-100: 0.00%
2018-05-28 14:26:15,285:INFO: Experiment Progress: 96.0% -- 503/519
2018-05-28 14:26:15,797:INFO: Myeloid Leukemia, Chronic Recall-at-100: 26.67%
2018-05-28 14:26:15,797:INFO: Experiment Progress: 97.0% -- 504/519
2018-05-28 14:26:16,238:INFO: Myeloid Leukemia Recall-at-100: 35.00%
2018-05-28 14:26:16,238:INFO: Experiment Progress: 97.0% -- 505/519
2018-05-28 14:26:16,861:INFO: Calcinosis Recall-at-100: 12.50%
2018-05-28 14:26:16,861:INFO: Experiment Progress: 97.0% -- 506/519
2018-05-28 14:26:17,256:INFO: Creutzfeldt-Jakob disease Recall-at-100: 0.00%
2018-05-28 14:26:17,256:INFO: Experiment Progress: 97.0% -- 507/519
2018-05-28 14:26:17,649:INFO: Left ventricular noncompaction Recall-at-100: 10.00%
2018-05-28 14:26:17,649:INFO: Experiment Progress: 97.0% -- 508/519
2018-05-28 14:26:18,808:INFO: Parkinson Disease Recall-at-100: 4.22%
2018-05-28 14:26:18,808:INFO: Experiment Progress: 98.0% -- 509/519
2018-05-28 14:26:19,612:INFO: Endometrial Neoplasms Recall-at-100: 12.00%
2018-05-28 14:26:19,612:INFO: Experiment Progress: 98.0% -- 510/519
2018-05-28 14:26:20,106:INFO: Sepsis Recall-at-100: 20.00%
2018-05-28 14:26:20,107:INFO: Experiment Progress: 98.0% -- 511/519
2018-05-28 14:26:21,862:INFO: Endometriosis Recall-at-100: 14.42%
2018-05-28 14:26:21,863:INFO: Experiment Progress: 98.0% -- 512/519
2018-05-28 14:26:22,873:INFO: Esophageal Neoplasms Recall-at-100: 8.81%
2018-05-28 14:26:22,873:INFO: Experiment Progress: 98.0% -- 513/519
2018-05-28 14:26:23,382:INFO: Eosinophilic esophagitis Recall-at-100: 0.00%
2018-05-28 14:26:23,382:INFO: Experiment Progress: 99.0% -- 514/519
2018-05-28 14:26:23,894:INFO: Malignant neoplasm of urinary bladder Recall-at-100: 15.00%
2018-05-28 14:26:23,895:INFO: Experiment Progress: 99.0% -- 515/519
2018-05-28 14:26:24,577:INFO: Lewy Body Disease Recall-at-100: 30.00%
2018-05-28 14:26:24,577:INFO: Experiment Progress: 99.0% -- 516/519
2018-05-28 14:26:25,278:INFO: PARKINSON DISEASE, LATE-ONSET Recall-at-100: 10.00%
2018-05-28 14:26:25,278:INFO: Experiment Progress: 99.0% -- 517/519
2018-05-28 14:26:26,716:INFO: Neoplastic Cell Transformation Recall-at-100: 14.44%
2018-05-28 14:26:26,716:INFO: Experiment Progress: 99.0% -- 518/519
2018-05-28 14:26:27,882:INFO: Arsenic Poisoning Recall-at-100: 1.67%
2018-05-28 14:27:27,657:INFO: Disease Protein Prediction in the PPI Network
2018-05-28 14:27:27,657:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-28 14:27:27,657:INFO: ======================================
2018-05-28 14:27:27,657:INFO: Loading PPI Network...
2018-05-28 14:27:39,845:INFO: Loading Disease Associations...
2018-05-28 14:27:39,881:INFO: Loading PPI Matrix...
2018-05-28 14:27:46,704:INFO: Running Experiment...
2018-05-28 14:27:46,704:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-28 14:27:47,883:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 40.00%
2018-05-28 14:27:47,884:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-28 14:27:48,945:INFO: Psychoses, Substance-Induced Recall-at-100: 5.00%
2018-05-28 14:27:48,946:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-28 14:27:49,655:INFO: Zellweger Syndrome Recall-at-100: 100.00%
2018-05-28 14:27:49,655:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-28 14:27:52,160:INFO: Psoriasis Recall-at-100: 12.38%
2018-05-28 14:27:52,160:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-28 14:27:52,708:INFO: Nephrotic Syndrome Recall-at-100: 18.33%
2018-05-28 14:27:52,708:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-28 14:27:53,225:INFO: Nephrosis Recall-at-100: 20.00%
2018-05-28 14:27:53,225:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-28 14:27:53,735:INFO: Mouth Diseases Recall-at-100: 20.00%
2018-05-28 14:27:53,735:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-28 14:27:54,499:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 86.67%
2018-05-28 14:27:54,500:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-28 14:27:56,422:INFO: Substance-Related Disorders Recall-at-100: 2.91%
2018-05-28 14:27:56,423:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-28 14:27:56,829:INFO: Anemia, Hemolytic Recall-at-100: 25.00%
2018-05-28 14:27:56,830:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-28 14:27:59,147:INFO: Rheumatoid Arthritis Recall-at-100: 2.84%
2018-05-28 14:27:59,148:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-28 14:27:59,581:INFO: Arthritis, Psoriatic Recall-at-100: 10.00%
2018-05-28 14:27:59,582:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-28 14:28:00,251:INFO: Anemia Recall-at-100: 3.33%
2018-05-28 14:28:00,252:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-28 14:28:00,943:INFO: Cholangiocarcinoma Recall-at-100: 16.67%
2018-05-28 14:28:00,943:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-28 14:28:01,354:INFO: Neuroendocrine Tumors Recall-at-100: 30.00%
2018-05-28 14:28:01,355:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-28 14:28:02,051:INFO: Malaria Recall-at-100: 5.00%
2018-05-28 14:28:02,051:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-28 14:28:02,467:INFO: Hyperhomocysteinemia Recall-at-100: 15.00%
2018-05-28 14:28:02,467:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-28 14:28:03,880:INFO: HIV Infections Recall-at-100: 19.00%
2018-05-28 14:28:03,881:INFO: Experiment Progress: 3.0% -- 18/519
2018-05-28 14:28:04,614:INFO: Ankylosing spondylitis Recall-at-100: 20.00%
2018-05-28 14:28:04,615:INFO: Experiment Progress: 3.0% -- 19/519
2018-05-28 14:28:06,401:INFO: Adenoid Cystic Carcinoma Recall-at-100: 9.11%
2018-05-28 14:28:06,401:INFO: Experiment Progress: 3.0% -- 20/519
2018-05-28 14:28:08,057:INFO: Juvenile arthritis Recall-at-100: 5.00%
2018-05-28 14:28:08,057:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-28 14:28:08,783:INFO: Neoplasms, Experimental Recall-at-100: 12.50%
2018-05-28 14:28:08,783:INFO: Experiment Progress: 4.0% -- 22/519
2018-05-28 14:28:09,216:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 20.00%
2018-05-28 14:28:09,216:INFO: Experiment Progress: 4.0% -- 23/519
2018-05-28 14:28:09,546:INFO: Alopecia Areata Recall-at-100: 33.33%
2018-05-28 14:28:09,546:INFO: Experiment Progress: 4.0% -- 24/519
2018-05-28 14:28:10,090:INFO: Alopecia Recall-at-100: 5.00%
2018-05-28 14:28:10,090:INFO: Experiment Progress: 4.0% -- 25/519
2018-05-28 14:28:10,633:INFO: Bradycardia Recall-at-100: 50.00%
2018-05-28 14:28:10,633:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-28 14:28:11,071:INFO: Common Variable Immunodeficiency Recall-at-100: 65.00%
2018-05-28 14:28:11,071:INFO: Experiment Progress: 5.0% -- 27/519
2018-05-28 14:28:11,637:INFO: Glomerulonephritis Recall-at-100: 31.67%
2018-05-28 14:28:11,637:INFO: Experiment Progress: 5.0% -- 28/519
2018-05-28 14:28:12,346:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 0.00%
2018-05-28 14:28:12,346:INFO: Experiment Progress: 5.0% -- 29/519
2018-05-28 14:28:12,854:INFO: Lung Injury Recall-at-100: 30.00%
2018-05-28 14:28:12,854:INFO: Experiment Progress: 5.0% -- 30/519
2018-05-28 14:28:13,238:INFO: Hypercalcemia Recall-at-100: 20.00%
2018-05-28 14:28:13,239:INFO: Experiment Progress: 5.0% -- 31/519
2018-05-28 14:28:13,997:INFO: Cerebrovascular accident Recall-at-100: 22.50%
2018-05-28 14:28:13,997:INFO: Experiment Progress: 6.0% -- 32/519
2018-05-28 14:28:14,694:INFO: Diaphragmatic Hernia Recall-at-100: 15.00%
2018-05-28 14:28:14,694:INFO: Experiment Progress: 6.0% -- 33/519
2018-05-28 14:28:15,123:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 30.00%
2018-05-28 14:28:15,123:INFO: Experiment Progress: 6.0% -- 34/519
2018-05-28 14:28:15,702:INFO: Migraine Disorders Recall-at-100: 0.00%
2018-05-28 14:28:15,703:INFO: Experiment Progress: 6.0% -- 35/519
2018-05-28 14:28:15,927:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-05-28 14:28:15,927:INFO: Experiment Progress: 6.0% -- 36/519
2018-05-28 14:28:16,376:INFO: Brugada Syndrome (disorder) Recall-at-100: 15.00%
2018-05-28 14:28:16,378:INFO: Experiment Progress: 7.0% -- 37/519
2018-05-28 14:28:16,771:INFO: Pathological accumulation of air in tissues Recall-at-100: 30.00%
2018-05-28 14:28:16,771:INFO: Experiment Progress: 7.0% -- 38/519
2018-05-28 14:28:17,178:INFO: Craniosynostosis Recall-at-100: 15.00%
2018-05-28 14:28:17,178:INFO: Experiment Progress: 7.0% -- 39/519
2018-05-28 14:28:17,719:INFO: Head and Neck Neoplasms Recall-at-100: 13.33%
2018-05-28 14:28:17,719:INFO: Experiment Progress: 7.0% -- 40/519
2018-05-28 14:28:18,282:INFO: Brain Neoplasms Recall-at-100: 18.33%
2018-05-28 14:28:18,282:INFO: Experiment Progress: 7.0% -- 41/519
2018-05-28 14:28:19,087:INFO: Hearing Loss, Partial Recall-at-100: 0.00%
2018-05-28 14:28:19,087:INFO: Experiment Progress: 8.0% -- 42/519
2018-05-28 14:28:19,718:INFO: Chromosome Aberrations Recall-at-100: 10.00%
2018-05-28 14:28:19,718:INFO: Experiment Progress: 8.0% -- 43/519
2018-05-28 14:28:20,689:INFO: Chronic Lymphocytic Leukemia Recall-at-100: 8.00%
2018-05-28 14:28:20,690:INFO: Experiment Progress: 8.0% -- 44/519
2018-05-28 14:28:21,234:INFO: Refractive Errors Recall-at-100: 0.00%
2018-05-28 14:28:21,235:INFO: Experiment Progress: 8.0% -- 45/519
2018-05-28 14:28:21,679:INFO: Hepatitis C Recall-at-100: 10.00%
2018-05-28 14:28:21,679:INFO: Experiment Progress: 8.0% -- 46/519
2018-05-28 14:28:22,413:INFO: Mesothelioma Recall-at-100: 5.00%
2018-05-28 14:28:22,413:INFO: Experiment Progress: 9.0% -- 47/519
2018-05-28 14:28:22,632:INFO: Noise-induced hearing loss Recall-at-100: 20.00%
2018-05-28 14:28:22,632:INFO: Experiment Progress: 9.0% -- 48/519
2018-05-28 14:28:23,392:INFO: Inflammatory dermatosis Recall-at-100: 0.00%
2018-05-28 14:28:23,392:INFO: Experiment Progress: 9.0% -- 49/519
2018-05-28 14:28:23,936:INFO: Kallmann Syndrome Recall-at-100: 15.00%
2018-05-28 14:28:23,936:INFO: Experiment Progress: 9.0% -- 50/519
2018-05-28 14:28:24,507:INFO: Lipoidosis Recall-at-100: 10.00%
2018-05-28 14:28:24,508:INFO: Experiment Progress: 9.0% -- 51/519
2018-05-28 14:28:25,229:INFO: Diabetes Mellitus Recall-at-100: 3.33%
2018-05-28 14:28:25,229:INFO: Experiment Progress: 10.0% -- 52/519
2018-05-28 14:28:26,048:INFO: Fibrosis Recall-at-100: 20.00%
2018-05-28 14:28:26,048:INFO: Experiment Progress: 10.0% -- 53/519
2018-05-28 14:28:26,630:INFO: Hypercholesterolemia Recall-at-100: 5.00%
2018-05-28 14:28:26,631:INFO: Experiment Progress: 10.0% -- 54/519
2018-05-28 14:28:27,503:INFO: Microcephaly Recall-at-100: 15.00%
2018-05-28 14:28:27,504:INFO: Experiment Progress: 10.0% -- 55/519
2018-05-28 14:28:27,909:INFO: Tongue Neoplasms Recall-at-100: 0.00%
2018-05-28 14:28:27,910:INFO: Experiment Progress: 10.0% -- 56/519
2018-05-28 14:28:28,316:INFO: Common Migraine Recall-at-100: 0.00%
2018-05-28 14:28:28,317:INFO: Experiment Progress: 10.0% -- 57/519
2018-05-28 14:28:28,744:INFO: Carotid Artery Diseases Recall-at-100: 0.00%
2018-05-28 14:28:28,744:INFO: Experiment Progress: 11.0% -- 58/519
2018-05-28 14:28:29,404:INFO: Growth Disorders Recall-at-100: 2.50%
2018-05-28 14:28:29,404:INFO: Experiment Progress: 11.0% -- 59/519
2018-05-28 14:28:29,770:INFO: Absence Epilepsy Recall-at-100: 22.22%
2018-05-28 14:28:29,770:INFO: Experiment Progress: 11.0% -- 60/519
2018-05-28 14:28:30,301:INFO: Epilepsy, Temporal Lobe Recall-at-100: 45.00%
2018-05-28 14:28:30,301:INFO: Experiment Progress: 11.0% -- 61/519
2018-05-28 14:28:30,950:INFO: Memory Disorders Recall-at-100: 7.50%
2018-05-28 14:28:30,950:INFO: Experiment Progress: 11.0% -- 62/519
2018-05-28 14:28:31,396:INFO: Catalepsy Recall-at-100: 45.00%
2018-05-28 14:28:31,396:INFO: Experiment Progress: 12.0% -- 63/519
2018-05-28 14:28:31,810:INFO: Hereditary Nonpolyposis Colorectal Cancer Recall-at-100: 35.00%
2018-05-28 14:28:31,810:INFO: Experiment Progress: 12.0% -- 64/519
2018-05-28 14:28:32,381:INFO: Acute Promyelocytic Leukemia Recall-at-100: 18.33%
2018-05-28 14:28:32,381:INFO: Experiment Progress: 12.0% -- 65/519
2018-05-28 14:28:32,802:INFO: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 10.00%
2018-05-28 14:28:32,802:INFO: Experiment Progress: 12.0% -- 66/519
2018-05-28 14:28:33,181:INFO: Gout Recall-at-100: 0.00%
2018-05-28 14:28:33,181:INFO: Experiment Progress: 12.0% -- 67/519
2018-05-28 14:28:34,163:INFO: Coronary Artery Disease Recall-at-100: 3.10%
2018-05-28 14:28:34,163:INFO: Experiment Progress: 13.0% -- 68/519
2018-05-28 14:28:34,763:INFO: Venous Thromboembolism Recall-at-100: 30.00%
2018-05-28 14:28:34,764:INFO: Experiment Progress: 13.0% -- 69/519
2018-05-28 14:28:35,704:INFO: Precancerous Conditions Recall-at-100: 8.81%
2018-05-28 14:28:35,704:INFO: Experiment Progress: 13.0% -- 70/519
2018-05-28 14:28:36,851:INFO: Crohn Disease Recall-at-100: 3.47%
2018-05-28 14:28:36,851:INFO: Experiment Progress: 13.0% -- 71/519
2018-05-28 14:28:37,360:INFO: Uterine Cervical Neoplasm Recall-at-100: 20.00%
2018-05-28 14:28:37,360:INFO: Experiment Progress: 13.0% -- 72/519
2018-05-28 14:28:37,791:INFO: Dyskinesia, Drug-Induced Recall-at-100: 20.00%
2018-05-28 14:28:37,792:INFO: Experiment Progress: 14.0% -- 73/519
2018-05-28 14:28:38,239:INFO: Ataxia, Spinocerebellar Recall-at-100: 30.00%
2018-05-28 14:28:38,240:INFO: Experiment Progress: 14.0% -- 74/519
2018-05-28 14:28:38,671:INFO: Optic Atrophy, Hereditary, Leber Recall-at-100: 70.00%
2018-05-28 14:28:38,671:INFO: Experiment Progress: 14.0% -- 75/519
2018-05-28 14:28:39,196:INFO: Liver Cirrhosis, Alcoholic Recall-at-100: 0.00%
2018-05-28 14:28:39,196:INFO: Experiment Progress: 14.0% -- 76/519
2018-05-28 14:28:39,847:INFO: Acute Lung Injury Recall-at-100: 5.00%
2018-05-28 14:28:39,848:INFO: Experiment Progress: 14.0% -- 77/519
2018-05-28 14:28:41,277:INFO: Liver Cirrhosis, Experimental Recall-at-100: 7.27%
2018-05-28 14:28:41,277:INFO: Experiment Progress: 15.0% -- 78/519
2018-05-28 14:28:41,952:INFO: Chloracne Recall-at-100: 11.67%
2018-05-28 14:28:41,953:INFO: Experiment Progress: 15.0% -- 79/519
2018-05-28 14:28:43,007:INFO: Liver diseases Recall-at-100: 1.43%
2018-05-28 14:28:43,007:INFO: Experiment Progress: 15.0% -- 80/519
2018-05-28 14:28:44,073:INFO: Kidney Failure, Chronic Recall-at-100: 13.50%
2018-05-28 14:28:44,073:INFO: Experiment Progress: 15.0% -- 81/519
2018-05-28 14:28:44,546:INFO: Weight decreased Recall-at-100: 0.00%
2018-05-28 14:28:44,546:INFO: Experiment Progress: 15.0% -- 82/519
2018-05-28 14:28:45,140:INFO: Leigh Disease Recall-at-100: 59.17%
2018-05-28 14:28:45,140:INFO: Experiment Progress: 15.0% -- 83/519
2018-05-28 14:28:45,858:INFO: Celiac Disease Recall-at-100: 15.00%
2018-05-28 14:28:45,858:INFO: Experiment Progress: 16.0% -- 84/519
2018-05-28 14:28:46,616:INFO: Glaucoma Recall-at-100: 0.00%
2018-05-28 14:28:46,617:INFO: Experiment Progress: 16.0% -- 85/519
2018-05-28 14:28:47,119:INFO: Tachycardia Recall-at-100: 40.00%
2018-05-28 14:28:47,119:INFO: Experiment Progress: 16.0% -- 86/519
2018-05-28 14:28:47,646:INFO: Breast Cancer, Familial Recall-at-100: 70.00%
2018-05-28 14:28:47,648:INFO: Experiment Progress: 16.0% -- 87/519
2018-05-28 14:28:48,327:INFO: Ischemia Recall-at-100: 11.67%
2018-05-28 14:28:48,327:INFO: Experiment Progress: 16.0% -- 88/519
2018-05-28 14:28:48,753:INFO: Adenomatous Polyposis Coli Recall-at-100: 0.00%
2018-05-28 14:28:48,753:INFO: Experiment Progress: 17.0% -- 89/519
2018-05-28 14:28:49,181:INFO: Thyroid Diseases Recall-at-100: 10.00%
2018-05-28 14:28:49,182:INFO: Experiment Progress: 17.0% -- 90/519
2018-05-28 14:28:49,509:INFO: Panic Disorder Recall-at-100: 0.00%
2018-05-28 14:28:49,509:INFO: Experiment Progress: 17.0% -- 91/519
2018-05-28 14:28:52,176:INFO: Colorectal Neoplasms Recall-at-100: 3.81%
2018-05-28 14:28:52,176:INFO: Experiment Progress: 17.0% -- 92/519
2018-05-28 14:28:52,772:INFO: Adrenal Gland Neoplasms Recall-at-100: 60.00%
2018-05-28 14:28:52,773:INFO: Experiment Progress: 17.0% -- 93/519
2018-05-28 14:28:53,397:INFO: Sudden infant death syndrome Recall-at-100: 25.00%
2018-05-28 14:28:53,397:INFO: Experiment Progress: 18.0% -- 94/519
2018-05-28 14:28:54,255:INFO: Neuroblastoma Recall-at-100: 9.00%
2018-05-28 14:28:54,255:INFO: Experiment Progress: 18.0% -- 95/519
2018-05-28 14:28:54,749:INFO: Prostate cancer, familial Recall-at-100: 15.00%
2018-05-28 14:28:54,750:INFO: Experiment Progress: 18.0% -- 96/519
2018-05-28 14:28:56,422:INFO: Animal Mammary Neoplasms Recall-at-100: 8.02%
2018-05-28 14:28:56,422:INFO: Experiment Progress: 18.0% -- 97/519
2018-05-28 14:28:56,871:INFO: Osteochondrodysplasias Recall-at-100: 30.00%
2018-05-28 14:28:56,871:INFO: Experiment Progress: 18.0% -- 98/519
2018-05-28 14:28:57,421:INFO: Hepatolenticular Degeneration Recall-at-100: 18.33%
2018-05-28 14:28:57,421:INFO: Experiment Progress: 19.0% -- 99/519
2018-05-28 14:28:57,897:INFO: Fanconi Anemia Recall-at-100: 70.00%
2018-05-28 14:28:57,898:INFO: Experiment Progress: 19.0% -- 100/519
2018-05-28 14:28:58,316:INFO: Eye Abnormalities Recall-at-100: 30.00%
2018-05-28 14:28:58,317:INFO: Experiment Progress: 19.0% -- 101/519
2018-05-28 14:28:58,776:INFO: Limb Deformities, Congenital Recall-at-100: 20.00%
2018-05-28 14:28:58,776:INFO: Experiment Progress: 19.0% -- 102/519
2018-05-28 14:28:59,139:INFO: Electrocardiogram: P-R interval Recall-at-100: 0.00%
2018-05-28 14:28:59,139:INFO: Experiment Progress: 19.0% -- 103/519
2018-05-28 14:29:00,803:INFO: Mammary Neoplasms, Experimental Recall-at-100: 5.96%
2018-05-28 14:29:00,803:INFO: Experiment Progress: 20.0% -- 104/519
2018-05-28 14:29:01,381:INFO: Heart valve disease Recall-at-100: 3.33%
2018-05-28 14:29:01,381:INFO: Experiment Progress: 20.0% -- 105/519
2018-05-28 14:29:02,354:INFO: Diffuse Large B-Cell Lymphoma Recall-at-100: 5.00%
2018-05-28 14:29:02,354:INFO: Experiment Progress: 20.0% -- 106/519
2018-05-28 14:29:02,836:INFO: Hepatitis Recall-at-100: 5.00%
2018-05-28 14:29:02,836:INFO: Experiment Progress: 20.0% -- 107/519
2018-05-28 14:29:03,315:INFO: Impaired glucose tolerance Recall-at-100: 15.00%
2018-05-28 14:29:03,316:INFO: Experiment Progress: 20.0% -- 108/519
2018-05-28 14:29:03,732:INFO: Mitochondrial Encephalomyopathies Recall-at-100: 25.00%
2018-05-28 14:29:03,733:INFO: Experiment Progress: 21.0% -- 109/519
2018-05-28 14:29:04,280:INFO: Colon Carcinoma Recall-at-100: 20.00%
2018-05-28 14:29:04,280:INFO: Experiment Progress: 21.0% -- 110/519
2018-05-28 14:29:05,034:INFO: Hepatic Encephalopathy Recall-at-100: 30.00%
2018-05-28 14:29:05,034:INFO: Experiment Progress: 21.0% -- 111/519
2018-05-28 14:29:06,462:INFO: Multiple Sclerosis Recall-at-100: 5.69%
2018-05-28 14:29:06,462:INFO: Experiment Progress: 21.0% -- 112/519
2018-05-28 14:29:06,889:INFO: Neurogenic Inflammation Recall-at-100: 20.00%
2018-05-28 14:29:06,889:INFO: Experiment Progress: 21.0% -- 113/519
2018-05-28 14:29:07,883:INFO: Lupus Erythematosus, Systemic Recall-at-100: 3.93%
2018-05-28 14:29:07,883:INFO: Experiment Progress: 21.0% -- 114/519
2018-05-28 14:29:08,280:INFO: Ceroid lipofuscinosis, neuronal 1, infantile Recall-at-100: 10.00%
2018-05-28 14:29:08,280:INFO: Experiment Progress: 22.0% -- 115/519
2018-05-28 14:29:09,104:INFO: Adenocarcinoma of lung (disorder) Recall-at-100: 7.00%
2018-05-28 14:29:09,104:INFO: Experiment Progress: 22.0% -- 116/519
2018-05-28 14:29:09,678:INFO: Charcot-Marie-Tooth Disease Recall-at-100: 5.00%
2018-05-28 14:29:09,678:INFO: Experiment Progress: 22.0% -- 117/519
2018-05-28 14:29:10,089:INFO: Osteogenesis imperfecta type III (disorder) Recall-at-100: 45.00%
2018-05-28 14:29:10,089:INFO: Experiment Progress: 22.0% -- 118/519
2018-05-28 14:29:10,465:INFO: Osteogenesis imperfecta type IV (disorder) Recall-at-100: 30.00%
2018-05-28 14:29:10,465:INFO: Experiment Progress: 22.0% -- 119/519
2018-05-28 14:29:10,894:INFO: Hepatitis, Autoimmune Recall-at-100: 30.00%
2018-05-28 14:29:10,894:INFO: Experiment Progress: 23.0% -- 120/519
2018-05-28 14:29:15,455:INFO: Prostatic Neoplasms Recall-at-100: 6.41%
2018-05-28 14:29:15,455:INFO: Experiment Progress: 23.0% -- 121/519
2018-05-28 14:29:15,925:INFO: NADH:Q(1) Oxidoreductase deficiency Recall-at-100: 85.00%
2018-05-28 14:29:15,925:INFO: Experiment Progress: 23.0% -- 122/519
2018-05-28 14:29:16,336:INFO: Hypospadias Recall-at-100: 0.00%
2018-05-28 14:29:16,336:INFO: Experiment Progress: 23.0% -- 123/519
2018-05-28 14:29:16,992:INFO: Multiple Myeloma Recall-at-100: 13.33%
2018-05-28 14:29:16,992:INFO: Experiment Progress: 23.0% -- 124/519
2018-05-28 14:29:17,729:INFO: Fatty Liver Recall-at-100: 8.00%
2018-05-28 14:29:17,729:INFO: Experiment Progress: 24.0% -- 125/519
2018-05-28 14:29:18,106:INFO: Leishmaniasis, Visceral Recall-at-100: 30.00%
2018-05-28 14:29:18,106:INFO: Experiment Progress: 24.0% -- 126/519
2018-05-28 14:29:18,578:INFO: Early infantile epileptic encephalopathy with suppression bursts Recall-at-100: 0.00%
2018-05-28 14:29:18,578:INFO: Experiment Progress: 24.0% -- 127/519
2018-05-28 14:29:19,088:INFO: Kartagener Syndrome Recall-at-100: 0.00%
2018-05-28 14:29:19,088:INFO: Experiment Progress: 24.0% -- 128/519
2018-05-28 14:29:19,525:INFO: Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse Recall-at-100: 45.00%
2018-05-28 14:29:19,525:INFO: Experiment Progress: 24.0% -- 129/519
2018-05-28 14:29:20,948:INFO: Bipolar Disorder Recall-at-100: 5.00%
2018-05-28 14:29:20,948:INFO: Experiment Progress: 25.0% -- 130/519
2018-05-28 14:29:21,836:INFO: Erectile dysfunction Recall-at-100: 30.00%
2018-05-28 14:29:21,836:INFO: Experiment Progress: 25.0% -- 131/519
2018-05-28 14:29:22,272:INFO: Meckel-Gruber syndrome Recall-at-100: 80.00%
2018-05-28 14:29:22,273:INFO: Experiment Progress: 25.0% -- 132/519
2018-05-28 14:29:24,356:INFO: Colonic Neoplasms Recall-at-100: 11.99%
2018-05-28 14:29:24,356:INFO: Experiment Progress: 25.0% -- 133/519
2018-05-28 14:29:27,006:INFO: Autistic Disorder Recall-at-100: 2.97%
2018-05-28 14:29:27,006:INFO: Experiment Progress: 25.0% -- 134/519
2018-05-28 14:29:27,826:INFO: Liver Neoplasms, Experimental Recall-at-100: 7.33%
2018-05-28 14:29:27,826:INFO: Experiment Progress: 26.0% -- 135/519
2018-05-28 14:29:28,325:INFO: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 5.00%
2018-05-28 14:29:28,326:INFO: Experiment Progress: 26.0% -- 136/519
2018-05-28 14:29:28,756:INFO: Narcolepsy Recall-at-100: 15.00%
2018-05-28 14:29:28,756:INFO: Experiment Progress: 26.0% -- 137/519
2018-05-28 14:29:29,213:INFO: Fever Recall-at-100: 10.00%
2018-05-28 14:29:29,213:INFO: Experiment Progress: 26.0% -- 138/519
2018-05-28 14:29:30,515:INFO: Adenocarcinoma Recall-at-100: 9.45%
2018-05-28 14:29:30,515:INFO: Experiment Progress: 26.0% -- 139/519
2018-05-28 14:29:30,905:INFO: Aortic Valve Insufficiency Recall-at-100: 70.00%
2018-05-28 14:29:30,905:INFO: Experiment Progress: 26.0% -- 140/519
2018-05-28 14:29:31,380:INFO: Carcinoma, Pancreatic Ductal Recall-at-100: 45.00%
2018-05-28 14:29:31,380:INFO: Experiment Progress: 27.0% -- 141/519
2018-05-28 14:29:31,912:INFO: Infarction, Middle Cerebral Artery Recall-at-100: 18.33%
2018-05-28 14:29:31,913:INFO: Experiment Progress: 27.0% -- 142/519
2018-05-28 14:29:33,937:INFO: Hypertensive disease Recall-at-100: 6.87%
2018-05-28 14:29:33,937:INFO: Experiment Progress: 27.0% -- 143/519
2018-05-28 14:29:34,462:INFO: Juvenile Myelomonocytic Leukemia Recall-at-100: 35.00%
2018-05-28 14:29:34,462:INFO: Experiment Progress: 27.0% -- 144/519
2018-05-28 14:29:34,995:INFO: Leprosy Recall-at-100: 0.00%
2018-05-28 14:29:34,996:INFO: Experiment Progress: 27.0% -- 145/519
2018-05-28 14:29:36,467:INFO: Myocardial Infarction Recall-at-100: 4.58%
2018-05-28 14:29:36,467:INFO: Experiment Progress: 28.0% -- 146/519
2018-05-28 14:29:37,144:INFO: Urticaria Recall-at-100: 10.00%
2018-05-28 14:29:37,144:INFO: Experiment Progress: 28.0% -- 147/519
2018-05-28 14:29:37,629:INFO: Cardiac Arrhythmia Recall-at-100: 10.00%
2018-05-28 14:29:37,629:INFO: Experiment Progress: 28.0% -- 148/519
2018-05-28 14:29:38,032:INFO: Hemochromatosis Recall-at-100: 50.00%
2018-05-28 14:29:38,033:INFO: Experiment Progress: 28.0% -- 149/519
2018-05-28 14:29:39,009:INFO: Pancreatic Neoplasm Recall-at-100: 16.25%
2018-05-28 14:29:39,009:INFO: Experiment Progress: 28.0% -- 150/519
2018-05-28 14:29:39,727:INFO: Cardiomyopathy, Dilated Recall-at-100: 22.00%
2018-05-28 14:29:39,727:INFO: Experiment Progress: 29.0% -- 151/519
2018-05-28 14:29:40,139:INFO: Papilloma Recall-at-100: 20.00%
2018-05-28 14:29:40,139:INFO: Experiment Progress: 29.0% -- 152/519
2018-05-28 14:29:40,836:INFO: Pain Recall-at-100: 16.50%
2018-05-28 14:29:40,837:INFO: Experiment Progress: 29.0% -- 153/519
2018-05-28 14:29:41,231:INFO: Congenital Abnormality Recall-at-100: 30.00%
2018-05-28 14:29:41,231:INFO: Experiment Progress: 29.0% -- 154/519
2018-05-28 14:29:41,593:INFO: MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) Recall-at-100: 40.00%
2018-05-28 14:29:41,593:INFO: Experiment Progress: 29.0% -- 155/519
2018-05-28 14:29:42,672:INFO: Kidney Diseases Recall-at-100: 1.11%
2018-05-28 14:29:42,672:INFO: Experiment Progress: 30.0% -- 156/519
2018-05-28 14:29:43,117:INFO: Lung Diseases, Interstitial Recall-at-100: 0.00%
2018-05-28 14:29:43,117:INFO: Experiment Progress: 30.0% -- 157/519
2018-05-28 14:29:43,629:INFO: Basal cell carcinoma Recall-at-100: 15.00%
2018-05-28 14:29:43,630:INFO: Experiment Progress: 30.0% -- 158/519
2018-05-28 14:29:45,846:INFO: Liver carcinoma Recall-at-100: 9.68%
2018-05-28 14:29:45,846:INFO: Experiment Progress: 30.0% -- 159/519
2018-05-28 14:29:46,308:INFO: gliosarcoma Recall-at-100: 25.00%
2018-05-28 14:29:46,308:INFO: Experiment Progress: 30.0% -- 160/519
2018-05-28 14:29:46,915:INFO: Acute Coronary Syndrome Recall-at-100: 22.50%
2018-05-28 14:29:46,915:INFO: Experiment Progress: 31.0% -- 161/519
2018-05-28 14:29:47,487:INFO: Ovarian Cysts Recall-at-100: 0.00%
2018-05-28 14:29:47,487:INFO: Experiment Progress: 31.0% -- 162/519
2018-05-28 14:29:47,914:INFO: Schizophrenia, Childhood Recall-at-100: 0.00%
2018-05-28 14:29:47,914:INFO: Experiment Progress: 31.0% -- 163/519
2018-05-28 14:29:48,362:INFO: Adrenocortical carcinoma Recall-at-100: 30.00%
2018-05-28 14:29:48,362:INFO: Experiment Progress: 31.0% -- 164/519
2018-05-28 14:29:51,028:INFO: Schizophrenia Recall-at-100: 2.10%
2018-05-28 14:29:51,028:INFO: Experiment Progress: 31.0% -- 165/519
2018-05-28 14:29:51,433:INFO: Atrophic Recall-at-100: 0.00%
2018-05-28 14:29:51,434:INFO: Experiment Progress: 31.0% -- 166/519
2018-05-28 14:29:51,907:INFO: Idiopathic Pulmonary Fibrosis Recall-at-100: 10.00%
2018-05-28 14:29:51,907:INFO: Experiment Progress: 32.0% -- 167/519
2018-05-28 14:29:52,334:INFO: Lobar Holoprosencephaly Recall-at-100: 25.00%
2018-05-28 14:29:52,334:INFO: Experiment Progress: 32.0% -- 168/519
2018-05-28 14:29:52,763:INFO: Alobar Holoprosencephaly Recall-at-100: 25.00%
2018-05-28 14:29:52,763:INFO: Experiment Progress: 32.0% -- 169/519
2018-05-28 14:29:53,212:INFO: Immunologic Deficiency Syndromes Recall-at-100: 40.00%
2018-05-28 14:29:53,212:INFO: Experiment Progress: 32.0% -- 170/519
2018-05-28 14:29:53,632:INFO: Ataxia Recall-at-100: 20.00%
2018-05-28 14:29:53,632:INFO: Experiment Progress: 32.0% -- 171/519
2018-05-28 14:29:54,088:INFO: Adenocarcinoma Of Esophagus Recall-at-100: 10.00%
2018-05-28 14:29:54,088:INFO: Experiment Progress: 33.0% -- 172/519
2018-05-28 14:29:55,094:INFO: Retinitis Pigmentosa Recall-at-100: 8.57%
2018-05-28 14:29:55,094:INFO: Experiment Progress: 33.0% -- 173/519
2018-05-28 14:29:56,170:INFO: Squamous cell carcinoma of esophagus Recall-at-100: 8.61%
2018-05-28 14:29:56,170:INFO: Experiment Progress: 33.0% -- 174/519
2018-05-28 14:29:56,781:INFO: Autoimmune Diseases Recall-at-100: 0.00%
2018-05-28 14:29:56,781:INFO: Experiment Progress: 33.0% -- 175/519
2018-05-28 14:29:57,151:INFO: Diarrhea Recall-at-100: 20.00%
2018-05-28 14:29:57,151:INFO: Experiment Progress: 33.0% -- 176/519
2018-05-28 14:29:58,914:INFO: Myocardial Ischemia Recall-at-100: 3.60%
2018-05-28 14:29:58,915:INFO: Experiment Progress: 34.0% -- 177/519
2018-05-28 14:29:59,345:INFO: Essential Hypertension Recall-at-100: 0.00%
2018-05-28 14:29:59,345:INFO: Experiment Progress: 34.0% -- 178/519
2018-05-28 14:29:59,676:INFO: Hepatomegaly Recall-at-100: 33.33%
2018-05-28 14:29:59,676:INFO: Experiment Progress: 34.0% -- 179/519
2018-05-28 14:30:00,223:INFO: Myopathy Recall-at-100: 0.00%
2018-05-28 14:30:00,223:INFO: Experiment Progress: 34.0% -- 180/519
2018-05-28 14:30:01,063:INFO: Adverse reaction to drug Recall-at-100: 10.67%
2018-05-28 14:30:01,063:INFO: Experiment Progress: 34.0% -- 181/519
2018-05-28 14:30:01,508:INFO: Myoclonic Epilepsies, Progressive Recall-at-100: 15.00%
2018-05-28 14:30:01,508:INFO: Experiment Progress: 35.0% -- 182/519
2018-05-28 14:30:01,962:INFO: Muscular Atrophy Recall-at-100: 15.00%
2018-05-28 14:30:01,962:INFO: Experiment Progress: 35.0% -- 183/519
2018-05-28 14:30:02,368:INFO: Basal Ganglia Diseases Recall-at-100: 20.00%
2018-05-28 14:30:02,368:INFO: Experiment Progress: 35.0% -- 184/519
2018-05-28 14:30:02,827:INFO: Hepatitis B Recall-at-100: 35.00%
2018-05-28 14:30:02,827:INFO: Experiment Progress: 35.0% -- 185/519
2018-05-28 14:30:03,742:INFO: Lung diseases Recall-at-100: 4.00%
2018-05-28 14:30:03,744:INFO: Experiment Progress: 35.0% -- 186/519
2018-05-28 14:30:04,963:INFO: Chronic Obstructive Airway Disease Recall-at-100: 5.00%
2018-05-28 14:30:04,963:INFO: Experiment Progress: 36.0% -- 187/519
2018-05-28 14:30:08,345:INFO: Peripheral Neuropathy Recall-at-100: 2.88%
2018-05-28 14:30:08,345:INFO: Experiment Progress: 36.0% -- 188/519
2018-05-28 14:30:09,511:INFO: Weight Gain Recall-at-100: 4.58%
2018-05-28 14:30:09,511:INFO: Experiment Progress: 36.0% -- 189/519
2018-05-28 14:30:09,973:INFO: Deafness Recall-at-100: 0.00%
2018-05-28 14:30:09,973:INFO: Experiment Progress: 36.0% -- 190/519
2018-05-28 14:30:10,387:INFO: Renal dysplasia and retinal aplasia (disorder) Recall-at-100: 50.00%
2018-05-28 14:30:10,387:INFO: Experiment Progress: 36.0% -- 191/519
2018-05-28 14:30:11,180:INFO: Attention deficit hyperactivity disorder Recall-at-100: 16.67%
2018-05-28 14:30:11,180:INFO: Experiment Progress: 36.0% -- 192/519
2018-05-28 14:30:11,629:INFO: Tetralogy of Fallot Recall-at-100: 45.00%
2018-05-28 14:30:11,629:INFO: Experiment Progress: 37.0% -- 193/519
2018-05-28 14:30:12,398:INFO: Neurodegenerative Disorders Recall-at-100: 15.00%
2018-05-28 14:30:12,398:INFO: Experiment Progress: 37.0% -- 194/519
2018-05-28 14:30:12,931:INFO: Barrett Esophagus Recall-at-100: 10.00%
2018-05-28 14:30:12,931:INFO: Experiment Progress: 37.0% -- 195/519
2018-05-28 14:30:14,642:INFO: Craniofacial Abnormalities Recall-at-100: 6.95%
2018-05-28 14:30:14,643:INFO: Experiment Progress: 37.0% -- 196/519
2018-05-28 14:30:15,137:INFO: Necrotizing Enterocolitis Recall-at-100: 30.00%
2018-05-28 14:30:15,137:INFO: Experiment Progress: 37.0% -- 197/519
2018-05-28 14:30:15,626:INFO: Hyperlipidemia Recall-at-100: 30.00%
2018-05-28 14:30:15,627:INFO: Experiment Progress: 38.0% -- 198/519
2018-05-28 14:30:16,228:INFO: MYELODYSPLASTIC SYNDROME Recall-at-100: 0.00%
2018-05-28 14:30:16,229:INFO: Experiment Progress: 38.0% -- 199/519
2018-05-28 14:30:16,920:INFO: Anoxia Recall-at-100: 2.50%
2018-05-28 14:30:16,920:INFO: Experiment Progress: 38.0% -- 200/519
2018-05-28 14:30:17,671:INFO: Small cell carcinoma of lung Recall-at-100: 15.00%
2018-05-28 14:30:17,671:INFO: Experiment Progress: 38.0% -- 201/519
2018-05-28 14:30:18,817:INFO: Epilepsy Recall-at-100: 7.86%
2018-05-28 14:30:18,817:INFO: Experiment Progress: 38.0% -- 202/519
2018-05-28 14:30:19,354:INFO: Liver Failure, Acute Recall-at-100: 21.67%
2018-05-28 14:30:19,354:INFO: Experiment Progress: 39.0% -- 203/519
2018-05-28 14:30:19,865:INFO: Micronuclei, Chromosome-Defective Recall-at-100: 10.00%
2018-05-28 14:30:19,865:INFO: Experiment Progress: 39.0% -- 204/519
2018-05-28 14:30:20,426:INFO: Cognition Disorders Recall-at-100: 5.00%
2018-05-28 14:30:20,427:INFO: Experiment Progress: 39.0% -- 205/519
2018-05-28 14:30:20,847:INFO: Tonic-Clonic Epilepsy Recall-at-100: 30.00%
2018-05-28 14:30:20,847:INFO: Experiment Progress: 39.0% -- 206/519
2018-05-28 14:30:21,688:INFO: Heart Diseases Recall-at-100: 7.00%
2018-05-28 14:30:21,689:INFO: Experiment Progress: 39.0% -- 207/519
2018-05-28 14:30:22,445:INFO: Adult T-Cell Lymphoma/Leukemia Recall-at-100: 13.33%
2018-05-28 14:30:22,446:INFO: Experiment Progress: 40.0% -- 208/519
2018-05-28 14:30:23,161:INFO: Primary biliary cirrhosis Recall-at-100: 30.00%
2018-05-28 14:30:23,161:INFO: Experiment Progress: 40.0% -- 209/519
2018-05-28 14:30:23,598:INFO: beta Thalassemia Recall-at-100: 20.00%
2018-05-28 14:30:23,598:INFO: Experiment Progress: 40.0% -- 210/519
2018-05-28 14:30:24,050:INFO: Marijuana Abuse Recall-at-100: 20.00%
2018-05-28 14:30:24,050:INFO: Experiment Progress: 40.0% -- 211/519
2018-05-28 14:30:24,514:INFO: Long QT Syndrome Recall-at-100: 60.00%
2018-05-28 14:30:24,514:INFO: Experiment Progress: 40.0% -- 212/519
2018-05-28 14:30:24,991:INFO: Burkitt Lymphoma Recall-at-100: 20.00%
2018-05-28 14:30:24,991:INFO: Experiment Progress: 41.0% -- 213/519
2018-05-28 14:30:25,368:INFO: TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) Recall-at-100: 30.00%
2018-05-28 14:30:25,368:INFO: Experiment Progress: 41.0% -- 214/519
2018-05-28 14:30:26,162:INFO: Insulin Resistance Recall-at-100: 14.50%
2018-05-28 14:30:26,162:INFO: Experiment Progress: 41.0% -- 215/519
2018-05-28 14:30:26,698:INFO: Left Ventricular Hypertrophy Recall-at-100: 26.67%
2018-05-28 14:30:26,699:INFO: Experiment Progress: 41.0% -- 216/519
2018-05-28 14:30:27,121:INFO: Bronchial Hyperreactivity Recall-at-100: 5.00%
2018-05-28 14:30:27,121:INFO: Experiment Progress: 41.0% -- 217/519
2018-05-28 14:30:27,888:INFO: AMYOTROPHIC LATERAL SCLEROSIS 1 Recall-at-100: 8.50%
2018-05-28 14:30:27,888:INFO: Experiment Progress: 42.0% -- 218/519
2018-05-28 14:30:28,303:INFO: Fetal Growth Retardation Recall-at-100: 10.00%
2018-05-28 14:30:28,303:INFO: Experiment Progress: 42.0% -- 219/519
2018-05-28 14:30:28,597:INFO: Holoprosencephaly Recall-at-100: 25.00%
2018-05-28 14:30:28,597:INFO: Experiment Progress: 42.0% -- 220/519
2018-05-28 14:30:29,260:INFO: Arthritis, Experimental Recall-at-100: 20.00%
2018-05-28 14:30:29,260:INFO: Experiment Progress: 42.0% -- 221/519
2018-05-28 14:30:29,890:INFO: Congenital Heart Defects Recall-at-100: 11.67%
2018-05-28 14:30:29,890:INFO: Experiment Progress: 42.0% -- 222/519
2018-05-28 14:30:30,231:INFO: Pseudohypoaldosteronism Recall-at-100: 66.67%
2018-05-28 14:30:30,231:INFO: Experiment Progress: 42.0% -- 223/519
2018-05-28 14:30:30,725:INFO: Cataract Recall-at-100: 31.67%
2018-05-28 14:30:30,725:INFO: Experiment Progress: 43.0% -- 224/519
2018-05-28 14:30:31,179:INFO: Giant Cell Glioblastoma Recall-at-100: 35.00%
2018-05-28 14:30:31,180:INFO: Experiment Progress: 43.0% -- 225/519
2018-05-28 14:30:31,752:INFO: Seizure Adverse Event Recall-at-100: 0.00%
2018-05-28 14:30:31,752:INFO: Experiment Progress: 43.0% -- 226/519
2018-05-28 14:30:32,255:INFO: Body Weight Recall-at-100: 0.00%
2018-05-28 14:30:32,256:INFO: Experiment Progress: 43.0% -- 227/519
2018-05-28 14:30:32,716:INFO: Huntington Disease Recall-at-100: 0.00%
2018-05-28 14:30:32,716:INFO: Experiment Progress: 43.0% -- 228/519
2018-05-28 14:30:33,936:INFO: Glioblastoma Recall-at-100: 11.43%
2018-05-28 14:30:33,936:INFO: Experiment Progress: 44.0% -- 229/519
2018-05-28 14:30:34,430:INFO: Congenital diaphragmatic hernia Recall-at-100: 20.00%
2018-05-28 14:30:34,431:INFO: Experiment Progress: 44.0% -- 230/519
2018-05-28 14:30:35,024:INFO: Systemic Scleroderma Recall-at-100: 0.00%
2018-05-28 14:30:35,024:INFO: Experiment Progress: 44.0% -- 231/519
2018-05-28 14:30:36,249:INFO: Acute kidney injury Recall-at-100: 10.24%
2018-05-28 14:30:36,250:INFO: Experiment Progress: 44.0% -- 232/519
2018-05-28 14:30:36,808:INFO: Copper-Overload Cirrhosis Recall-at-100: 10.00%
2018-05-28 14:30:36,808:INFO: Experiment Progress: 44.0% -- 233/519
2018-05-28 14:30:38,297:INFO: Spontaneous abortion Recall-at-100: 6.82%
2018-05-28 14:30:38,297:INFO: Experiment Progress: 45.0% -- 234/519
2018-05-28 14:30:39,411:INFO: Glioma Recall-at-100: 7.38%
2018-05-28 14:30:39,411:INFO: Experiment Progress: 45.0% -- 235/519
2018-05-28 14:30:39,884:INFO: Gliosis Recall-at-100: 60.00%
2018-05-28 14:30:39,884:INFO: Experiment Progress: 45.0% -- 236/519
2018-05-28 14:30:40,377:INFO: LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 80.00%
2018-05-28 14:30:40,377:INFO: Experiment Progress: 45.0% -- 237/519
2018-05-28 14:30:40,859:INFO: Dementia Recall-at-100: 0.00%
2018-05-28 14:30:40,859:INFO: Experiment Progress: 45.0% -- 238/519
2018-05-28 14:30:41,424:INFO: Pancreatitis Recall-at-100: 10.00%
2018-05-28 14:30:41,425:INFO: Experiment Progress: 46.0% -- 239/519
2018-05-28 14:30:41,846:INFO: Amino Acid Metabolism, Inborn Errors Recall-at-100: 0.00%
2018-05-28 14:30:41,846:INFO: Experiment Progress: 46.0% -- 240/519
2018-05-28 14:30:42,489:INFO: Thyroid Neoplasm Recall-at-100: 10.00%
2018-05-28 14:30:42,489:INFO: Experiment Progress: 46.0% -- 241/519
2018-05-28 14:30:44,552:INFO: Neoplasm Invasiveness Recall-at-100: 13.53%
2018-05-28 14:30:44,554:INFO: Experiment Progress: 46.0% -- 242/519
2018-05-28 14:30:46,933:INFO: Neoplasm Metastasis Recall-at-100: 12.25%
2018-05-28 14:30:46,934:INFO: Experiment Progress: 46.0% -- 243/519
2018-05-28 14:30:47,594:INFO: Albuminuria Recall-at-100: 20.00%
2018-05-28 14:30:47,595:INFO: Experiment Progress: 47.0% -- 244/519
2018-05-28 14:30:48,153:INFO: Pre-Eclampsia Recall-at-100: 10.00%
2018-05-28 14:30:48,154:INFO: Experiment Progress: 47.0% -- 245/519
2018-05-28 14:30:49,481:INFO: Nerve Degeneration Recall-at-100: 11.96%
2018-05-28 14:30:49,481:INFO: Experiment Progress: 47.0% -- 246/519
2018-05-28 14:30:50,007:INFO: Thromboembolism Recall-at-100: 75.00%
2018-05-28 14:30:50,008:INFO: Experiment Progress: 47.0% -- 247/519
2018-05-28 14:30:51,906:INFO: Polycystic Ovary Syndrome Recall-at-100: 2.05%
2018-05-28 14:30:51,906:INFO: Experiment Progress: 47.0% -- 248/519
2018-05-28 14:30:52,298:INFO: Transient Ischemic Attack Recall-at-100: 30.00%
2018-05-28 14:30:52,298:INFO: Experiment Progress: 47.0% -- 249/519
2018-05-28 14:30:53,137:INFO: Brain Ischemia Recall-at-100: 20.00%
2018-05-28 14:30:53,137:INFO: Experiment Progress: 48.0% -- 250/519
2018-05-28 14:30:53,525:INFO: Cerebral Infarction Recall-at-100: 40.00%
2018-05-28 14:30:53,525:INFO: Experiment Progress: 48.0% -- 251/519
2018-05-28 14:30:54,004:INFO: Malignant neoplasm of esophagus Recall-at-100: 20.00%
2018-05-28 14:30:54,005:INFO: Experiment Progress: 48.0% -- 252/519
2018-05-28 14:30:55,222:INFO: Degenerative polyarthritis Recall-at-100: 6.44%
2018-05-28 14:30:55,223:INFO: Experiment Progress: 48.0% -- 253/519
2018-05-28 14:30:55,518:INFO: Osteitis Deformans Recall-at-100: 0.00%
2018-05-28 14:30:55,518:INFO: Experiment Progress: 48.0% -- 254/519
2018-05-28 14:30:55,918:INFO: Diabetic Cardiomyopathies Recall-at-100: 20.00%
2018-05-28 14:30:55,918:INFO: Experiment Progress: 49.0% -- 255/519
2018-05-28 14:30:56,319:INFO: Nuclear cataract Recall-at-100: 50.00%
2018-05-28 14:30:56,319:INFO: Experiment Progress: 49.0% -- 256/519
2018-05-28 14:30:56,737:INFO: Anorexia Recall-at-100: 65.00%
2018-05-28 14:30:56,737:INFO: Experiment Progress: 49.0% -- 257/519
2018-05-28 14:30:57,824:INFO: Cocaine-Related Disorders Recall-at-100: 11.81%
2018-05-28 14:30:57,824:INFO: Experiment Progress: 49.0% -- 258/519
2018-05-28 14:30:58,200:INFO: MELAS Syndrome Recall-at-100: 60.00%
2018-05-28 14:30:58,200:INFO: Experiment Progress: 49.0% -- 259/519
2018-05-28 14:30:58,400:INFO: Mitochondrial Myopathies Recall-at-100: 33.33%
2018-05-28 14:30:58,401:INFO: Experiment Progress: 50.0% -- 260/519
2018-05-28 14:30:59,404:INFO: Amphetamine-Related Disorders Recall-at-100: 3.93%
2018-05-28 14:30:59,405:INFO: Experiment Progress: 50.0% -- 261/519
2018-05-28 14:30:59,767:INFO: Birth Weight Recall-at-100: 0.00%
2018-05-28 14:30:59,767:INFO: Experiment Progress: 50.0% -- 262/519
2018-05-28 14:31:00,264:INFO: Brain Diseases Recall-at-100: 0.00%
2018-05-28 14:31:00,264:INFO: Experiment Progress: 50.0% -- 263/519
2018-05-28 14:31:00,687:INFO: Dyslipidemias Recall-at-100: 30.00%
2018-05-28 14:31:00,688:INFO: Experiment Progress: 50.0% -- 264/519
2018-05-28 14:31:01,018:INFO: Berylliosis Recall-at-100: 0.00%
2018-05-28 14:31:01,018:INFO: Experiment Progress: 51.0% -- 265/519
2018-05-28 14:31:01,490:INFO: Mental Retardation, X-Linked Recall-at-100: 0.00%
2018-05-28 14:31:01,490:INFO: Experiment Progress: 51.0% -- 266/519
2018-05-28 14:31:01,770:INFO: Sarcoidosis Recall-at-100: 0.00%
2018-05-28 14:31:01,771:INFO: Experiment Progress: 51.0% -- 267/519
2018-05-28 14:31:03,039:INFO: Liver neoplasms Recall-at-100: 8.64%
2018-05-28 14:31:03,039:INFO: Experiment Progress: 51.0% -- 268/519
2018-05-28 14:31:03,654:INFO: Myocardial Reperfusion Injury Recall-at-100: 18.33%
2018-05-28 14:31:03,654:INFO: Experiment Progress: 51.0% -- 269/519
2018-05-28 14:31:04,059:INFO: Microsatellite Instability Recall-at-100: 0.00%
2018-05-28 14:31:04,059:INFO: Experiment Progress: 52.0% -- 270/519
2018-05-28 14:31:04,413:INFO: Night blindness, congenital stationary Recall-at-100: 25.00%
2018-05-28 14:31:04,413:INFO: Experiment Progress: 52.0% -- 271/519
2018-05-28 14:31:04,974:INFO: Stevens-Johnson Syndrome Recall-at-100: 26.67%
2018-05-28 14:31:04,974:INFO: Experiment Progress: 52.0% -- 272/519
2018-05-28 14:31:05,363:INFO: Leukemia, Lymphocytic, Acute, L1 Recall-at-100: 0.00%
2018-05-28 14:31:05,363:INFO: Experiment Progress: 52.0% -- 273/519
2018-05-28 14:31:06,152:INFO: Systemic arterial pressure Recall-at-100: 0.00%
2018-05-28 14:31:06,152:INFO: Experiment Progress: 52.0% -- 274/519
2018-05-28 14:31:06,673:INFO: Learning Disorders Recall-at-100: 10.00%
2018-05-28 14:31:06,673:INFO: Experiment Progress: 52.0% -- 275/519
2018-05-28 14:31:07,073:INFO: Walker-Warburg congenital muscular dystrophy Recall-at-100: 30.00%
2018-05-28 14:31:07,073:INFO: Experiment Progress: 53.0% -- 276/519
2018-05-28 14:31:07,444:INFO: Marfan Syndrome Recall-at-100: 50.00%
2018-05-28 14:31:07,444:INFO: Experiment Progress: 53.0% -- 277/519
2018-05-28 14:31:07,848:INFO: Congenital ocular coloboma (disorder) Recall-at-100: 10.00%
2018-05-28 14:31:07,848:INFO: Experiment Progress: 53.0% -- 278/519
2018-05-28 14:31:09,588:INFO: Lung Neoplasms Recall-at-100: 10.42%
2018-05-28 14:31:09,588:INFO: Experiment Progress: 53.0% -- 279/519
2018-05-28 14:31:09,805:INFO: Myoclonic Epilepsy, Juvenile Recall-at-100: 0.00%
2018-05-28 14:31:09,805:INFO: Experiment Progress: 53.0% -- 280/519
2018-05-28 14:31:10,829:INFO: Inflammatory Bowel Diseases Recall-at-100: 2.50%
2018-05-28 14:31:10,829:INFO: Experiment Progress: 54.0% -- 281/519
2018-05-28 14:31:14,648:INFO: Mammary Neoplasms Recall-at-100: 6.87%
2018-05-28 14:31:14,649:INFO: Experiment Progress: 54.0% -- 282/519
2018-05-28 14:31:14,845:INFO: Idiopathic generalized epilepsy Recall-at-100: 0.00%
2018-05-28 14:31:14,845:INFO: Experiment Progress: 54.0% -- 283/519
2018-05-28 14:31:15,257:INFO: Neuralgia Recall-at-100: 0.00%
2018-05-28 14:31:15,257:INFO: Experiment Progress: 54.0% -- 284/519
2018-05-28 14:31:15,801:INFO: Neural Tube Defects Recall-at-100: 0.00%
2018-05-28 14:31:15,801:INFO: Experiment Progress: 54.0% -- 285/519
2018-05-28 14:31:16,704:INFO: Dermatitis, Allergic Contact Recall-at-100: 0.00%
2018-05-28 14:31:16,704:INFO: Experiment Progress: 55.0% -- 286/519
2018-05-28 14:31:17,135:INFO: Inborn Errors of Metabolism Recall-at-100: 10.00%
2018-05-28 14:31:17,136:INFO: Experiment Progress: 55.0% -- 287/519
2018-05-28 14:31:17,699:INFO: Platelet mean volume finding Recall-at-100: 0.00%
2018-05-28 14:31:17,699:INFO: Experiment Progress: 55.0% -- 288/519
2018-05-28 14:31:18,105:INFO: Intestinal Neoplasms Recall-at-100: 55.00%
2018-05-28 14:31:18,105:INFO: Experiment Progress: 55.0% -- 289/519
2018-05-28 14:31:18,485:INFO: Allergic rhinitis (disorder) Recall-at-100: 0.00%
2018-05-28 14:31:18,485:INFO: Experiment Progress: 55.0% -- 290/519
2018-05-28 14:31:19,260:INFO: Blood pressure finding Recall-at-100: 0.00%
2018-05-28 14:31:19,260:INFO: Experiment Progress: 56.0% -- 291/519
2018-05-28 14:31:19,893:INFO: Age related macular degeneration Recall-at-100: 14.17%
2018-05-28 14:31:19,893:INFO: Experiment Progress: 56.0% -- 292/519
2018-05-28 14:31:20,412:INFO: Hyperplasia Recall-at-100: 6.67%
2018-05-28 14:31:20,412:INFO: Experiment Progress: 56.0% -- 293/519
2018-05-28 14:31:20,992:INFO: Pulmonary function (finding) Recall-at-100: 0.00%
2018-05-28 14:31:20,992:INFO: Experiment Progress: 56.0% -- 294/519
2018-05-28 14:31:21,392:INFO: Spina Bifida Recall-at-100: 20.00%
2018-05-28 14:31:21,394:INFO: Experiment Progress: 56.0% -- 295/519
2018-05-28 14:31:21,869:INFO: Hypertrophic Cardiomyopathy Recall-at-100: 8.33%
2018-05-28 14:31:21,869:INFO: Experiment Progress: 57.0% -- 296/519
2018-05-28 14:31:22,351:INFO: Bardet-Biedl Syndrome Recall-at-100: 71.67%
2018-05-28 14:31:22,351:INFO: Experiment Progress: 57.0% -- 297/519
2018-05-28 14:31:22,942:INFO: Keloid Recall-at-100: 18.33%
2018-05-28 14:31:22,942:INFO: Experiment Progress: 57.0% -- 298/519
2018-05-28 14:31:24,988:INFO: melanoma Recall-at-100: 3.13%
2018-05-28 14:31:24,988:INFO: Experiment Progress: 57.0% -- 299/519
2018-05-28 14:31:25,476:INFO: LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3 Recall-at-100: 15.00%
2018-05-28 14:31:25,476:INFO: Experiment Progress: 57.0% -- 300/519
2018-05-28 14:31:26,171:INFO: Pneumonia Recall-at-100: 44.00%
2018-05-28 14:31:26,171:INFO: Experiment Progress: 57.0% -- 301/519
2018-05-28 14:31:27,597:INFO: Disease Progression Recall-at-100: 5.71%
2018-05-28 14:31:27,597:INFO: Experiment Progress: 58.0% -- 302/519
2018-05-28 14:31:28,042:INFO: Nephroblastoma Recall-at-100: 0.00%
2018-05-28 14:31:28,042:INFO: Experiment Progress: 58.0% -- 303/519
2018-05-28 14:31:28,420:INFO: Severe Combined Immunodeficiency Recall-at-100: 30.00%
2018-05-28 14:31:28,420:INFO: Experiment Progress: 58.0% -- 304/519
2018-05-28 14:31:28,821:INFO: Malignant neoplasm of ovary Recall-at-100: 10.00%
2018-05-28 14:31:28,822:INFO: Experiment Progress: 58.0% -- 305/519
2018-05-28 14:31:29,252:INFO: Pheochromocytoma Recall-at-100: 20.00%
2018-05-28 14:31:29,252:INFO: Experiment Progress: 58.0% -- 306/519
2018-05-28 14:31:29,761:INFO: Testicular Germ Cell Tumor Recall-at-100: 0.00%
2018-05-28 14:31:29,762:INFO: Experiment Progress: 59.0% -- 307/519
2018-05-28 14:31:30,196:INFO: Hypogonadism Recall-at-100: 55.00%
2018-05-28 14:31:30,197:INFO: Experiment Progress: 59.0% -- 308/519
2018-05-28 14:31:30,709:INFO: Movement Disorders Recall-at-100: 23.33%
2018-05-28 14:31:30,709:INFO: Experiment Progress: 59.0% -- 309/519
2018-05-28 14:31:31,177:INFO: Sarcoma Recall-at-100: 15.00%
2018-05-28 14:31:31,177:INFO: Experiment Progress: 59.0% -- 310/519
2018-05-28 14:31:31,697:INFO: Lymphatic Metastasis Recall-at-100: 0.00%
2018-05-28 14:31:31,697:INFO: Experiment Progress: 59.0% -- 311/519
2018-05-28 14:31:32,253:INFO: Hypoglycemia Recall-at-100: 30.00%
2018-05-28 14:31:32,254:INFO: Experiment Progress: 60.0% -- 312/519
2018-05-28 14:31:32,961:INFO: Anemia, Sickle Cell Recall-at-100: 0.00%
2018-05-28 14:31:32,962:INFO: Experiment Progress: 60.0% -- 313/519
2018-05-28 14:31:33,729:INFO: Muscular Dystrophy, Facioscapulohumeral Recall-at-100: 0.00%
2018-05-28 14:31:33,729:INFO: Experiment Progress: 60.0% -- 314/519
2018-05-28 14:31:34,476:INFO: Colorectal Cancer Recall-at-100: 6.67%
2018-05-28 14:31:34,476:INFO: Experiment Progress: 60.0% -- 315/519
2018-05-28 14:31:35,644:INFO: Atherosclerosis Recall-at-100: 10.67%
2018-05-28 14:31:35,645:INFO: Experiment Progress: 60.0% -- 316/519
2018-05-28 14:31:37,389:INFO: Asthma Recall-at-100: 2.91%
2018-05-28 14:31:37,390:INFO: Experiment Progress: 61.0% -- 317/519
2018-05-28 14:31:37,930:INFO: Cardiomyopathy, Hypertrophic, Familial Recall-at-100: 38.33%
2018-05-28 14:31:37,931:INFO: Experiment Progress: 61.0% -- 318/519
2018-05-28 14:31:38,673:INFO: Skin Neoplasms Recall-at-100: 14.50%
2018-05-28 14:31:38,673:INFO: Experiment Progress: 61.0% -- 319/519
2018-05-28 14:31:39,819:INFO: Seizures Recall-at-100: 6.44%
2018-05-28 14:31:39,819:INFO: Experiment Progress: 61.0% -- 320/519
2018-05-28 14:31:41,617:INFO: Alzheimer's Disease Recall-at-100: 5.52%
2018-05-28 14:31:41,618:INFO: Experiment Progress: 61.0% -- 321/519
2018-05-28 14:31:42,195:INFO: Menopause present (finding) Recall-at-100: 0.00%
2018-05-28 14:31:42,195:INFO: Experiment Progress: 62.0% -- 322/519
2018-05-28 14:31:43,085:INFO: Neoplastic Syndromes, Hereditary Recall-at-100: 28.50%
2018-05-28 14:31:43,085:INFO: Experiment Progress: 62.0% -- 323/519
2018-05-28 14:31:43,591:INFO: Gastrointestinal Diseases Recall-at-100: 20.00%
2018-05-28 14:31:43,591:INFO: Experiment Progress: 62.0% -- 324/519
2018-05-28 14:31:44,378:INFO: Cytochrome-c Oxidase Deficiency Recall-at-100: 40.00%
2018-05-28 14:31:44,378:INFO: Experiment Progress: 62.0% -- 325/519
2018-05-28 14:31:44,931:INFO: Retinal Degeneration Recall-at-100: 5.00%
2018-05-28 14:31:44,931:INFO: Experiment Progress: 62.0% -- 326/519
2018-05-28 14:31:45,477:INFO: Retinal Diseases Recall-at-100: 8.33%
2018-05-28 14:31:45,478:INFO: Experiment Progress: 63.0% -- 327/519
2018-05-28 14:31:45,941:INFO: Methylmalonic acidemia Recall-at-100: 40.00%
2018-05-28 14:31:45,941:INFO: Experiment Progress: 63.0% -- 328/519
2018-05-28 14:31:47,139:INFO: Contact Dermatitis Recall-at-100: 5.71%
2018-05-28 14:31:47,139:INFO: Experiment Progress: 63.0% -- 329/519
2018-05-28 14:31:47,831:INFO: Dermatitis, Atopic Recall-at-100: 35.00%
2018-05-28 14:31:47,831:INFO: Experiment Progress: 63.0% -- 330/519
2018-05-28 14:31:48,658:INFO: Coronary heart disease Recall-at-100: 5.00%
2018-05-28 14:31:48,658:INFO: Experiment Progress: 63.0% -- 331/519
2018-05-28 14:31:49,555:INFO: Osteoporosis Recall-at-100: 9.29%
2018-05-28 14:31:49,556:INFO: Experiment Progress: 63.0% -- 332/519
2018-05-28 14:31:50,961:INFO: Cardiomegaly Recall-at-100: 15.00%
2018-05-28 14:31:50,961:INFO: Experiment Progress: 64.0% -- 333/519
2018-05-28 14:31:52,577:INFO: Heart failure Recall-at-100: 6.25%
2018-05-28 14:31:52,578:INFO: Experiment Progress: 64.0% -- 334/519
2018-05-28 14:31:53,166:INFO: Hereditary Breast and Ovarian Cancer Syndrome Recall-at-100: 95.00%
2018-05-28 14:31:53,166:INFO: Experiment Progress: 64.0% -- 335/519
2018-05-28 14:31:53,780:INFO: Major Depressive Disorder Recall-at-100: 0.00%
2018-05-28 14:31:53,780:INFO: Experiment Progress: 64.0% -- 336/519
2018-05-28 14:31:54,921:INFO: Dermatologic disorders Recall-at-100: 0.00%
2018-05-28 14:31:54,921:INFO: Experiment Progress: 64.0% -- 337/519
2018-05-28 14:31:56,635:INFO: Inflammation Recall-at-100: 9.27%
2018-05-28 14:31:56,635:INFO: Experiment Progress: 65.0% -- 338/519
2018-05-28 14:31:57,116:INFO: Diabetic Neuropathies Recall-at-100: 25.00%
2018-05-28 14:31:57,116:INFO: Experiment Progress: 65.0% -- 339/519
2018-05-28 14:31:58,011:INFO: Male infertility Recall-at-100: 12.50%
2018-05-28 14:31:58,011:INFO: Experiment Progress: 65.0% -- 340/519
2018-05-28 14:31:58,505:INFO: Vascular Diseases Recall-at-100: 0.00%
2018-05-28 14:31:58,505:INFO: Experiment Progress: 65.0% -- 341/519
2018-05-28 14:31:59,127:INFO: Female infertility Recall-at-100: 35.00%
2018-05-28 14:31:59,127:INFO: Experiment Progress: 65.0% -- 342/519
2018-05-28 14:31:59,829:INFO: leukemia Recall-at-100: 22.50%
2018-05-28 14:31:59,830:INFO: Experiment Progress: 66.0% -- 343/519
2018-05-28 14:32:00,992:INFO: Ulcerative Colitis Recall-at-100: 7.50%
2018-05-28 14:32:00,992:INFO: Experiment Progress: 66.0% -- 344/519
2018-05-28 14:32:01,936:INFO: Influenza Recall-at-100: 20.00%
2018-05-28 14:32:01,936:INFO: Experiment Progress: 66.0% -- 345/519
2018-05-28 14:32:02,315:INFO: Nephritis, Interstitial Recall-at-100: 60.00%
2018-05-28 14:32:02,316:INFO: Experiment Progress: 66.0% -- 346/519
2018-05-28 14:32:02,766:INFO: Sjogren's Syndrome Recall-at-100: 20.00%
2018-05-28 14:32:02,767:INFO: Experiment Progress: 66.0% -- 347/519
2018-05-28 14:32:03,293:INFO: Infant length Recall-at-100: 0.00%
2018-05-28 14:32:03,293:INFO: Experiment Progress: 67.0% -- 348/519
2018-05-28 14:32:04,211:INFO: Child Development Disorders, Pervasive Recall-at-100: 15.67%
2018-05-28 14:32:04,211:INFO: Experiment Progress: 67.0% -- 349/519
2018-05-28 14:32:05,205:INFO: Substance Withdrawal Syndrome Recall-at-100: 23.67%
2018-05-28 14:32:05,205:INFO: Experiment Progress: 67.0% -- 350/519
2018-05-28 14:32:05,682:INFO: Malformations of Cortical Development Recall-at-100: 0.00%
2018-05-28 14:32:05,682:INFO: Experiment Progress: 67.0% -- 351/519
2018-05-28 14:32:07,034:INFO: Amyotrophic Lateral Sclerosis Recall-at-100: 8.10%
2018-05-28 14:32:07,034:INFO: Experiment Progress: 67.0% -- 352/519
2018-05-28 14:32:07,959:INFO: Developmental Disabilities Recall-at-100: 5.00%
2018-05-28 14:32:07,960:INFO: Experiment Progress: 68.0% -- 353/519
2018-05-28 14:32:08,500:INFO: Febrile Convulsions Recall-at-100: 0.00%
2018-05-28 14:32:08,500:INFO: Experiment Progress: 68.0% -- 354/519
2018-05-28 14:32:09,594:INFO: Cholestasis Recall-at-100: 7.50%
2018-05-28 14:32:09,594:INFO: Experiment Progress: 68.0% -- 355/519
2018-05-28 14:32:10,329:INFO: Pulmonary Hypertension Recall-at-100: 0.00%
2018-05-28 14:32:10,329:INFO: Experiment Progress: 68.0% -- 356/519
2018-05-28 14:32:10,974:INFO: Papillary thyroid carcinoma Recall-at-100: 10.00%
2018-05-28 14:32:10,974:INFO: Experiment Progress: 68.0% -- 357/519
2018-05-28 14:32:11,784:INFO: Salivary Gland Neoplasms Recall-at-100: 0.00%
2018-05-28 14:32:11,784:INFO: Experiment Progress: 68.0% -- 358/519
2018-05-28 14:32:12,559:INFO: Non-alcoholic Fatty Liver Disease Recall-at-100: 0.00%
2018-05-28 14:32:12,559:INFO: Experiment Progress: 69.0% -- 359/519
2018-05-28 14:32:13,049:INFO: Hay fever Recall-at-100: 0.00%
2018-05-28 14:32:13,049:INFO: Experiment Progress: 69.0% -- 360/519
2018-05-28 14:32:13,608:INFO: Hypercholesterolemia, Familial Recall-at-100: 55.00%
2018-05-28 14:32:13,608:INFO: Experiment Progress: 69.0% -- 361/519
2018-05-28 14:32:15,333:INFO: Down Syndrome Recall-at-100: 1.11%
2018-05-28 14:32:15,334:INFO: Experiment Progress: 69.0% -- 362/519
2018-05-28 14:32:15,739:INFO: Arrhythmogenic Right Ventricular Dysplasia Recall-at-100: 40.00%
2018-05-28 14:32:15,739:INFO: Experiment Progress: 69.0% -- 363/519
2018-05-28 14:32:16,169:INFO: Semilobar Holoprosencephaly Recall-at-100: 25.00%
2018-05-28 14:32:16,169:INFO: Experiment Progress: 70.0% -- 364/519
2018-05-28 14:32:16,608:INFO: Hypertriglyceridemia Recall-at-100: 20.00%
2018-05-28 14:32:16,608:INFO: Experiment Progress: 70.0% -- 365/519
2018-05-28 14:32:16,967:INFO: Sensorineural Hearing Loss (disorder) Recall-at-100: 22.22%
2018-05-28 14:32:16,967:INFO: Experiment Progress: 70.0% -- 366/519
2018-05-28 14:32:17,707:INFO: Metabolic Syndrome X Recall-at-100: 7.50%
2018-05-28 14:32:17,707:INFO: Experiment Progress: 70.0% -- 367/519
2018-05-28 14:32:18,201:INFO: Malignant neoplasm of lung Recall-at-100: 0.00%
2018-05-28 14:32:18,201:INFO: Experiment Progress: 70.0% -- 368/519
2018-05-28 14:32:19,607:INFO: Leukemia, Myelocytic, Acute Recall-at-100: 5.30%
2018-05-28 14:32:19,607:INFO: Experiment Progress: 71.0% -- 369/519
2018-05-28 14:32:20,588:INFO: Malignant neoplasm of prostate Recall-at-100: 4.76%
2018-05-28 14:32:20,588:INFO: Experiment Progress: 71.0% -- 370/519
2018-05-28 14:32:21,006:INFO: Renal Insufficiency Recall-at-100: 40.00%
2018-05-28 14:32:21,006:INFO: Experiment Progress: 71.0% -- 371/519
2018-05-28 14:32:21,404:INFO: Jeune thoracic dystrophy Recall-at-100: 66.67%
2018-05-28 14:32:21,404:INFO: Experiment Progress: 71.0% -- 372/519
2018-05-28 14:32:22,974:INFO: Renal Cell Carcinoma Recall-at-100: 5.77%
2018-05-28 14:32:22,974:INFO: Experiment Progress: 71.0% -- 373/519
2018-05-28 14:32:23,974:INFO: Squamous cell carcinoma Recall-at-100: 17.22%
2018-05-28 14:32:23,974:INFO: Experiment Progress: 72.0% -- 374/519
2018-05-28 14:32:25,267:INFO: Non-Small Cell Lung Carcinoma Recall-at-100: 7.12%
2018-05-28 14:32:25,267:INFO: Experiment Progress: 72.0% -- 375/519
2018-05-28 14:32:25,670:INFO: Manganese Poisoning Recall-at-100: 20.00%
2018-05-28 14:32:25,670:INFO: Experiment Progress: 72.0% -- 376/519
2018-05-28 14:32:26,105:INFO: Ventricular Dysfunction, Left Recall-at-100: 10.00%
2018-05-28 14:32:26,105:INFO: Experiment Progress: 72.0% -- 377/519
2018-05-28 14:32:26,697:INFO: Carcinoma, Transitional Cell Recall-at-100: 18.33%
2018-05-28 14:32:26,697:INFO: Experiment Progress: 72.0% -- 378/519
2018-05-28 14:32:27,101:INFO: Mucocutaneous Lymph Node Syndrome Recall-at-100: 0.00%
2018-05-28 14:32:27,101:INFO: Experiment Progress: 73.0% -- 379/519
2018-05-28 14:32:27,493:INFO: Tobacco Use Disorder Recall-at-100: 20.00%
2018-05-28 14:32:27,494:INFO: Experiment Progress: 73.0% -- 380/519
2018-05-28 14:32:28,165:INFO: Proteinuria Recall-at-100: 13.33%
2018-05-28 14:32:28,165:INFO: Experiment Progress: 73.0% -- 381/519
2018-05-28 14:32:29,197:INFO: Diabetic Nephropathy Recall-at-100: 0.00%
2018-05-28 14:32:29,198:INFO: Experiment Progress: 73.0% -- 382/519
2018-05-28 14:32:29,620:INFO: Williams Syndrome Recall-at-100: 10.00%
2018-05-28 14:32:29,620:INFO: Experiment Progress: 73.0% -- 383/519
2018-05-28 14:32:30,348:INFO: Oral Submucous Fibrosis Recall-at-100: 50.00%
2018-05-28 14:32:30,348:INFO: Experiment Progress: 73.0% -- 384/519
2018-05-28 14:32:30,937:INFO: Adenoma Recall-at-100: 6.67%
2018-05-28 14:32:30,937:INFO: Experiment Progress: 74.0% -- 385/519
2018-05-28 14:32:31,360:INFO: Neutropenia Recall-at-100: 10.00%
2018-05-28 14:32:31,360:INFO: Experiment Progress: 74.0% -- 386/519
2018-05-28 14:32:31,824:INFO: Poor school performance Recall-at-100: 0.00%
2018-05-28 14:32:31,825:INFO: Experiment Progress: 74.0% -- 387/519
2018-05-28 14:32:32,311:INFO: Pneumoconiosis Recall-at-100: 0.00%
2018-05-28 14:32:32,312:INFO: Experiment Progress: 74.0% -- 388/519
2018-05-28 14:32:33,206:INFO: Cardiovascular Diseases Recall-at-100: 12.00%
2018-05-28 14:32:33,206:INFO: Experiment Progress: 74.0% -- 389/519
2018-05-28 14:32:33,820:INFO: Fibrinogen Adverse Event Recall-at-100: 10.00%
2018-05-28 14:32:33,820:INFO: Experiment Progress: 75.0% -- 390/519
2018-05-28 14:32:35,728:INFO: Diabetes Mellitus, Non-Insulin-Dependent Recall-at-100: 6.46%
2018-05-28 14:32:35,728:INFO: Experiment Progress: 75.0% -- 391/519
2018-05-28 14:32:36,217:INFO: Thrombocytopenia Recall-at-100: 15.00%
2018-05-28 14:32:36,217:INFO: Experiment Progress: 75.0% -- 392/519
2018-05-28 14:32:36,758:INFO: Sezary Syndrome Recall-at-100: 25.00%
2018-05-28 14:32:36,758:INFO: Experiment Progress: 75.0% -- 393/519
2018-05-28 14:32:37,140:INFO: Nuclear non-senile cataract Recall-at-100: 50.00%
2018-05-28 14:32:37,140:INFO: Experiment Progress: 75.0% -- 394/519
2018-05-28 14:32:37,606:INFO: Diabetic Retinopathy Recall-at-100: 0.00%
2018-05-28 14:32:37,606:INFO: Experiment Progress: 76.0% -- 395/519
2018-05-28 14:32:38,374:INFO: hearing impairment Recall-at-100: 0.00%
2018-05-28 14:32:38,374:INFO: Experiment Progress: 76.0% -- 396/519
2018-05-28 14:32:38,838:INFO: Psychotic Disorders Recall-at-100: 25.00%
2018-05-28 14:32:38,839:INFO: Experiment Progress: 76.0% -- 397/519
2018-05-28 14:32:39,415:INFO: Anxiety Disorders Recall-at-100: 8.33%
2018-05-28 14:32:39,415:INFO: Experiment Progress: 76.0% -- 398/519
2018-05-28 14:32:39,833:INFO: Finding of Mean Corpuscular Hemoglobin Recall-at-100: 15.00%
2018-05-28 14:32:39,833:INFO: Experiment Progress: 76.0% -- 399/519
2018-05-28 14:32:40,246:INFO: Motion Sickness Recall-at-100: 0.00%
2018-05-28 14:32:40,246:INFO: Experiment Progress: 77.0% -- 400/519
2018-05-28 14:32:40,732:INFO: Lymphoma, Non-Hodgkin Recall-at-100: 28.33%
2018-05-28 14:32:40,733:INFO: Experiment Progress: 77.0% -- 401/519
2018-05-28 14:32:41,227:INFO: Lymphoma, Follicular Recall-at-100: 5.00%
2018-05-28 14:32:41,227:INFO: Experiment Progress: 77.0% -- 402/519
2018-05-28 14:32:41,644:INFO: Thrombocythemia, Essential Recall-at-100: 25.00%
2018-05-28 14:32:41,644:INFO: Experiment Progress: 77.0% -- 403/519
2018-05-28 14:32:41,973:INFO: Arthritis Recall-at-100: 0.00%
2018-05-28 14:32:41,973:INFO: Experiment Progress: 77.0% -- 404/519
2018-05-28 14:32:42,698:INFO: Hypotension Recall-at-100: 28.33%
2018-05-28 14:32:42,698:INFO: Experiment Progress: 78.0% -- 405/519
2018-05-28 14:32:43,695:INFO: Reperfusion Injury Recall-at-100: 15.14%
2018-05-28 14:32:43,695:INFO: Experiment Progress: 78.0% -- 406/519
2018-05-28 14:32:44,115:INFO: Heat Stroke Recall-at-100: 70.00%
2018-05-28 14:32:44,115:INFO: Experiment Progress: 78.0% -- 407/519
2018-05-28 14:32:44,609:INFO: Hemangiosarcoma Recall-at-100: 55.00%
2018-05-28 14:32:44,609:INFO: Experiment Progress: 78.0% -- 408/519
2018-05-28 14:32:45,684:INFO: Drug Allergy Recall-at-100: 11.67%
2018-05-28 14:32:45,684:INFO: Experiment Progress: 78.0% -- 409/519
2018-05-28 14:32:46,101:INFO: SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR Recall-at-100: 25.00%
2018-05-28 14:32:46,101:INFO: Experiment Progress: 78.0% -- 410/519
2018-05-28 14:32:47,040:INFO: Medulloblastoma Recall-at-100: 9.50%
2018-05-28 14:32:47,040:INFO: Experiment Progress: 79.0% -- 411/519
2018-05-28 14:32:47,645:INFO: Cleft Lip Recall-at-100: 50.00%
2018-05-28 14:32:47,646:INFO: Experiment Progress: 79.0% -- 412/519
2018-05-28 14:32:48,347:INFO: Cleft Palate Recall-at-100: 22.50%
2018-05-28 14:32:48,347:INFO: Experiment Progress: 79.0% -- 413/519
2018-05-28 14:32:49,568:INFO: Muscle Weakness Recall-at-100: 0.00%
2018-05-28 14:32:49,568:INFO: Experiment Progress: 79.0% -- 414/519
2018-05-28 14:32:49,994:INFO: Mental disorders Recall-at-100: 10.00%
2018-05-28 14:32:49,995:INFO: Experiment Progress: 79.0% -- 415/519
2018-05-28 14:32:50,520:INFO: Astrocytoma Recall-at-100: 36.67%
2018-05-28 14:32:50,520:INFO: Experiment Progress: 80.0% -- 416/519
2018-05-28 14:32:50,939:INFO: Anemia, Diamond-Blackfan Recall-at-100: 85.00%
2018-05-28 14:32:50,939:INFO: Experiment Progress: 80.0% -- 417/519
2018-05-28 14:32:51,401:INFO: Asthma, Aspirin-Induced Recall-at-100: 20.00%
2018-05-28 14:32:51,401:INFO: Experiment Progress: 80.0% -- 418/519
2018-05-28 14:32:51,927:INFO: Leber Congenital Amaurosis Recall-at-100: 10.00%
2018-05-28 14:32:51,927:INFO: Experiment Progress: 80.0% -- 419/519
2018-05-28 14:32:52,294:INFO: Cachexia Recall-at-100: 0.00%
2018-05-28 14:32:52,294:INFO: Experiment Progress: 80.0% -- 420/519
2018-05-28 14:32:52,671:INFO: Respiratory Insufficiency Recall-at-100: 0.00%
2018-05-28 14:32:52,671:INFO: Experiment Progress: 81.0% -- 421/519
2018-05-28 14:32:53,161:INFO: Respiratory Hypersensitivity Recall-at-100: 10.00%
2018-05-28 14:32:53,161:INFO: Experiment Progress: 81.0% -- 422/519
2018-05-28 14:32:53,715:INFO: Nasopharyngeal carcinoma Recall-at-100: 10.00%
2018-05-28 14:32:53,715:INFO: Experiment Progress: 81.0% -- 423/519
2018-05-28 14:32:54,710:INFO: Hyperalgesia Recall-at-100: 20.00%
2018-05-28 14:32:54,711:INFO: Experiment Progress: 81.0% -- 424/519
2018-05-28 14:32:55,218:INFO: Meningioma Recall-at-100: 35.00%
2018-05-28 14:32:55,218:INFO: Experiment Progress: 81.0% -- 425/519
2018-05-28 14:32:55,681:INFO: Sudden Cardiac Arrest Recall-at-100: 0.00%
2018-05-28 14:32:55,681:INFO: Experiment Progress: 82.0% -- 426/519
2018-05-28 14:32:57,226:INFO: Intellectual Disability Recall-at-100: 0.77%
2018-05-28 14:32:57,226:INFO: Experiment Progress: 82.0% -- 427/519
2018-05-28 14:32:57,642:INFO: Graves Disease Recall-at-100: 10.00%
2018-05-28 14:32:57,642:INFO: Experiment Progress: 82.0% -- 428/519
2018-05-28 14:32:58,231:INFO: Neurotoxicity Syndromes Recall-at-100: 0.00%
2018-05-28 14:32:58,231:INFO: Experiment Progress: 82.0% -- 429/519
2018-05-28 14:32:58,663:INFO: Cardiomyopathy, Familial Hypertrophic, 1 (disorder) Recall-at-100: 70.00%
2018-05-28 14:32:58,663:INFO: Experiment Progress: 82.0% -- 430/519
2018-05-28 14:32:59,501:INFO: Atrial Fibrillation Recall-at-100: 8.33%
2018-05-28 14:32:59,502:INFO: Experiment Progress: 83.0% -- 431/519
2018-05-28 14:33:00,043:INFO: Hepatitis, Chronic Recall-at-100: 28.33%
2018-05-28 14:33:00,044:INFO: Experiment Progress: 83.0% -- 432/519
2018-05-28 14:33:00,627:INFO: Behcet Syndrome Recall-at-100: 16.67%
2018-05-28 14:33:00,627:INFO: Experiment Progress: 83.0% -- 433/519
2018-05-28 14:33:01,659:INFO: Diabetes Mellitus, Insulin-Dependent Recall-at-100: 5.71%
2018-05-28 14:33:01,659:INFO: Experiment Progress: 83.0% -- 434/519
2018-05-28 14:33:03,268:INFO: Diabetes Mellitus, Experimental Recall-at-100: 8.55%
2018-05-28 14:33:03,269:INFO: Experiment Progress: 83.0% -- 435/519
2018-05-28 14:33:03,964:INFO: Parkinsonian Disorders Recall-at-100: 21.67%
2018-05-28 14:33:03,965:INFO: Experiment Progress: 84.0% -- 436/519
2018-05-28 14:33:04,747:INFO: Necrosis Recall-at-100: 12.00%
2018-05-28 14:33:04,747:INFO: Experiment Progress: 84.0% -- 437/519
2018-05-28 14:33:05,152:INFO: Gestational Diabetes Recall-at-100: 0.00%
2018-05-28 14:33:05,152:INFO: Experiment Progress: 84.0% -- 438/519
2018-05-28 14:33:05,601:INFO: Idiopathic Membranous Glomerulonephritis Recall-at-100: 0.00%
2018-05-28 14:33:05,601:INFO: Experiment Progress: 84.0% -- 439/519
2018-05-28 14:33:06,455:INFO: Hypersensitivity Recall-at-100: 32.14%
2018-05-28 14:33:06,456:INFO: Experiment Progress: 84.0% -- 440/519
2018-05-28 14:33:07,002:INFO: Myopia Recall-at-100: 3.33%
2018-05-28 14:33:07,002:INFO: Experiment Progress: 84.0% -- 441/519
2018-05-28 14:33:07,395:INFO: Hyperemia Recall-at-100: 20.00%
2018-05-28 14:33:07,396:INFO: Experiment Progress: 85.0% -- 442/519
2018-05-28 14:33:07,761:INFO: Tooth Abnormalities Recall-at-100: 10.00%
2018-05-28 14:33:07,761:INFO: Experiment Progress: 85.0% -- 443/519
2018-05-28 14:33:08,225:INFO: Hyperglycemia Recall-at-100: 10.00%
2018-05-28 14:33:08,225:INFO: Experiment Progress: 85.0% -- 444/519
2018-05-28 14:33:08,670:INFO: Noonan Syndrome Recall-at-100: 70.00%
2018-05-28 14:33:08,670:INFO: Experiment Progress: 85.0% -- 445/519
2018-05-28 14:33:09,089:INFO: Hyperinsulinism Recall-at-100: 25.00%
2018-05-28 14:33:09,089:INFO: Experiment Progress: 85.0% -- 446/519
2018-05-28 14:33:09,592:INFO: Edema Recall-at-100: 16.67%
2018-05-28 14:33:09,593:INFO: Experiment Progress: 86.0% -- 447/519
2018-05-28 14:33:10,034:INFO: Hodgkin Disease Recall-at-100: 0.00%
2018-05-28 14:33:10,034:INFO: Experiment Progress: 86.0% -- 448/519
2018-05-28 14:33:10,428:INFO: Metabolic Bone Disorder Recall-at-100: 0.00%
2018-05-28 14:33:10,428:INFO: Experiment Progress: 86.0% -- 449/519
2018-05-28 14:33:10,937:INFO: Bone Diseases, Developmental Recall-at-100: 0.00%
2018-05-28 14:33:10,938:INFO: Experiment Progress: 86.0% -- 450/519
2018-05-28 14:33:11,330:INFO: Tachycardia, Ventricular Recall-at-100: 10.00%
2018-05-28 14:33:11,330:INFO: Experiment Progress: 86.0% -- 451/519
2018-05-28 14:33:11,745:INFO: Dystonia Recall-at-100: 0.00%
2018-05-28 14:33:11,745:INFO: Experiment Progress: 87.0% -- 452/519
2018-05-28 14:33:12,264:INFO: Squamous cell carcinoma of the head and neck Recall-at-100: 13.33%
2018-05-28 14:33:12,264:INFO: Experiment Progress: 87.0% -- 453/519
2018-05-28 14:33:12,635:INFO: Pulmonary Embolism Recall-at-100: 35.00%
2018-05-28 14:33:12,635:INFO: Experiment Progress: 87.0% -- 454/519
2018-05-28 14:33:13,331:INFO: Pulmonary Fibrosis Recall-at-100: 35.00%
2018-05-28 14:33:13,331:INFO: Experiment Progress: 87.0% -- 455/519
2018-05-28 14:33:13,752:INFO: West Syndrome Recall-at-100: 0.00%
2018-05-28 14:33:13,753:INFO: Experiment Progress: 87.0% -- 456/519
2018-05-28 14:33:14,280:INFO: Cerebral Hemorrhage Recall-at-100: 53.33%
2018-05-28 14:33:14,280:INFO: Experiment Progress: 88.0% -- 457/519
2018-05-28 14:33:14,706:INFO: Romano-Ward Syndrome Recall-at-100: 45.00%
2018-05-28 14:33:14,706:INFO: Experiment Progress: 88.0% -- 458/519
2018-05-28 14:33:15,385:INFO: Mouth Neoplasms Recall-at-100: 17.00%
2018-05-28 14:33:15,385:INFO: Experiment Progress: 88.0% -- 459/519
2018-05-28 14:33:16,143:INFO: Liver Cirrhosis Recall-at-100: 21.33%
2018-05-28 14:33:16,143:INFO: Experiment Progress: 88.0% -- 460/519
2018-05-28 14:33:16,656:INFO: Neoplasm Recurrence, Local Recall-at-100: 13.33%
2018-05-28 14:33:16,656:INFO: Experiment Progress: 88.0% -- 461/519
2018-05-28 14:33:19,269:INFO: Obesity Recall-at-100: 3.51%
2018-05-28 14:33:19,269:INFO: Experiment Progress: 89.0% -- 462/519
2018-05-28 14:33:19,859:INFO: Biliary cirrhosis Recall-at-100: 15.00%
2018-05-28 14:33:19,860:INFO: Experiment Progress: 89.0% -- 463/519
2018-05-28 14:33:20,531:INFO: Precursor Cell Lymphoblastic Leukemia Lymphoma Recall-at-100: 12.00%
2018-05-28 14:33:20,531:INFO: Experiment Progress: 89.0% -- 464/519
2018-05-28 14:33:21,619:INFO: Cardiomyopathies Recall-at-100: 7.78%
2018-05-28 14:33:21,619:INFO: Experiment Progress: 89.0% -- 465/519
2018-05-28 14:33:21,996:INFO: Peroxisome biogenesis disorders Recall-at-100: 100.00%
2018-05-28 14:33:21,996:INFO: Experiment Progress: 89.0% -- 466/519
2018-05-28 14:33:22,399:INFO: Dyskeratosis Congenita Recall-at-100: 55.00%
2018-05-28 14:33:22,399:INFO: Experiment Progress: 89.0% -- 467/519
2018-05-28 14:33:22,840:INFO: Uremia Recall-at-100: 15.00%
2018-05-28 14:33:22,840:INFO: Experiment Progress: 90.0% -- 468/519
2018-05-28 14:33:23,458:INFO: Depressive disorder Recall-at-100: 6.67%
2018-05-28 14:33:23,458:INFO: Experiment Progress: 90.0% -- 469/519
2018-05-28 14:33:24,081:INFO: Thrombosis Recall-at-100: 40.00%
2018-05-28 14:33:24,081:INFO: Experiment Progress: 90.0% -- 470/519
2018-05-28 14:33:24,834:INFO: nervous system disorder Recall-at-100: 5.67%
2018-05-28 14:33:24,835:INFO: Experiment Progress: 90.0% -- 471/519
2018-05-28 14:33:25,305:INFO: Lymphoma Recall-at-100: 0.00%
2018-05-28 14:33:25,305:INFO: Experiment Progress: 90.0% -- 472/519
2018-05-28 14:33:29,553:INFO: IGA Glomerulonephritis Recall-at-100: 1.40%
2018-05-28 14:33:29,553:INFO: Experiment Progress: 91.0% -- 473/519
2018-05-28 14:33:30,102:INFO: Kidney Neoplasm Recall-at-100: 16.67%
2018-05-28 14:33:30,102:INFO: Experiment Progress: 91.0% -- 474/519
2018-05-28 14:33:30,493:INFO: Hypothermia, natural Recall-at-100: 25.00%
2018-05-28 14:33:30,493:INFO: Experiment Progress: 91.0% -- 475/519
2018-05-28 14:33:30,989:INFO: Focal glomerulosclerosis Recall-at-100: 21.67%
2018-05-28 14:33:30,989:INFO: Experiment Progress: 91.0% -- 476/519
2018-05-28 14:33:31,401:INFO: Hepatitis B, Chronic Recall-at-100: 0.00%
2018-05-28 14:33:31,401:INFO: Experiment Progress: 91.0% -- 477/519
2018-05-28 14:33:31,827:INFO: Drug Eruptions Recall-at-100: 0.00%
2018-05-28 14:33:31,827:INFO: Experiment Progress: 92.0% -- 478/519
2018-05-28 14:33:32,237:INFO: Malignant neoplasm of pancreas Recall-at-100: 0.00%
2018-05-28 14:33:32,237:INFO: Experiment Progress: 92.0% -- 479/519
2018-05-28 14:33:34,983:INFO: Stomach Neoplasms Recall-at-100: 3.88%
2018-05-28 14:33:34,983:INFO: Experiment Progress: 92.0% -- 480/519
2018-05-28 14:33:35,592:INFO: Osteosarcoma Recall-at-100: 14.17%
2018-05-28 14:33:35,592:INFO: Experiment Progress: 92.0% -- 481/519
2018-05-28 14:33:36,172:INFO: Vitiligo Recall-at-100: 6.67%
2018-05-28 14:33:36,172:INFO: Experiment Progress: 92.0% -- 482/519
2018-05-28 14:33:36,622:INFO: Gastric ulcer Recall-at-100: 0.00%
2018-05-28 14:33:36,622:INFO: Experiment Progress: 93.0% -- 483/519
2018-05-28 14:33:37,509:INFO: Malignant neoplasm of breast Recall-at-100: 9.76%
2018-05-28 14:33:37,509:INFO: Experiment Progress: 93.0% -- 484/519
2018-05-28 14:33:38,807:INFO: Drug-Induced Liver Injury Recall-at-100: 9.24%
2018-05-28 14:33:38,807:INFO: Experiment Progress: 93.0% -- 485/519
2018-05-28 14:33:39,432:INFO: Colitis Recall-at-100: 6.67%
2018-05-28 14:33:39,432:INFO: Experiment Progress: 93.0% -- 486/519
2018-05-28 14:33:39,928:INFO: Lymphoma, T-Cell, Cutaneous Recall-at-100: 5.00%
2018-05-28 14:33:39,928:INFO: Experiment Progress: 93.0% -- 487/519
2018-05-28 14:33:40,331:INFO: T-Cell Lymphoma Recall-at-100: 40.00%
2018-05-28 14:33:40,331:INFO: Experiment Progress: 94.0% -- 488/519
2018-05-28 14:33:40,872:INFO: Hyperactive behavior Recall-at-100: 26.67%
2018-05-28 14:33:40,873:INFO: Experiment Progress: 94.0% -- 489/519
2018-05-28 14:33:41,249:INFO: Skin Abnormalities Recall-at-100: 0.00%
2018-05-28 14:33:41,249:INFO: Experiment Progress: 94.0% -- 490/519
2018-05-28 14:33:41,713:INFO: Epithelial ovarian cancer Recall-at-100: 0.00%
2018-05-28 14:33:41,714:INFO: Experiment Progress: 94.0% -- 491/519
2018-05-28 14:33:42,107:INFO: Infantile Refsum Disease (disorder) Recall-at-100: 100.00%
2018-05-28 14:33:42,107:INFO: Experiment Progress: 94.0% -- 492/519
2018-05-28 14:33:42,488:INFO: Adrenoleukodystrophy, Neonatal Recall-at-100: 100.00%
2018-05-28 14:33:42,488:INFO: Experiment Progress: 94.0% -- 493/519
2018-05-28 14:33:42,841:INFO: Hirschsprung Disease Recall-at-100: 30.00%
2018-05-28 14:33:42,841:INFO: Experiment Progress: 95.0% -- 494/519
2018-05-28 14:33:43,288:INFO: Female Urogenital Diseases Recall-at-100: 10.00%
2018-05-28 14:33:43,288:INFO: Experiment Progress: 95.0% -- 495/519
2018-05-28 14:33:44,462:INFO: ovarian neoplasm Recall-at-100: 12.33%
2018-05-28 14:33:44,462:INFO: Experiment Progress: 95.0% -- 496/519
2018-05-28 14:33:44,860:INFO: Aortic Aneurysm, Abdominal Recall-at-100: 15.00%
2018-05-28 14:33:44,860:INFO: Experiment Progress: 95.0% -- 497/519
2018-05-28 14:33:45,318:INFO: Venous Thrombosis Recall-at-100: 75.00%
2018-05-28 14:33:45,319:INFO: Experiment Progress: 95.0% -- 498/519
2018-05-28 14:33:45,760:INFO: Amnesia Recall-at-100: 20.00%
2018-05-28 14:33:45,760:INFO: Experiment Progress: 96.0% -- 499/519
2018-05-28 14:33:46,979:INFO: Bladder Neoplasm Recall-at-100: 9.55%
2018-05-28 14:33:46,979:INFO: Experiment Progress: 96.0% -- 500/519
2018-05-28 14:33:47,411:INFO: Hemorrhage Recall-at-100: 15.00%
2018-05-28 14:33:47,411:INFO: Experiment Progress: 96.0% -- 501/519
2018-05-28 14:33:48,272:INFO: Status Epilepticus Recall-at-100: 25.71%
2018-05-28 14:33:48,272:INFO: Experiment Progress: 96.0% -- 502/519
2018-05-28 14:33:48,763:INFO: Chronic Kidney Diseases Recall-at-100: 0.00%
2018-05-28 14:33:48,763:INFO: Experiment Progress: 96.0% -- 503/519
2018-05-28 14:33:49,279:INFO: Myeloid Leukemia, Chronic Recall-at-100: 26.67%
2018-05-28 14:33:49,279:INFO: Experiment Progress: 97.0% -- 504/519
2018-05-28 14:33:49,716:INFO: Myeloid Leukemia Recall-at-100: 35.00%
2018-05-28 14:33:49,717:INFO: Experiment Progress: 97.0% -- 505/519
2018-05-28 14:33:50,350:INFO: Calcinosis Recall-at-100: 12.50%
2018-05-28 14:33:50,351:INFO: Experiment Progress: 97.0% -- 506/519
2018-05-28 14:33:50,773:INFO: Creutzfeldt-Jakob disease Recall-at-100: 0.00%
2018-05-28 14:33:50,773:INFO: Experiment Progress: 97.0% -- 507/519
2018-05-28 14:33:51,187:INFO: Left ventricular noncompaction Recall-at-100: 10.00%
2018-05-28 14:33:51,187:INFO: Experiment Progress: 97.0% -- 508/519
2018-05-28 14:33:52,311:INFO: Parkinson Disease Recall-at-100: 4.22%
2018-05-28 14:33:52,312:INFO: Experiment Progress: 98.0% -- 509/519
2018-05-28 14:33:53,071:INFO: Endometrial Neoplasms Recall-at-100: 12.00%
2018-05-28 14:33:53,071:INFO: Experiment Progress: 98.0% -- 510/519
2018-05-28 14:33:53,559:INFO: Sepsis Recall-at-100: 20.00%
2018-05-28 14:33:53,559:INFO: Experiment Progress: 98.0% -- 511/519
2018-05-28 14:33:55,243:INFO: Endometriosis Recall-at-100: 14.42%
2018-05-28 14:33:55,243:INFO: Experiment Progress: 98.0% -- 512/519
2018-05-28 14:33:56,125:INFO: Esophageal Neoplasms Recall-at-100: 8.81%
2018-05-28 14:33:56,125:INFO: Experiment Progress: 98.0% -- 513/519
2018-05-28 14:33:56,566:INFO: Eosinophilic esophagitis Recall-at-100: 0.00%
2018-05-28 14:33:56,566:INFO: Experiment Progress: 99.0% -- 514/519
2018-05-28 14:33:57,014:INFO: Malignant neoplasm of urinary bladder Recall-at-100: 15.00%
2018-05-28 14:33:57,014:INFO: Experiment Progress: 99.0% -- 515/519
2018-05-28 14:33:57,477:INFO: Lewy Body Disease Recall-at-100: 30.00%
2018-05-28 14:33:57,477:INFO: Experiment Progress: 99.0% -- 516/519
2018-05-28 14:33:57,901:INFO: PARKINSON DISEASE, LATE-ONSET Recall-at-100: 10.00%
2018-05-28 14:33:57,901:INFO: Experiment Progress: 99.0% -- 517/519
2018-05-28 14:33:58,901:INFO: Neoplastic Cell Transformation Recall-at-100: 14.44%
2018-05-28 14:33:58,902:INFO: Experiment Progress: 99.0% -- 518/519
2018-05-28 14:33:59,722:INFO: Arsenic Poisoning Recall-at-100: 1.67%
